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Asbestos is a naturally occurring fibrous silicate mineral which has
extensive industrial and domestic application. Exposure to asbestos is associated
with pulmonary fibrosis and lung cancer. In addition, the pleura is also a major
target for the harmful effects of asbestos exposure which include pleural plaques,
pleural fibrosis and pleural mesothelioma. These pleural pathological changes
severely affect the normal pleural functions. However, in spite of its importance,
few studies have addressed the process of fibre-related pleural pathology. The aim
of the present study was to assess the pleural response, in particular, the pleural
leukocyte response to asbestos fibres following their deposition in the
bronchoalveolar space using a rat intratracheal instillation model.
In an attempt to investigate whether asbestos or other particles deposited
in the lung could reach the pleural space, a number of approaches were taken:
1). intratracheal instillation of fluorescent beads, which could be easily visualised,
alone or in combination with heat-killed C.parvum organism causing
inflammation; 2). intratracheally instilled asbestos and 3). inhaled asbestos. A
combination of light, fluorescent and transmission electron microscopes were then
used to assess the transfer of fibres or particles to the pleural space. No evidence
could be found for the transfer of any particles or fibres to the pleural space
under any conditions.
Normal pleural leukocytes were found to be comprised of macrophages,
mast cells, eosinophils and lymphocytes and this population was confirmed to
produce urokinase-type plasminogen activator inhibitor (PAI) in vitro and to
contain plasminogen activator (PA) intracellularly. Normal pleural leukocytes also
released tumour necrosis factor (TNF) and interleukin-1 (IL-1) in culture and the
release was enhanced further with LPS stimulation.
After intratracheal instillation (I/T) of crocidolite asbestos, pleural leukocyte
components were changed as from 3 days after instillation, by a significant
recruitment of macrophages and eosinophils. These populations were found to
release increased PAI activity and decreased TNF activity in a dose-related
manner to the quantity of asbestos instilled; no time-dependent effect was
observed. In contrast, I/T asbestos coupled with mineral dusts, titanium dioxide
(TiO 2) or quartz, considerably increased TNF production by pleural leukocytes.
The elaboration of IL-1 by the leukocytes showed an inverse relationship to
asbestos up to 14 days, but was dramatically increased by one month after
instillation compared to control.
During the early stage of pleural inflammation caused by C.parvum
organisms, the pleural leukocytes which contain a substantial neutrophil infiltrate
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produced increased PAI activity, but decreased TNF and IL-1 release. By 5 days
after 1/T C.parvum, the pleural leukocytes with a predominant newly- recruited
macrophage population, released even less TNF and IL-1, whereas PAI production
by the cells recovered to control level.
Studies on the normal pleural lavage fluid indicated that components of the
fluid inhibited both TNF and IL-1 activity, which imply a suppressive environment
in the pleural space. However, pleural lavage from rats one month after I/T
asbestos was shown to stimulate the proliferation of mesothelial cells in vitro.
In comparison with pleural leukocytes, after I/T asbestos, bronchoalveolar
leukocytes produced increased TNF and IL-1 activity in vitro in an asbestos
dose-related manner. However, IL-1 production by the alveolar leukocytes showed
a transient reduction over control level.
The investigation on interaction of pleural leukocytes and pleural
mesothelial cells showed that the pleural leukocytes one day after I/T asbestos
caused mesothelial cell detachment injury in vitro, whereas the cells from rats
longer term after instillation showed no such effect. The leukocytes from
C.parvum- induced inflamed pleura also caused mesothelial cell detachment injury
during the acute phase of inflammation.
In in vitro studies, long fibre amosite was demonstrated to have more
ability to stimulate TNF and IL-1 production by alveolar macrophages than short
fibre amosite or TiOz. Immunoglobulin G dramatically enhanced the ability of
dusts to stimulate TNF production by the macrophages.
To sum up we have demonstrated, that I/T asbestos causes the following
pleural leukocyte changes: 1). long standing recruitment of macrophages; 2).
increased PAI secretion; 3). decreased production of TNF but enhanced release of
TNF when the fibre and particles are in combination; 4). first decreased then
increased IL-1 elaboration; 5). causing transient mesothelial cell detachment in
vitro. All of these changes occur in the apparent absence of transfer of fibres to
the pleural space. These observations may help to elucidate the pathogenesis of
some pleural disorders caused by exposure to fibrous dusts.
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1.1. Asbestos history and application
The term asbestos refers to a family of naturally occurring, flexible, fibrous,
hydrous silicate crystalline minerals with a high length-to-thickness ratio
(Craighead et al, 1982; Michaels and Chissick, 1979).
Asbestos has been known and used in small amounts for thousands of years,
but it was not widely used prior to the latter part of the 19th Century (Wright,
1969). World-wide consumption of asbestos during the past 80 years has increased
by at least 1000-fold (Buchanan, 1979).
Because of its heat- and fire-resistant properties, as well as its high
tensible strength and flexibility, asbestos finds its greatest use in industry. Some
3000 uses for asbestos have been recorded (Rosato, 1959), mainly in the
construction industry (about two thirds of the total) (Michaels and Chissick, 1979).
These include flat sheets or sidings and corrugated sheets for roofing, rain-water
pipes and pressure pipes (Hodgson, 1979).
Second only to its use in building materials, asbestos has a large range of
applications, in conjunction with organic resins and similar matrices, such as brake
linings and clutch facings. Packings, gaskets, asbestos papers and millboards,
spray insulation and electrically resistant reinforced plastics are further examples
of the varied applications of asbestos (Hodgson, 1979).
1.2. Asbestos chemistry
Six species of asbestiform minerals are known, these being derived from
two large groups of rock-forming minerals, the serpentines and the amphiboles.
Chrysotile is the sole species classified in the serpentine group, but it is by far
the most abundant kind of asbestos. The amphibole group includes the following
asbestiform types: crocidolite, amosite, anthophyllite, tremolite, and actinolite. The
mineralogical classification and chemical composition of common commercial
asbestos is shown in Figure 1.1 (Michaels and Chissick, 1979).
These four main types of asbestos are chemically different: 1. chrysotile or
white asbestos, which occurs as fine silky flexible white fibres and is mined
mainly in Canada, Russia and Rhodesia; 2. amosite, a straight brittle fibre, light
grey to pale brown in colour and found in South Africa; 3. crocidolite or blue
asbestos, a straight blue fibre which is found in South Africa, Western Australia,
and Bolivia; and 4. anthophyllite, a brittle white fibre mined in Finland and
Africa. Other types of asbestos included in the amphibole group are tremolite
[Ca2Mg5Sig022-(OFI)2] and actinolite [Ca0.3(MgFe)0.4Si02] (Michaels and
Chissick, 1979; Zussman, 1979).
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Chemically, the commercial asbestos minerals are all hydrous silicates. The
chemical constitution of the asbestos minerals and their apparent complexities are
crystal structures. Chrysotile has a predominant surface of hydroxyl sites connected
to an adjacent inner layer of magnesium sites (Hodgson, 1979). In serpentine
minerals, the magnesium hydroxide layer has slightly larger dimensions than the
silicate (linked SiC>4) layer, resulting in a mis-match, which is resolved in
chrysotile into a curvilinear structure of a scroll or coil form. The basic subunit
of the amphiboles is a silicon dioxide tetrahedron arranged in parallel chains and
linked laterally by various cations (Hodgson, 1979). Amphiboles differ only in the
















In the electron microscope, chrysotile asbestos has a characteristic
appearance, usually as long, thin, curved fibrils. The fine structure of crystalline
amphiboles is repeated on a superfine scale in fibrous amphiboles and the
cross-section of a fibre bundle has been shown structures skin to the basal
cleavage lines in the crystal form (Zussman, 1979; Craighead and Mossman,
1982).
1.3. Asbestos properties
The properties of asbestos include chemical resistance, particularly to acids,
fire resistance, tensile strength, and good friction and wear characteristics. Asbestos
readily lends itself to a variety of manufacturing processes on account of its wet
strength, ease of formation of slurries with water, and good drying characteristics
(Michaels and Chissick, 1979; Zussman, 1979).
In view of elemental composition, chrysotile and the amphiboles have
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totally different surface properties. Presumably because of the high surface
concentrations of magnesium hydroxide, chrysotile fibres exhibit a strong positive
surface charge. Amphiboles, by contrast, have a weakly acidic nature and possess
a slightly negative surface charge because of cations linked laterally on the fibre
surface (Hodgson et al, 1979; Craighead and Mossman, 1982).
The various properties of chrysotile and amphibole fibres determine their
uses in industry, and in certain respects, may be responsible for their apparently
different behaviour in the lungs and in their pathogenic potential (Parkes, 1973).
Due to its high flexibility, chrysotile asbestos lends itself mostly to incorporation
into textiles (Parkes, 1973). Crocidolite is the strongest of the asbestos fibres and
its high mechanical strength combined with its acid resistance makes it a valuable
industrial material. The characteristic features of amosite are resistance to
corrosion, the springiness of the fibres and so it is widely used for heat insulation
applications. Anthophyllite finds use as an expansive filler and in specialised
applications on account of its good heat and chemical resistance (Michaels and
Chissick, 1979).
Asbestos does not cause a hazard if the fibres are firmly bonded together
and incorporated into structures such as asbestos -cement sheets, or into various
composite materials. However, because the material is relatively uncontained during
the manipulation of asbestos products, high dust levels can occur in processes
(Craighead and Mossman, 1982), such as sawing, drilling, mining, processing,
manufacturing, installing, transporting, removing, and dumping of any asbestos
products (Jones, 1979). Contamination of the environment with asbestos fibres
often is subtle but difficult to assess (Harries, 1976; Skidmore and Jones, 1975).
The major pathological effects result from the inhalation of fibres
suspended in ambient air. Resulting disease was influenced by the type and
dimension of the fibres, (Craighead and Mossman, 1982). For certain types of
interactions, such as haemolytic activity, the degree of reactivity depends primarily
on the charge of the fibre (Light and Wei, 1977).
Dimensional characteristics have also been shown to be important in
activating cellular responses such as phagocytosis (Craighead and Mossman, 1982).
The diameter of the fibres is important in determining their deposition in the
respiratory tract. Thin fibres are carried peripherally into the parenchyma of the
lung where they lodge in the terminal airways (Mossman et al, 1983). Chrysotile
fibres, with their characteristic curled configuration tend to be deposited more
proximally than the needle like amphiboles which are transported more readily to
the periphery of the lung (Parkes, 1973). Furthermore, animal experiments have
6
demonstrated that the longer the fibres, the more fibrogenic and carcinogenic they
are like to be (Davis et al, 1986a, 1989; Wagner et al, 1984).
2. Biological effect of asbestos
2.1. Asbestos related diseases
2.1.1. Historical aspects
The first case of asbestos-associated lung disease in the UK was noted in
1900. In 1935, the first cases of asbestosis and carcinoma of the bronchus were
described by Lynch and Smith and by Gloyne, but it was not until 1955 that Doll
showed the true significance of this association. Further evidence of the increased
risk of bronchial carcinoma in asbestos workers was provided by Newhouse (1969).
In the succeeding years, this association has been amply confirmed in many
countries (Jones, 1979).
Mesothelioma is a cancer affecting the lining membrane of the pleura or
peritoneum. Wagner et al (1960), in south Africa, first demonstrated convincingly
that individuals with mesotheliomas had been exposed to crocidolite occupationally
or environmentally. By the mid-1960s, this association had been firmly
established (Elmes and Wade, 1965). Further pleural pathological entities associated
with asbestos dust exposure were described by Kiviluoto (1960) and Meurman
(1966), such as pleural plaques and thickening of the parietal pleura.
2.1.2. Effect of asbestos in the lungs
The falling speed of fibrous dusts in air is the critical parameter and is
dependent on their diameter rather than on their length (Timbrell et al, 1970a).
Following inhalation of dust- laden air, most large asbestos fibres (10 fim or larger
in diameter) are trapped in the mucus and hair of the nasal passages. Fibres of
smaller size may enter the bronchial tree; most particles which deposit there are
cleared by the mucociliary process, particularly if they are larger than 5 fim in
diameter. Smaller fibres (particularly if less than 3 fini in diameter) which are of
respirable size may enter the terminal bronchioles and alveoli. It is these smaller
fibres, particularly those with a diameter of less than 1 fim, which are considered
to be the most significant in inducing biological effects in man (Buchanan,
1979).
A fibre which is relatively straight will tend to align itself with its major
axis lying in the direction of air flow. A curved fibre, predominantly a fibre of
the chrysotile type, shows no such preferred axial orientation (Parkes, 1973).
There is therefore a greater possibility of chrysotile fibres coming into contact
with the wall of the airways and of them being removed by the mucociliary
escalator, than would be the case with amphibole fibres. Amphibole fibres are
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therefore more likely to reach the periphery of the lung (Jones, 1979).
Pulmonary alveolar macrophages are highly active in their ability to
phagocytose a variety of foreign particles. Alveolar macrophages have receptors on
their surface for IgG and C 3^, which mediate phagocytosis of foreign substances
that have been trapped in immune complexes (Daughaday and Douglas, 1976).
Ingestion of particles is in general beneficial to the host. However, ingestion
frequently leads to release of various enzymes and oxygen metabolites, which can
be injurious to surrounding cells and tissue. Ingestion of asbestos which is a
nondigestible substance may result in a macrophage that chronically continues to
release these potentially injurious substances (Musson and Henson, 1984).
In many instances, asbestos bodies may be formed as the results of
reaction of the lung cells and asbestos fibres. Asbestos bodies are usually
rod-shaped structures with clubbed ends, often beaded along their length and
yellow to brown in colour. The coating consists of ferritin granules and an
amorphous material, probably protein (Gaensler and Addington, 1969). Suzuki and
Churg (1969) believed that coating is an intracellular process and follows the
engulfing of particles by macrophages to which they adhere. Although all fibre
types may become coated in the laboratory animal, in man the amphibole fibre
is found more frequently as the core of a ferruginous body than the chrysotile
fibre (Becklake, 1976). Over the years, they tend to break down, releasing pieces
of fibre and the lung tissue is gradually destroyed and replaced with scar tissue.
In some cases, the changes are particularly marked in the pleura, which becomes
thickened (Buchanan, 1979).
Following the inhalation of asbestos dust, the following possibilities may
occur:
1. The majority of the dust is removed from the tracheobronchial tree by
exhalation, the mucociliary escalator and swallowing.
2. Asbestos retained in the lung enters the bronchioles and alveoli. Some fibres
may penetrate bronchiolar and alveolar walls to remain in the interstitial tissue,
some may migrate to the pleural surface or enter lymphatic vessels.
3. A high proportion of inhaled asbestos fibres that are retained in the lung
become asbestos bodies.
2.1.3. Pathological changes associated with asbestos exposure
The main pathological changes associated with the inhalation of asbestos




Asbestosis is a lung fibrosis of the professional asbestos worker in that its
onset is generally dependent on prolonged and relatively heavy exposures to
asbestos dust. Asbestosis is associated with all commercially used types of asbestos
and tends to progress even although exposure may have been ended (Buchanan,
1979).
Asbestos exposure is also associated with a variety of diseases affecting
multiple organ systems, such as the gastrointestinal system (Becklake, 1976).
Immunologic abnormalities have also been described in asbestosis patients (Miller
and Kagan, 1981; Lawrence et al, 1982).
The mechanisms whereby asbestos fibres exert their fibrogenic effects in
the lungs are not fully understood. However, alveolar macrophages are likely to
play a central role. Macrophages may mediate asbestos-induced fibrosis by
releasing lysosomal enzymes (Kagan, 1985^), free radicals (Kandaswami et al,
1988), prostaglandins, leukotrienes, and macrophage derived growth factor for
fibroblasts (Lemaire et al, 1986^) as well as IL-1 (Beckert et al, 1989) and TNF
(Driscoll et al, 1990).
During asbestosis, there is almost invariably some fibrotic thickening of the
visceral pleura, predominantly in the basal region. Fusion of the visceral and
parietal layers of pleura may be present (Jones, 1979).
2.1.3.2. Bronchial carcinoma
Workers exposed to asbestos have an increased risk of developing bronchial
carcinoma. This risk appears to be related to the exposure dose as well as the
type of asbestos, being greater among workers exposed to crocidolite and amosite
than among those exposed to chrysotile or anthophyllite (Seaton, 1984). More
than the expected number of cases of alimentary tract carcinoma have also been
reported in asbestos workers (Harington, 1981).
2.1.3.3. Mesothelioma
It has been generally accepted that primary serosal tumours of the pleural
and peritoneum (mesothelioma) exist as a distinct pathological entity.
Characteristically, the dense white or grey- yellow tumour is usually found initially
in one pleural cavity, and both the visceral and parietal layers of the pleura are
involved (Jones, 1979). Wagner and his colleagues (1960) first reported 33 cases
of the rare pleural or peritoneal mesothelioma from the North-West Cape of
South Africa. A variety of animal studies by intrapleural injection and inhalation
of different kinds of asbestos confirmed the pathogenesis of asbestos in induction




Plaques are pleural lesions made up of hyalinized fibrous tissue located on
the parietal pleural of the thorax, diaphragm, mediastinum, and pericardium
(Craighead and Mossman, 1982). They appear as yellow-white areas of patchy
thickening, projecting slightly above the contour of the parietal pleura. Pleural
plaque formation does not seem to depend on particularly heavy exposure to
asbestos dust, and any of the commercially used types of asbestos can lead to this
pleural change (Jones, 1979). In general term, the formation of pleural plaques
indicates exposure to asbestos, but the plaques are not harmful.
2.2. Mechanisms of asbestos-induced lung damage
The pathogenic framework common to all interstitial lung diseases consists
of a stimulus, activation of immune effector cells, and the development of an
alveolitis. The outcome of this alveolitis may be resolution either with or without
scarring or the development of pulmonary fibrosis. In asbestos-related pathologic
changes, the asbestos fibre is the responsible stimulus.
2.2.1. Role of alveolitis in interstitial lung diseases
The interstitial lung diseases including asbestosis are a group of chronic
disorders that involve the entire parenchyma as well as the alveolar interstitium
(Crystal et al, 1981). The central pathogenic mechanisms operative in these
diseases are those that relate to maintenance of alveolitis. The alveolitis of the
interstitial lung disorders is characterized by an increase and shift in the relative
proportions of inflammatory and immune effector cells present, such as activated
macrophages and PMN (Fulmer and Crystal, 1979). This shift is thought to be a
key to the pathogenesis of these disorders through the release of inflammatory
and immune mediators by effector cells, which have the potential to markedly
derange the alveolar structure (Crystal et al, 1981).
In the acute lung disorders, the amount of inflammation does not
significantly damage the alveolar structure. In contrast, the chronic alveolitis of
the interstitial lung disorders, such as asbestos-induced lung disorders, presents a
continual burden of immunoglobulins (Bignon et al, 1978), oxidants (Case et al,
1986) and proteolytic enzymes (Begin et al; 1983) that overcome the protective
measures of the lower respiratory tract.
Alveolar macrophages from asbestos-exposed sheep were found to produce
a chemotactic factor which attracted peripheral blood neutrophils in vitro. The
chemoattractant attracted neutrophils more efficiently when it was obtained from
higher-exposure than from lower-exposure animals. Bronchoalveolar lavage fluids
from the animals also showed chemotactic activity for peripheral blood
neutrophils. Supernatants of control macrophages exposed to asbestos in vitro were
also chemotactic for PMN (Rola- Pleszczynski et al, 1984). In a hamster study,
bronchoalveolar lavage revealed a persistent neutrophil increase that began within
24 h of asbestos treatment; this was associated with the spontaneous release of
neutrophil chemotactic activity by cultured alveolar macrophages (Glassroth et al,
1984). Schoenberger et al (1982) confirmed that macrophage-derived neutrophil
chemotactic factor plays a role in modulation of PMN migration to the lung after
acute asbestos exposure. Similar results were shown by Hayes et al (1990) that
asbestos induced the release of a human alveolar macrophage-derived neutrophil
chemotactic factor.
Kagan et al (1986) demonstrated that macrophage culture supernatants
obtained from both crocidolite-exposed and chrysotile-exposed rats showed
significantly greater chemoattractant activity towards rat fibroblasts than similar
culture supernatants from sham-exposed animals.
2.2.2. Effects of asbestos on bronchoalveolar lavage profile
In an observation by Gellert et al (1985), 46% of patients with asbestosis
showed an increase in the percentage of neutrophils and 29% showed an increased
percentage of lymphocytes. Begin et al (1983) observed that when individuals
were expose to asbestos, neutrophils were found in the bronchoalveolar lavage
(BAL) fluid. Xaubet et al (1986) and Robinson et al (1986) have described
increased levels of eosinophils in the BAL of asbestos-exposed individuals.
When sheep were instilled with UICC Canadian chrysotile fibres at
low-dose, there was a significantly higher yield in the total BAL cells due to a
marked increase in the macrophage and a small quantitative rise in the
lymphocyte populations (Begin et al, 1981). The anatomically isolated sheep
tracheal lobe was exposed to chrysotile fibres and BAL analysis documented
persistent increases in macrophages and neutrophils. Lung histology revealed a
macrophage and neutrophil peribronchiolitis and alveolitis (Begin et al, 1983).
Rats inhaling chrysotile asbestos also showed a macrophage/ neutrophil
alveolitis (Donaldson et al, 1988c). Bozelka et al (1983) described an increase in
the total cell number and numbers of neutrophils in mice inhaling chrysotile
asbestos. Adamson and Bowden (1987^) also confirmed a neutrophil alveolitis
following the instillation of a long fibre sample of amosite using mouse model.
The use of a short sample of the same mineral was only associated with a
transient, resolving inflammatory response in BAL (Adamson and Bowden, 1987a).
Rola-Pleszczynski et al (1981) demonstrated that after receiving monthly
intratracheal instillation of chrysotile asbestos, sheep BAL leukocytes were found
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to have enhanced proliferative activity in response to concanavalin A, pokeweed
mitogen, and staphylococcal lysate.
Asbestos exposure is also associated with changes in the immune system.
Bignon et al (1978) demonstrated that patients with asbestosis had higher average
concentrations of albumin, IgG, IgA and aj anti-trypsin in their BAL fluid than
did subjects with asbestos exposure with or without other asbestos related
diseases. Guzman et al (1986) showed activated T-cells and increased
helper/suppressor ratios in BAL fluid of asbestos- exposed individuals. Rat alveolar
macrophages exposed to asbestos have increased numbers of surface IgG-Fc and
C3 receptors (Tetley et al, 1976). Begin et al (1983) found an increase in y-
globulins in BAL of sheep following exposure to chrysotile asbestos.
Asbestos exposure also affects the metabolism of extracellular matrix in the
lung. One investigation (Begin et al, 1986) indicated that the levels of fibronectin
and procollagen 3 in BAL fluid were significantly elevated in the asbestos-exposed
sheep, as well as in those with asbestos-associated alveolitis or asbestosis.
2.2.3. The change of enzyme in BAL caused by asbestos
Begin et al (1983) showed that proteins and enzymes in the BAL fluid
increased significantly in the high-dose group of chrysotile-exposed sheep. Tetley
et al (1976) demonstrated that chrysotile induces elevated levels of lysosomal
enzyme in both the whole lung and free cell population. Significantly higher
(3-glucuronidase and lactate dehydrogenase activity was found in BAL fluids from
chrysotile and crocidolite asbestos-exposed groups compared to controls (Kagan et
al, 1983a; Begin et al, 1983). An inhalation exposure of rats to chrysotile asbestos
also resulted in increased levels of free enzymes and total protein (Donaldson
et al, 1988^). In vitro pulmonary alveolar macrophages exposed to asbestos
produce lysosomal enzymes (Schoenberger et al, 1982).
Davies (1980) reported that asbestos was cytotoxic towards the macrophage
releasing both lactate dehydrogenase and /3- glucuronidase and asbestos containing
long fibres caused a significantly higher release of the lysosomal (3-glucuronidase.
The observation of Hamilton (1980) indicated that intraperitoneal injection of
chrysotile fibres in mice elicited a cellular exudate. The macrophages in the
exudate produced high levels of the neutral protease, plasminogen activator. White
and Kuhn (1980) showed that peritoneal exudative macrophages increased their
secretion of elastase in response to phagocytosis of chrysotile and crocidolite.
2.2.4. Oxidant metabolism during alveolitis caused by asbestos
The exposure of hamster and rat alveolar macrophages in vitro to nontoxic
concentrations of crocidolite asbestos caused a significant increase in both release
of superoxide from rat macrophages and enhancement of zymosan-triggered
superoxide from hamster macrophages (Hansen and Mossman, 1987). An inhalation
study of sheep exposed repeatedly to UICC chrysotile B asbestos and quartz
indicated that lung-inflammatory cells from sheep exposed to asbestos released
much highMevels of superoxide in the presence of phorbol myristate acetate than
did cells of unexposed sheep (Cantin et al, 1988)
Goodglick et al (1989) showed that after mouse peritoneal exposure to
crocidolite asbestos the macrophages produce lipid peroxidation. Case et al (1986)
reported that the presence of crocidolite and chrysotile evoked significant rises in
C>2- release by alveolar macrophages.
Roney and Holian (1989) investigated the possible mechanism of
asbestos-stimulated superoxide anion production and showed that the mechanism of
guinea pig alveolar macrophage stimulation by chrysotile is consistent with a
mechanism which is similar to that used by agonists such as
A'-formyl-Nle-Leu-Phe resulting in stimulated phoxphatidylinositol turnover,
calcium mobilization, and activation of protein kinase C. Scheule and Holian
(1989) in another study demonstrated that immunoglobulin G specifically enhances
chrysotile asbestos-stimulated superoxide anion production by guinea pig alveolar
macrophages. It was suggested that asbestos may stimulate macrophages by
crosslinking cell- surface immunoglobulin Fc receptors (Scheule and Holian, 1989).
2.2.5. Fibrogenicity of asbestos
Wagner et al (1974) reported that in a animal inhalation study, amosite
invariably gave the least fibrosis and Canadian chrysotile the most. Crocidolite and
Rhodesian chrysotile were intermediate. The animal inhalation studies by Davis et
al (1978) showed that chrysotile dust caused far more lung fibrosis than
crocidolite or amosite when dust clouds contained roughly the same number of
fibres. Johnson (1987) found that crocidolite appears to be weakly fibrogenic, and
other factors may be needed to produce the marked lesions seen in human
asbestosis.
In a study comparing inhaled asbestos with other dusts, Lee et al (1981)
found that asbestos was the most potent fibrogenic agent with more than 10 times
more fibrogenicity than fibreglass particles.
Chang et al (1988) demonstrated that a brief inhalation exposure to
chrysotile asbestos caused a rapid response that involves an influx of macrophages
to the first alveolar duct bifurcations and alterations in the alveolar epithelium.
Johnson (1987) also found a significant increase in the numbers of rat interstitial
and alveolar macrophages after asbestos inhalation. Polymorphs appeared in the
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interstitium at airway bifurcations, prior to their appearance in the alveolar space.
These bifurcations were revealed to be the initial sites of cell damage and
collagen deposition. Chang et al (1988) suggested that these acute structural
changes are followed by a progressive response manifested by increased numbers
of interstitial cells and localized interstitial fibrosis.
2.2.6. Carcinogenesis of asbestos
Workers exposed to asbestos have an increased risk of developing bronchial
carcinoma (Harington, 1981) and the risk appears to be related to the exposed
dose as well as to the type of asbestos, being greater among workers exposed to
crocidolite and amosite than among those exposed to chrysotile or anthophyllite
(Seaton, 1984). Many studies have also shown an increased risk of other
neoplasms in asbestos workers (Liddell, 1981).
Evidence exists that asbestos is a complete carcinogen, an initiator and a
promoter (Barrett et al, 1989). Multiple mechanisms for the carcinogenic effects
of asbestos have been suggested: asbestos induces chromosomal mutations, such as
chromosomal changes in rat pleural mesothelial cells (Wang et al, 1987), sister
chromatid exchange in human fibroblast and lymphoblastoid cells in vitro (Casey,
1983) and in circulating lymphocytes of asbestos workers (Rom et al, 1983).
Asbestos also induces transformation of cells in culture, such as morphological
and neoplastic transformation of Syrian hamster embryo cells induced by asbestos
(Barrett et al, 1989).
2.2.7. Localisation of asbestos fibres after inhalation
Holt et al (1965) found in a short term Guinea pig inhalation experiment
that dust reached the terminal bronchioles after a few days and trace amounts
entered the alveoli. A bronchiolitis with damage to the surface epithelium
followed, and the lumen became filled with cellular debris and dust-laden
macrophages. There was later extension of the inflammatory infiltrate from the
bronchioles into the lung, with thickening of alveolar walls and spreading fibrosis.
The tracheal lymph nodes contained dust-laden macrophages in which asbestos
fibres and bodies were identified.
After rats were exposed to aerosolized chrysotile, Pinkerton et al (1984)
found that macrophages and alveolar epithelial cells contain significant amounts of
asbestos and are associated with histological changes indicating marked epithelial
injury. With continued exposure to asbestos, increased amounts of fibres are also
localized in the lung interstitium and are associated with a progressive interstitial
fibrotic reaction. Following cessation of exposure, macrophages and epithelial cells
are cleared of fibres and resolve toward normal proportions. However, significant
clearance of fibres from the lung interstitium does not occur after cessation of
exposure and there is a continuing process of fibrogenesis.
It was demonstrated by Pinkerton et al (1989) that exposure to low levels
of ozone resulted in enhanced rat pulmonary retention of inhaled asbestos and
implied that ambient levels of ozone can impair clearance of asbestos from the
lungs.
Asbestos may also reach the pleura to cause pleural pathologic changes
(Sebastien et al, 1979) after inhalation exposure (Section 3.4).
2.2.8. Asbestos size in pathogenesis
The historical aspects of studies on the role of fibre size in asbestos
pathology has been reviewed by Davis (1979), these have emphasized the
pathogenicity of long thin fibres compared to short fibres which are much less
active.
A major part of the pathogenicity of mineral fibres is attributed to
physical shape. The most dangerous fibres studied are erionite, which has a high
length to diameter ratio, and crocidolite, which is also long and thin (Hillerdal,
1984). Hillerdal (1985) suggested that the fibrous structure is the cause of the
pathological reactions. Consequently, any fibre with the critical minimal diameter
(0.2 /un or less) and length (3-5 /xm or more) is presumably dangerous and has
been proven so in animal experiments. It was thought (Stanton et al, 1981;
Hirsch and Bignon, 1985) that fibres less than 1.5 /xm in diameter and greater
than 8 /an in length cause cancer irrespective of their physicochemical nature
simply because they are fibres.
Pott and Muhle (1983) suggested that a fibre with a diameter of 0.1 /im
possesses a maximal carcinogenic potency. When the diameter increases the
carcinogenic potency is reduced and nearly reaches the zero point at 2 /xm. With
regard to the length, the carcinogenic potency is beginning at about 2 /xm and
increases with increasing length.
A study in rats with a single intratracheal instillation of chrysotile asbestos
by Lemaire et al (1985a) showed that long chrysotile B has significant pathological
effects on the lung. The lesions were localized in and around terminal bronchioles
and consisted of inflammatory cells, fibroblasts and collagen deposition with
distorted and obstructed small airways. However, no fibrosis was apparent in the
lungs of these animals for short chrysotile fibres.
Davis et al (1986a) found that exposure to dust clouds of long amosite
fibres caused deposits of granulation tissue and progressive thickening of alveolar
septa, as well as pulmonary carcinomas and pleural mesotheliomas, while exposure
to short amosite fibres showed no, or much less, pathogenicity. In another
long-term inhalation and intraperitoneal injection study with rats, Davis and Jones
(1988^) confirmed that rats treated with long-fibre chrysotile developed 6 times
more advanced interstitial fibrosis and 3 times more pulmonary tumours than
animals treated with short-fibre chrysotile. In addition, following intraperitoneal
injection, long-fibre dust produced more mesotheliomas than the short-fibre.
Adamson et al (1987a) demonstrated that after short crocidolite fibres were
instilled into the lungs of mice, only a high dose of short fibres produces
minimal lung injury and fibrosis. However, same treatment of long crocidolite
fibres resulted in a severe fibrotic reaction (Adamson et al, 1987^).
Lemaire (1985^) found that there was longer increase in inflammatory cells
in animals treated with long chrysotile than with short chrysotile. Differential
cellular analysis indicated that after injection of long chrysotile fibres, PMN and
multinucleated cells (MGC) were found in lavage fluid and most of these cells
were binucleated. By contrast, exposure to very short chrysotile fibres caused only
a very transient influx of PMN. Many of MGC had 3 or more nuclei. Donaldson
et al (1989) have also demonstrated the high tissue injuring potential of long
fibres after intraperitoneal deposition while a short fibre sample was virtually
inactive in these respects.
Davis et al (1986) showed that after dust inhalation, one third of animals
treated with long amosite fibre dust developed mesotheliomas but there was none
in animals treated with short fibre amosite. Intraperitoneal injection also confirmed
the greater carcinogenisis of the long fibre amosite than that of short fibre dust.
It was presumed that under experimental conditions short asbestos fibres
(that is less than about 10 /xm) are engulfed and removed by alveolar
macrophages, but longer fibres cannot be properly ingested, in which case a
number of macrophages become attached to them and release various enzymes
and oxygen metabolites chronically, which can be injurious to surrounding cells
and tissue (Parkes, 1973; Musson and Henson, 1984 and Davis et al, 1988a). In
addition, long fibre asbestos may cause injury to bronchial and bronchiolar
epithelium so that it can reach the interstitium to induce macrophage-fibroblast
interactions there (Adamson et al, 1987a).
However, Monchaux et al (1981) found that oxalic and hydrochloric acid
leaching dramatically decreases the carcinogenic effect of chrysotile asbestos. Evans
et al (1983) showed that surface modification of asbestos by glutaraldehyde-
coupled protein can reduce the rate of fibre/cell interaction. The effect of surface
modification by effectively adding Cg and Cjg hydrocarbon chains was investigated
by Brown et al (1990). They found that both surface silylation treatments reduced
the toxicity of the asbestos and had reduced fibre/cell interaction. Furthermore,
in rat intrapleural studies, the Cqg derivatized fibre was markedly less active in
the production of mesotheliomas, however, Cg material had the same activity as
the parent material but induced the tumors earlier. These data indicates that not
only size characteristics but also parameters such as chemical composition and
physicochemical properties must intervene (Monchaux et al, 1981).
3. The pleura
The principal function of the pleura is to decrease the friction and
consequently enhance the efficiency of respiratory movements (Andrews and
Porter, 1973; Staub et al, 1985).
3.1. Structure and exchange functions of the pleura
3.1.1. Anatomy and physiology of the pleura
3.1.1.1. Mesothelium
The surface lining of the parietal and visceral pleura consists of a single
layer of stretchable, polygonal, mesothelial cells being diffusely covered by
microvilli (Pistolesi et al, 1989) (Section 3.2).
3.1.1.2. Pleural connective tissue
The connective tissue of the pleura is a complex structure or layers of
structure that underlies the surface layer of mesothelial cells (Bernaudin and
Fleury, 1985). Pleural connective tissue contains both dense collagenous and elastic
fibres which permit it to modulate lung expansion during normal respiration and
to limit lung expansion during maximum ventilatory conditions. In quantitative
terms, the collagens are the major component of the pleural extracellular matrix,
and type I collagen comprises a major portion of pleural connective tissue
(Prockop et al, 1979). Elastic fibres which are comprised of two components:
elastin and microfibrils, make up the layers of elastic laminae present in the
pleura (Agostoni, 1972). A large number of glycoproteins are found as components
of the extracellular connective tissue of the pleura. Two glycoproteins, fibronectin
and laminin are likely to be present in pleura. The former may play a similar
role in anchoring cells to the pleural matrix (McDonald et al, 1982) and the
latter is known to modulate the adhesion of cells to basement membranes
(Terranova et al, 1980). In the pleural space, proteoglycans and glycosaminoglycan
hyaluronic acid are also present and may function as a lubricant (Arai et al,
1975; Herbert, 1986).
3.1.1.3. Anatomy of the blood and lymphatic circulation of the pleural serosa
In the human visceral pleura, the two different groups of arteries, the
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pulmonary and bronchial arteries, can both potentially ensure the blood supply,
but the former supplies the greatest part of the pleura. The arteries of the
human parietal pleura are branches of the arteries supplying the adjacent
thoracic wall (Bernaudin and Fleury, 1985).
The pleural space is faced by two very different lymphatic circulations.
The parietal pleura lymphatics are the true lymphatic system of the pleura,
whereas the visceral pleura lymphatics are the superficial portion of the lymphatic
system of the lung. The usual direction of the lymph flow in visceral pleura is
from the surface of the lung to the hilum and valves ensure a one-way flow
(Bernaudin and Fleury, 1985). It is believed that the visceral pleura lymphatic
circulation has no direct communication with the pleural space (Albertine et al,
1982).
In the parietal pleura, two lymphatic plexuses can be differentiated: one in
the subpleural space and a more superficial one just beneath the mesothelial
layer. The lymphatics of the parietal pleura is of major physiological significance
since they play an essential role in the removal of components of the pleural
fluid in the normal state as well as in the case of pleural effusion (Bernaudin and
Fleury, 1985). This removal is sustained by true anatomical connections, the
stomata (Section 3.1.2), between the pleural space and the lumen of lymphatics
of the parietal pleura (Pistolesi et al, 1989).
3.1.2. Exchange across the pleura
3.1.2.1 Volume, proteins, and cells of pleural liquid
Physiological experiments strongly suggest that the pleural membrane is
permeable. Additionally, the existence of stomas means that the pleural cavity is
directly open to the lymphatics of the chest wall without any interposed
epithelium (Wang, 1975; Pistolesi et al, 1989).
The pleural space is a real space, not a potential one with width being
10-20 fim. Since the microvilli of the visceral and parietal mesothelial cells are
3-5 fim long, this means that there is little or no contact between these surfaces.
The normal volume of liquid in the pleural spaces is small:- 0.1-0.2 ml/Kg body
weight in most mammals. The protein concentration in the pleural liquid of dogs
was found to be 1.06 ± O.llg per 100 ml. The computed colloid osmotic pressure
was 3.2 cm H2O (Staub et al, 1985). Mesothelial cells, monocytic cells, and a
few lymphocytes have been found in the pleural liquid of dogs at 2208 ± 734
per mm3. Pleural leukocyte studies indicated that normal lavaged pleural
leukocytes are comprised mainly of macrophages, mast cells, eosinophils, PMNs
and lymphocytes (Oberdoerster et al, 1983; Zlotnik et al, 1982; Pitt, 1985).
3.1.2.2. Liquid and solute exchange
The passage of water and small solutes across a mesothelial cell layer can
be either transcellular or paracellular via numerous plasmalemmal vesicles in the
mesothelial cells (Gil, 1983). Vesicles act as shuttle vehicles in a process of
transcellular transport. The alveolar/pleural boundary is also incomplete because
the pleural interstitium is continuous with the alveolar septa (Gil, 1985).
Kanazawa (1985) suggested that water, electrolytes, and small molecular
substances are excreted, mainly from the parietal pleura into the pleural cavity,
and are absorbed via blood capillaries in the visceral pleura after penetrating the
mesothelial lining cells or through the intercellular junctions. Larger molecules,
such as protein, are mainly absorbed via the lymphatics in the parietal pleura.
They penetrate through the pleura along the intermesothelial junctions or are
transported through the mesothelial cells (Black, 1972).
3.1.2.3. Particle exchange
The absorption of fairly large particles from the pleural cavity takes place
through various routes. Using injected erythrocytes, ^ at least three different
pathways to remove the erythrocytes from the pleural cavity: (1) by stomata in
the pleura, which are 2-6 /mi openings and distribute over parietal pleura at a
density of about 300-400 mm~2 (Albertine et al, 1984; Kanazawa, 1985) (2) by
crevices in the mediastinal pleura which are 1-10 /im in width and 5-30 /im in
length (Kanazawa, 1985) and (3) in particular, by milky spots, discernible by the
naked eye as small white flecks, which are the aggregates of macrophages and
specialised mesothelial cells with the distribution similar to that of stomata
(Herbert, 1986). It is suggested that serosal stomas and crevices are the sewage
system and milky spots the surveillance system of the serosal cavities (Kanazawa,
1985).
Transportation of particles to the pleura is presumed mainly by three
routes:- (1) penetration of particles through the visceral pleura (transpleural
migration). Fibres located in peripheral alveoli can cross the visceral pleura and
also this translocation could be facilitated by respiratory movements, macrophage
migration, and mesothelial cell exfoliation (Kanazawa, 1985).
(2) Lymphatic transportation. The lymphatics from the pulmonary alveoli
are connected with the submesothelial lymphatics in the visceral pleura
(Lauweryns, 1974) and there is the negative pressure in the pleural cavity
(Kanazawa, 1985). In addition, during asbestos exposure, partial obstruction of the
trachea may increase the negative pressure of the pleura. These factors would
result in transport of asbestos fibre through the visceral pleura.
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(3) Blood transportation. Milky spots would allow blood- borne particles,
such asbestos fibres, to pass through the mesothelial cells into the pleural cavity
(Kanazawa et al, 1979) because the bloodstream is slowed down within the milky
spot and the basement membrane of the blood capillaries in milky spots is less
well developed and discontinuous. Many phagocytes exist in milky spots to trap
the particles which may be brought into the pleural cavity (Kanazawa, 1985).
However, the controversy whether or not some particles, such asbestos
fibres, can reach the pleura space exists and the mechanisms whereby the fibres
reach the pleural space are still in question (Herbert, 1986).
3.2. Pleural mesothelial cells
3.2.1. Normal mesothelial cells
The pleural mesothelial cells are single-layered stretchable cells between 1
/xm and 4 /xm in thickness and ranging from 16.4 to 41.9 /xm in surface diameter
(Cooray, 1949). They have abundant elongated "brushlike" microvilli that entrap
hyaluronic acid-rich glycoprotein. The microvilli on the mesothelial cell surface
are characteristically elongated and randomly oriented. They are up to 3 /xm in
length and approximately 0.1 /xm in diameter, with the length to diameter ratio
usually over 10 (Wang, 1974). The pinocytic vesicles are well developed on both
luminal and basal surfaces of the mesothelial cell (Madison et al, 1979). Mesothelial
cells on rigid substructures are flat tend, stable with a low turnover rate, and
well-developed intercellular junctions (Wang, 1985). Apical tight (zonula
occludens) and gap (nexus) junctions and well-developed desmosomes are present
between human mesothelial cells (Wang, 1974). The estimated life span of the
pleural mesothelial cell in the rat is 33 days (Bryks and Bertalanfly, 1971).
■foyiwl
Whitaker et al, (1982a) that the normal flattened (resting) mesothelial cells
show, predominantly, the enzymes of the pentose pathway whilst cuboidal
(activated) cells have, predominantly, the enzymes of the oxidative pathway.
The renewal of damaged mesothelial cells include maturation of
submesothelial mesenchymal cells (Ryan et al, 1973); the transition of free-floating
cells (monocytes) in the serous exudate (Watters and Buck, 1972) and replication
of already differentiated mesothelial cells at the periphery of the wounded area
or from the opposite mesothelial surface (Whitaker et al, 1982^). It is postulated
that exudate macrophages secrete mitogenic factor(s) which stimulate mesothelial
proliferation, and initiate healing (Fotev et al, 1987).
Rennard et al (1984) hypothesized that the mesothelial cells are the major
source of the pleural connective tissue. Those include collagen (Harvey and
Amlot, 1983; whitaker, 1977), elastin, glycoprotein and proteoglycan (Rennard et
al, 1984). It has been shown that mesothelial cells exert effect in fibrinolysis
(Porter et al, 1971). Newly regenerated mesothelium has greatly enhanced
fibrinolytic activity, but fibrinolytic activity is depressed by damage to mesothelial
cells (Whitaker et al, 1982c).
Various types of inflammatory agent, physicochemical irritation, and
biochemical irritations or stimuli (endotoxin, bovin serum albumin, and
microorganisms), when deposited in the pleural space, have been shown to induce
a rapid desquamation of the mesothelium (Bignon and Gee, 1985).
3.2.2. The mesothelial response to asbestos
The pleura, with its mesothelial cells, is very reactive in response to
inhaled asbestos by producing two specific pathologies, fibrosis and cancer
(Jaurand, 1985). Asbestos has been confirmed to cause pleural mesothelioma
(Section 3.4.2). Jaurand et al (1983a) reported that chrysotile asbestos induces a
significant increase in the number of sister chromatid exchanges of mesothelial
cells.
As confirmed by Donaldson et al (1988c), crocidolite asbestos produced
inhibition of plasminogen dependent fibrinolysis of mesothelial cells and may thus
permit formation of a fibrin scaffold which would favour fibrinogenesis. Bryks et
al (1971) observed a marked increase in the proliferation of visceral mesothelium
5-7 days after intratracheal administration of chrysotile in the rat (Herbert, 1986).
Renier et al (1990) reported that rat pleural mesothelial cells treated with
chrysotile or crocidolite showed a significant dose-dependent increase in [^HjdThd
incorporation compared to untreated cells, which indicates that asbestos produces
unscheduled DNA synthesis in the cells.
Antony et al (1989) reported that mesothelial cells in the presence of
crocidolite asbestos released chemotaxins for neutrophils which can produce
proteases capable of degrading supporting matrix to increase the pleural
permeability.
Additionally, inflammatory processes related to asbestos exposure can lead
to the development of adhesions between the parietal and visceral pleura
(Stephens and Gibbs, 1987), which may result from the disruption of the adhesive
molecules that likely maintain the normal anchorage of mesothelial cells
(MacDonald et al, 1979). With the loss of the lining of cells from a pleural
surface, the exposed underlying connective tissue could serve as a substrate for
attachment of the opposite pleural surface and lead to adhesion formation
(Rennard et al, 1985).
Davis (1974) found that at an early stage after intrapleural injection
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mesothelial cells became rounded and less clearly attached to one another. Later
in the studies the mesothelium returned to normal, but where mesothelium
covered asbestos granulomata, the cells were extremely flattened, and without
surface microvilli. In some areas pores were found penetrating the mesothelial cell
cytoplasm and leaving areas of connective tissue in direct contact with the pleural
cavity.
3.3. Leukocytes of the pleural space
The pleural space, like the peritoneal space and other serosal surfaces, has
a permanent leukocyte population. Pleural leukocyte numbers found in dog were
2208 ± 734 per mm^ (Miserocchi and Agostoni, 1971). Lavaged leukocyte numbers
were 7-13 x 10^ in rat (Oberdoerster et al, 1983), 3.295 x 10^ BALB/c mice
and 1.758 x 106 in CF-1 mice respectively (Zlotnic et al, 1982) the differential
counts indicated that pleural leukocyte population obtained from normal BALB/c
mice contained: 51.3% macrophages, 47.6% lymphocytes, 0.4% eosinophils and
0.8% mast cells. Pitt (1985) reported that the cell population obtained from
3-18 months old BALB/c mice pleural space was 2.9 x 10^ cells. Of these,
lymphocytes comprised 70% of the total population, monocytes/macrophages 27%,
PMNs less than 1% and degenerate cells 3%. The work of Oberdoerster et al
(1983) revealed that in control pleural lavages, PMN accounted for 27- 45%,
mast cells 11-22%, eosinophils 11-17% whilst others were 25- 45%.
3.3.1. Macrophages/monocytes
Most tissue macrophages derive from the circulating monocytes (Sibille and
Reynolds, 1990) although some are derived from local replication (Evans et al,
1987). Maturation in a given tissue location confers distinctive properties on the
specific macrophage type although they still retain considerable adaptive ability
(Bignon and Gee, 1985). In the pleura, it would be anticipated that the same
situation pertains.
A study comparing pleural macrophages to peritoneal and alveolar
macrophages in mice showed that pleural and peritoneal macrophages were more
similar to each other than to alveolar macrophages. Compared to alveolar
macrophages, pleural macrophages migrate well on the plastic surface of the
dishes, phagocytise BCG more efficiently; pleural macrophages are also capable
of producing arginase whereas alveolar macrophages are not (Zlotnik et al, 1982).
Peritoneal macrophages have been extensively studied. They are more
dependent on anaerobic glycolysis and the O2 tension in both the peritoneal and
pleural cavities is low, suggesting that a similar energy metabolism will be shown
by pleural macrophages. Peritoneal macrophages induced by acute and chronic
inflammatory stimuli variably produce oxidants and generally secrete large
amounts of neutral proteases such as elastase, collagenase, and plasminogen
activator (Bignon and Gee, 1985).
3.3.2. Lymphocytes
Lymphocytes may influence fibrogenesis in the pleura. Human peritoneal
blood T lymphocytes, activated by nonspecific mitogens or antigen, produce a
nondialyzable factor that stimulates proliferation of dermal fibroblast and synthesis
of collagen (Wahl et al, 1978). They also release fibroblast chemotactic factors
(Postlethwaite et al, 1976). Postlethwaite and Kang (1982) found that the
monocyte-derived IL-1 effects on fibroblast proliferation via the
lymphocyte-derived fibroblast chemotactic factor. However, as regards the
peritoneal cavity, T lymphocytes alone seem insufficient for producing a fibrogenic
factor (Bignon and Gee, 1985).
Lymphocytes are present in almost every pleural effusion and tend to be
particularly abundant in effusions caused by tuberculosis or neoplasia and in
long-standing effusion (Herbert, 1986), indicating a role for T-cells in mediating
pleural fibrosis. Since certain lymphokines are capable of activating the
coagulation system, local cellular immunity may have a role in pleural
inflammation via the generation of a fibrin meshwork (Pettersson, 1985). The
deposition of fibrin would form a scaffold that activates fibroblast proliferation and
subsequently is colonized by fibroblasts, which may lead to fibrosis finally
(Bignon and Gee, 1985).
3.3.3. Eosinophils
Morphologically, the eosinophil is characterised by its content of
eosinophilic granules. The granules contain four main proteins: the eosinophil
cationic protein, eosinophil peroxidase, eosinophil protein X (or eosinophil derived
neurotoxin), and major basic protein (Gleich and Adolphson, 1986). Besides as a
potent ribonuclease, these proteins are cytotoxic and capable of inducing histamine
release from mast cells and basophils and also, stimulating glycosaminoglycan
production by human fibroblasts. In addition, eosinophils produce inhibitors of T
lymphocyte responses and also potently produce oxygen derived toxic metabolites
such as C>2-, H2O2 and OH- (Pincus et al, 1981) and of various lipid mediators,
such as prostaglandins (Hubscher, 1975). These cells also contain proteolytic
enzymes and are cytotoxic to mesothelial cells by releasing oxygen metabolites
(Bignon and Gee, 1985). Since murine eosinophils were found to be able to
express IL-1 mRNA when stimulated with LPS (Pozo et al, 1990), eosinophils
may have proinflammatory activity through the production of IL-1.
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By these means the eosinophils may regulate cell mediated immunological
reactions and tissue injury/repair processes (Venge, 1990).
3.3.4. Mast cells
Mast cells are characterised by their metachromatic granules and by their
synthesis of a number of recognized pharmacologically potent mediators. Some of
these mediators, such as histamine, heparin, eosinophil chemotactic factor,
platelet- activating factor and proteolytic enzymes, are produced and stored in the
granules, to be released on stimulation (Lee et al, 1985). Others, such as
prostaglandin and lymphokines, are produced when the cells are stimulated (Plaut
et al, 1989). Besides allergy and anaphylaxis, mast cells have role in stimulation
of fibroblast proliferation (Atkins et al, 1985) and cytotoxicity against tumour cells
(Henderson et al, 1981). Mast cells are also involved in TNF mediated biological
processes by synthesis of TNF mRNA in their cytoplasm and TNF protein in their
granules (Steffen et al, 1989).
The presence of large numbers of mast cells in the pleural interstitium
(Pinchon et al, 1980) is relevant to permeability because the mast cell contains
many large secretory granules rich in vasoactive substances, in particular histamine,
known to play a role in altering vascular permeability, during inflammatory
reactions. Clearly, a local release of histamine could lead to increased
extravasation of fluids (Gil, 1985).
3.3.5. Polymorphonuclear neutrophils
Polymorphonuclear neutrophils (PMNs) are specialized cells present early in
any kind of inflammation. The main function of PMN is to sense, approach, and
destroy invading microorganism (Lew, 1990).
PMN can release large amounts of oxygen metabolites, including O2-,
H2O2, and OH-, depending on the stimulus and on its concentration (Rosen and
Klebanoff, 1979). The azurophilic and specific granules in PMN contain proteolytic
enzymes. These include acid hydrolases, myeloperoxidase, lysozyme, and neutral
serine proteases. Among those enzymes, neutrophil collagenase degrades type I
collagen and neutrophil elastase cleaves elastin, types III and IV collagens, and
other proteins, including immunoglobulins at neutral pH (Mainardi et al, 1980;
Fick et al, 1984). PMN are a source of another neutral protease, plasminogen
activator (Unkeless et al, 1974). Furthermore, neutrophils also contain acid
L/utvi'fck
proteases, notably chymotrypsin and cathepsins, ^are needed for killing bacteria,
can also act extracellularly and injure tissues as well as structural material such as
hyaluronic acid, a compound present in some pleural effusions (Bignon and Gee,
1985). PMN could release cytokines, such as IL-1 (Canning and Neill, 1989), and
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sometimes this release requires the presence of zymosan or prolonged periods of
incubation time. They also release concomitantly one or several IL-1 inhibitors
(Sibille and Reynolds, 1990).
3.4. Pleural response to asbestos
The pleura is a primary target for various reactions resulting from asbestos
exposure. The main reactions are acute pleurisy, pleural plaques, and diffuse
pleural fibrosis (Hillerdal, 1984), as well as mesothelioma (Wagner, 1986).
3.4.1. Pleural leukocyte response to asbestos exposure
In the study by Oberdoerster et al (1983), rats received an intrabronchial
instillation of amosite or saline. Beginning at 62 days after instillation, lavaged cell
numbers increased significantly in the amosite group compared to controls.
Furthermore, the average number of peroxidase positive macrophages, young
monocytic cells, was significantly greater in amosite treated animals throughout the
experiment. Pitt (1985) showed that there was a significant increase in the mouse
pleural cavity free cell population after 6 months inhalation of UICC crocidolite
asbestos, and this increased further with prolonged exposure. Pleural macrophages
showing a marked increase in number after 9 months exposure and further
investigation indicated that they were a stimulated population.
Shore et al (1983) demonstrated that crocidolite asbestos intrapleural
injection in rabbit resulted in the appearance of chemotactic activity to PMN in
an exudative effusion peak&| 4 hr after the injection. Edwards et al (1984) found
that after intrapleural injection with crocidolite and chrysotile asbestos, pleural
lavage showed a predominance of PMN and eosinophils at 72 hours. Total
macrophages were greater with crocidolite than with chrysotile, and mast cells
were markedly decreased with the two types of fibres. In rats with mesotheliomas,
the pleural lavages showed a 10 to 20 fold increase in cell numbers, as might be
expected with many of these being tumour cells.
3.4.2. Pleural pathologic changes caused by asbestos exposure
3.4.2.1. Pleural effusion
Patients working with asbestos may develop pleural effusion and this is the
commonest asbestos-related disease during the first two decades of exposure at
work (Seaton et al, 1989). Hillerdal and Ozesmi (1987) reported that, for
developing benign asbestos pleural effusion, the mean latency time from the first
exposure to asbestos was 30 years, with a range of 1 to 58 years. Even a
comparatively slight occupational exposure may be sufficient and the effusion can
occur many years after exposure to asbestos. Preger (1978) found that
asbestos-related pleural inffusion was an exudate with a protein content varying
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from 3.4 to 7.5 mg/lOOml. Cell counts including RJBC and leukocytes in the
range of 5,000 to 50,000 cells/ml are usually present. The inflammatory cell
content, PMN, monocytes, lymphocytes, and eosinophils are variable.
Herbert (1986) suggested that diffuse effusion may follow acute asbestos
pleurisy and is probably caused by direct damage to the mesothelium. Extensive,
irregular pleural calcification as well as diffuse fibrosis of the visceral pleura may
be a sequel to pleural effusion (Seaton, 1984).
3.4.2.2. Pleural plaques
Pleural plaques are strongly associated with an occupational and
environmental exposure to all types of asbestos and with the presence of asbestos
bodies in lung tissue (Herbert, 1986). Fibrohyaline plaques locate typically on the
posterolateral and inferior part of the parietal pleura and on the dome of the
thoracic surface of the diaphragm (Bignon and Gee, 1985). Hillerdal (1978)
believed that pleural plaques generally are radiologically visible only after a long
period, at least 15 years from initial exposure to asbestos.
Hillerdal (1980) suggested that pleural plaques can be regarded as a mild
reaction to fibres that have reached the pleura by piercing lung tissue under the
influence of mechanical forces within the lung and lymphatic drainage in the
parietal pleura, where they possibly cause traumatic micro-haemorrhages and
fibrin deposition (Parkes, 1982).
Asbestos fibre counts of the lungs of patients with pleural plaques showed
a relative predominance of commercial amphiboles (crocidolite and amosite) in
contrast with the predominance of chrysotile fibres found in controls (Churg, 1982;
Seaton, 1984). However, the presence of plaques does not correlate with the
degree of pulmonary asbestosis (Parkes, 1982).
Sahn and Antony (1984) found that following intrapleural asbestos,
treatment of animals with nitrogen-mustard, which causes neutrop. enia, and
asbestos resulted in less total inflammatory cells than in asbestos alone treated
rabbits. At autopsy, nitrogen-mustard/asbestos-treated animals developed marked
fibrosis in the pleural space instead of pleural plaques observed in asbestos treated
animal. They suggested that the pleural macrophage is important in localizing the
asbestos fibre and in the ultimate formation of the pleural plaque. Without a
critical number of macrophages, plaques are not formed and instead, diffuse
pleural fibrosis results.
3.4.2.3. Pleural thickening and diffuse pleural fibrosis
Pleural thickening is a common result of asbestos exposure and appears
accompanying plaques on the parietal pleura. Diffuse pleural thickening affects
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both parietal and visceral pleura (Hillerdal, 1981). Bignon and Gee (1985)
reported that a diffuse or focal fibrous thickening of visceral pleura is commonly
seen as an accompaniment of asbestos alveolitis. Klerk et al (1989) investigated a
population of crocidolite mine workers and found that the level of total
cumulative exposure to crocidolite increased the rate of onset of pleural
thickening.
Pleural fibrosis is usually the sequel to an unabsorbed pleural effusion.
Any cause of pleural exudate may be responsible for the subsequent development
of pleural fibrosis (Seaton et al, 1989). A study on diffuse pleural fibrosis
(Stephens and Gibbs, 1987) indicated that all of the cases had extensive visceral
pleural fibrosis and extensive areas of adhesions.
Herbert (1986) believed that the mechanisms concerned in mesothelial
injury and repair are important in the pathogenesis of pleural fibrosis. The
fibrinolytic power of serosal surfaces, with respect to the fibrinolytic activity of
mesothelial cells, is closely related to whether fibrous exudate is absorbed
(Whitaker et al, 1982c). Ryan et al (1973) showed that the fibrinolytic activity of
mesothelial cells was depressed by damage to the cells. In an in vitro rat study,
Donaldson et al (1988c) demonstrated that the fibrinolytic activity of mesothelial
cells was inhibited by co-culture of the cells with crocidolite asbestos. Therefore,
the inhibition of the fibrinolytic activity of mesothelial cells by exposure to
asbestos may partly explain the pathogenesis of pleural fibrosis. Good et al (1979)
reported that intrapleural urokinase inhibited the development of pleural fibrosis in
rabbits treated with high- dose tetracycline. This suggests that the pathogenesis of
pleural fibrosis caused by asbestos is mediated through fibrin deposition.
3.4.2.4. Pleural mesothelioma
Wagner and his colleagues (1960) first reported 33 cases of the rare
pleural or peritoneal mesothelioma from the North-West Cape of South Africa.
Mesothelioma may result from low exposure levels, particularly with
crocidolite dust, although other types of asbestos can also cause this variety of
cancer (Wagner et al, 1980). The exposure may not only have been brief but
may also have occurred many years (20-30 years) previous to the appearance of
the mesothelioma (Buchanan, 1979; Jones et al, 1977).
Berry and Newhouse (1983) showed convincingly that there is a gradient
from crocidolite > amosite > chrysotile in the potential to cause mesothelioma.
Wagner (1986) also presented evidence that crocidolite carries the greatest risk of
subsequent mesothelioma formation. Other mineral fibres, if straight and having
the defined length and diameter, may have the potential for causing malignant
transformation of the mesothelial membranes. However, on the vexed question of
dose-response relationship in mesothelioma formation, it is too early to draw
firm conclusions (Jones, 1979).
Wagner et al (1962) was the first to induce mesotheliomas in rats after
the intrapleural inoculation of asbestos fibres. Later, many studies confirmed that
after intrapleural and intraperitoneal exposure, chrysotile, crocidolite and amosite
asbestos induced mesotheliomas in rat, rabbit and Syrian golden hamsters (Reeves
et al, 1971; Stanton and Wrench, 1972). Smith and Hubert (1974) as well as
Bolton (1983) showed that the mesothelioma response to chrysotile, amosite, and
crocidolite was dose related.
The comparison between different kinds of asbestos revealed that after
intraperitoneal injection, chrysotile samples tended to be more carcinogenic than
the amosite and crocidolite preparations and these fibres produced a graded dose
response for mesothelioma development with no effective minimum threshold
(Bolton et al, 1982; 1983 and Davis et al, 1986). In the studies of Wagner and
Berry (1969), amosite was found to produce fewer tumors than did chrysotile and
crocidolite and needed a longer induction period.
Pott et al (1980) reported that rabbits developed mesothelioma and
fibrosarcoma six years after intraperitoneal injection of UICC chrysotile asbestos
and found that fibrosis is not an absolute requirement for the development of a
fibre- induced mesothelioma.
Asbestos was also compared with other fibres in rat intrapleural inoculation
study. Wagner et al (1973) reported that very small number of mesotheliomas
were found in groups treated with synthetic aluminium silicate fibres, barium
sulfate, glass powder, and aluminium oxide. No mesothelioma was observed in rats
injected with glass fibres, or in control rats. However, Stanton (1974) developed
mesothelioma in rats after intrapleural glass fibres.
As the more realistic experiments, rats were exposed by inhalation to the
UICC asbestos for periods between 1 day and 2 years (Wagner et al] 1974).
Mesothelioma were obtained with crocidolite, chrysotile, and amosite. Two such
tumors occurred after only 1-day's exposure to crocidolite and amosite.
The combined effect of asbestos given by intratracheal instillation and
cigarette smoke in dogs was investigated by Humphrey et al (1981). The results
showed that there was not a clear synergistic effect between asbestos and cigarette
smoke in induction of mesotheliomas. Davis and his colleagues (1991) reported
that when rats were exposed to dust clouds consisting of a mixture of amosite or
chrysotile asbestos with quartz or titanium dioxide, the incidence of mesotheliomas
increased and tended to occur earlier compared to asbestos alone. There was
evidence of increased transport of fibres across the visceral pleural surface.
Besides asbestos, erionite, a fibrous zeolite differing markedly from asbestos
in many physicochemical characteristics (Coffin et al, 1989), was recognized to
cause the high incidence of mesotheliomas in the Anatolian region in Turkey
(Baris et al, 1978). Wagner et al (1985) confirmed in rat inhalation studies that
erionite produced much higher incidence of mesothelioma than crocidolite did.
In addition, ceramic fibres, a type of synthetic, amorphous and glassy
fibre, were found to induce pleural mesothelioma on hamsters and rats in
high-dose inhalation studies (ECFIA, 1991).
3.4.3. Translocation of asbestos fibre into the pleura
It is controversial whether asbestos depositing in airspaces following
inhalation will be transferred into the pleural space. A kinetic study was
performed by Viallat et al (1986) with rats injected intratracheally with chrysotile
asbestos. The overall number of fibres present in the pleural cavity ranged from
3.6 x 10^ on day 14 to 12.8 x 10^ on day 21. Most fibres retrieved were short
fibrils, lA/iti mean lengths ranging from 0.44 to 1.32 microns, and about 0.3
microns in diameter. They proposed the occurrence of an early blood migration.
Asbestos fibres in pleural and parenchymal tissues were measured in
humans (Sebastien et al, 1980). In parietal pleura there were 27, 64 and 71
percent significantly positive samples from the normal location, normal plaques,
and diaphragmatic plaques, respectively and they were mostly chrysotile type
fibres. There was an increased short fibre frequency and decreased long fibre
frequency from lung to pleura. Sebastien et al (1979) also found that almost all the
fibres in the pleura were chrysotile fibres, but no fibre type predominated in
parenchymal samples.
With regard to the mechanisms of translocation of asbestos fibres into the
pleura, Holt (1983) demonstrated the migration of macrophages carrying asbestos
fibres through the parenchyma of the lung towards the pleura. An inhalation study
by Morgan et al (1977) with radiolabeled anthophyllite exhibited the
accumulation of fibres within a few months in mediastinal lymph nodes which
might serve as a reservoir or as a filter between the lung parenchyma and the
pleura or subpleural foci. Kanazawa et al (1979) demonstrated in mice that after
subcutaneous and intravenous injections of asbestos significant numbers of fibres
were found in the milky spots of the serous cavities. A study in rats
intratracheally injected with asbestos indicated two phases of asbestos translocation
into the pleura also in favor of asbestos blood transportation (Viallat et al, 1986).
However, some experiments had opposite findings. A study on rats indicated
that after intrabronchial instillation of amosite, no fibres were detected in pleural
lavage samples over the experimental period (Oberdoerster et al, 1983). In a
study on guinea pigs intratracheally instilled with amosite, Dodson and Ford
(1985) showed that in all time periods up to 3 months postexposure, asbestos
fibres were never found within the pleura or subpleural regions, although some
fibres were observed close to the pleura. However, pleural changes occurred in
the absence of direct fibre contact, including mesothelial cell plieomorphic
changes, proliferation and increased vacuolization.
4. Leukocyte cytokines (monokines)
The cytokines are extracellular signalling proteins secreted by specific cells
(Goustin et al, 1986) and these molecules have, as their primary function, the
ability to modify the behaviour of other closely adjacent cells. Each cytokine acts
on a particular subset of neighboring cells by interacting with specific high
affinity receptors (Larrick and Kunkel, 1988). These receptors are glycoproteins,
integrally located within the cell membrane that have extracellular, transmembrane,
and intracellular domains. The extracellular portion of the receptor binds the
cytokine ligand; the intracellular portion is involved in initiating a signalling
cascade (Kelley, 1990).
It has become clear that the actions of combinations of cytokines are
complex and cannot be predicted (Kelley, 1990). The complex interactions
between cytokines has led to the concept that tissue homeostatic mechanisms are
controlled by cytokine cascades and networks rather than by individual cytokines
(Kohase et al, 1987).
4.1. Interleukin 1
Interleukin-1 (IL-1) is the term given to two polypeptides (IL-la and (3)
that possess a wide spectrum of immunological and nonimmunological activities.
Although both forms of IL-1 are distinct gene products, they recognize the same
receptor (Larrick and Kunkel, 1988). In general, there does not seem to be any
difference in the spectrum of biological activities of either form (Dinarello, 1988).
4.1.1. Cellular sources of IL-1
A variety of cells have been shown to produce IL-1, including
mononuclear phagocytes, B-cell, epidermal cell, glial cells and PMN (Canning and
Neill, 1989); the major producers, however, appear to be monocytes/ macrophages
(Martin and Resch, 1988), these include circulating blood monocytes, pulmonary
alveolar macrophages, hepatic Kupffer's cells, peritoneal macrophages and splenic
macrophages (Dinarello, 1984).
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Although small amounts of IL-1 may be released spontaneously, most
normal cells produce IL-1 only in response to exogenous stimulants (Martin and
Resch, 1988), such as infection, microbial toxins, inflammatory agents, products of
activated lymphocytes, complement, and clotting components (Dinarello, 1989).
Oppenheim et al (1989) suggested that constitutive production of IL-1 by normal
cells can probably be attributed to prior stimulation in vivo or, alternatively, due
to the presence of a contaminating stimulant in vitro such as the ubiquitous
endotoxin.
Lonnemann et al (1989) reported that human mononuclear cells produced
both cell-associated and secreted IL-1 a and IL-1 (3 in vitro in response to
lipopolysaccharide (LPS). Wewers et al (1984) found that alveolar macrophages
were at least 1,000 times less sensitive to LPS compared with blood monocytes in
terms of IL-1 release. This limitation was thought to be linked to the
maturational state of the mononuclear phagocyte. The study of Elias et al (1985)
also showed that LPS stimulated blood monocytes elaborated more IL-1 than
stimulated alveolar macrophages. In addition, denser alveolar macrophages and
blood monocytes elaborated more IL-1 than less dense alveolar macrophages and
monocytes. When monocytes matured in vitro, they lost their ability to elaborate
IL-1, and became less dense. Fuchs et al (1988) found that after intravenously
administrated bacillus Calmette-Guerin, lavaged alveolar macrophages containing
increased percentages of higher density cells and elaborated increased IL-1.
PMN have been demonstrated to be capable of synthesizing IL- 1. Tiku et
al (1986a) found that normal human PMN can be stimulated by particulate agents
such as zymosan and soluble agents such as phorbol myristic acetate to produce
IL-1. Canning and Neill (1989) reported that the supernatants of purified
peripheral bovine blood PMN cultured in the presence of opsonized zymosan
particles exhibited IL-1 activity. Kusaka and Donaldson (1990^) showed that IL-1
like activity was spontaneously produced by neutrophils obtained from
experimentally inflamed rat lung at high levels, but it could still be enhanced by
stimulation with endotoxin in vitro.
Besides monocytes, macrophages and PMN, murine eosinophils were also
reported to produce IL-1 (Pozo et al, 1990) when they were stimulated with LPS.
4.1.2. Modulation of IL-1 production
The production of IL-1 is regulated by many factors, such as interferon
and TNF. Incubation of human blood monocytes with interferon y or a prevented
the losS of IL-1 secretory potential in response to endotoxin during the
differentiation from monocytes to macrophages and interferon y was more potent
than interferon a (Haq and Maca, 1986). Gerrard et al (1987) reported that
interferon a directly induced IL-1 secretion by monocytes whereas interferon y
greatly enhanced IL-1 secretion by priming monocytes to be more sensitive to
IL-1-inducing stimuli.
Some antiphlogistic drugs can influence IL-1 production. Paegelow and
Werner (1989) reported that during calcium pyrophosphate-induced pleurisy in
mice there was enhanced production of IL-1 in the pleural exudate and in serum.
Warner and Libby (1989) have shown that both human rTNFa and /3
induced transient accumulation of IL-1 mRNA by human vascular smooth muscle
cells. TNFa treatment also increased intracellular biologically active IL-1 and
subsequent release of IL-1 activity from the cells. Nawroth et al (1986) found
that specific interaction of TNF with human umbilical vein endothelial cell
receptors leads to the synthesis and release of IL-1.
IL-1 is also an autoregulator of IL-1 production. Manson et al (1989)
found that IL-1 can stimulate its own production by human blood mononuclear
cells and that this effect is IL-1 concentration dependent.
4.1.3. The biological properties of IL-1
Bronson et al (1987) found that the amount of hyaluronate in the medium
of normal dermal fibroblasts was increased approximately 10-fold in the presence
of IL-1. Postlethwaite et al (1988) observed that both human recombinant IL-1 a
(rIL-la) and /3 stimulate the synthesis and accumulation of type I procollagen
chains by fibroblasts. They also found that both types of IL-1 stimulate synthesis
of tissue inhibitor of metalloproteinase, prostaglandin E2, and growth of fibroblasts
in vitro.
IL-1 induced a significant influx of PMN in a mouse subcutaneous sponge
implantation model (Mason and Epps, 1989), in a rabbit inflammation model
(Rampart et al, 1989) and in a mouse intraperitoneal injection model (Sayers et
al, 1988). Martin and Resch (1988) showed evidence that IL-1 is chemotactic for
mononuclear phagocytes and lympnocytes.
It has been demonstrated that the synthesis of plasminogen activator
inhibitor (PAI) by cultured human and bovine endothelial cells was enhanced by
IL-1 (Gramse et al, 1986; Nachman et al, 1986). Medina et al (1989) reported
that treatment of bovine aortic endothelial cells with IL-1 dramatically increased
the level of PAI messager RNA. Bevilacqua et al (1985) reported that
pretreatment of cultured human umbilical vein endothelial monolayers with IL-1
resulted in an increase in human peripheral blood PMN and monocyte adhesion.
Schmidt et al (1984) found that monocyte derived IL-1 was able to
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regulate fibroblast proliferation, which suggests that the local release of IL-1 may
contribute to abnormal connective tissue deposition in silicosis and other fibrotic
diseases by stimulating fibroblast proliferation and amplifying other signals
stimulating the synthesis of connective tissue components.
IL-1 also has a negative control of cell functions. Cavender and Edelbaum
(1988) reported that both human rIL-la and (3 totally inhibited the increases in
endothelial cell RNA synthesis, protein synthesis, and cell volumes induced by
TNF and lymphotoxin. Cominelli et al (1990) demonstrated that pretreatment
with IL-1 /3 before the induction of colitis reduces inflammation by a mechanism
that requires prostaglandin synthesis.
IL-1 also exerts its role as an important mediator in inflammation and
immunity via other interleukins. Sironi et al (1989) showed that in vitro exposure
to recombinant IL-1/3 markedly increased IL-6 production by human endothelial
cells and IL-1 -treated human endothelial cells expressed high levels of IL- 6
mRNA. Dinarello (1989) suggested that IL-1 has effect on IL-2 production from
T-cell lines. However IL-1 itself does not induce IL-2 secretion but requires a
second signal, such as mitogen.
Presumably all biological effects of IL-1 are mediated by the high affinity
binding of IL-1 to its receptor (Martin et al, 1988). A variety of cell types are
known to have IL-1 receptors, such as cell lines of T lymphoma, epithelial cells,
fibroblasts (Ohkawara et al, 1989) as well as human and murine PMN (Parker et
al, 1988). However, little is known concerning the biochemical events following
IL-1 receptor interactions. Oppenheim et al (1986) suggested that IL-1 does not
induce intracellular changes in calcium concentration directly, but does depend on
calcium channel formation for its effects.
4.1.4. IL-1 Inhibitor
Roberts et al (1986) reported that an IL-1 inhibitor was produced by
human macrophages exposed to influenza virus or respiratory syncytial virus.
Alveolar macrophages from normals and allergic asthmatic patients were also found
(Gosset et al, 1988) to produce an IL-1 inhibitory factor.
Schwarz et al (1987) found that the fractions from ultraviolet (UV)
irradiation-treated murine epidermal cells and from transformed keratinocytes
eluting at around 40 kilodaltons inhibited IL-1 activity. In another study (Schwarz
et al, 1988), they demonstrated the presence of a specific epidermal cell derived
inhibitor of IL-1 in the sera of mice irradiated with UV.
Tiku et al (1986^) found that normal human PMN are a source of a
specific IL-1 inhibitor. The inhibitor is constitutively present in the PMN and
inhibits IL-1 in a dose-responsive manner. Arend et al (1989) described an IL-1
inhibitor produced by human monocytes cultured on adherent immune complexes
or adherent IgG. The inhibitor specifically blocked binding of IL-1 to its
receptor on the murine thymoma cell line EL4-6.1.
4.1.5. Production of IL-1 and pathogenesis
Fireman et al, (1989a and found that IL-1 secretion by alveolar
macrophages was greatly increased in sarcoid patients but within the normal limits
in patients with idiopathic pulmonary fibrosis. However, Yamaguchi et al (1989)
found that the amount of IL-1 released from LPS-stimulated alveolar
macrophages from smokers as well as pulmonary sarcoidosis was significantly
decreased compared with that in nonsmokers. Eastgate et al (1988) demonstrated
that the mean plasma IL-1 (3 was significantly higher in patients with rheumatoid
arthritis than in healthy controls of similar age.
Becherucci et al (1989) found that rat macrophages collected either from
exudates in pertussis-induced air pouches or from the peritoneum during adjuvant
arthritis released more IL-1 when stimulated with LPS than cells from control
rats. Lassalle et al (1990) demonstrated higher levels of spontaneous IL-1
secretion by alveolar macrophages from patients with coal worker's
pneumoconiosis than by those from healthy controls.
Kusaka et al (1990a) reported that both high rank and low rank coal mine
dusts caused substantial release of IL-1 from normal alveolar macrophages in vitro
and the levels were higher than those caused by quartz. In an in vitro study,
alveolar macrophages from low rank coal mine dust- or titanium dioxide- exposed
lungs showed increased ability to release IL-1 in vitro. They also showed (Kusaka
et al, 1990a) that quartz-elicited bronchoalveolar leukocytes, especially neutrophils,
elaborated increased IL-1.
4.2. Tumour necrosis factor
Tumour necrosis factor (TNF) is produced primarily by activated
macrophages. It acts via specific cell surface receptor and possesses an extensive
array of biologic activities. Besides its in vitro cytotoxicity against various tumor
cell lines, TNF also induces in vivo hemorrhagic necrosis in several tumors
(Schollmeier, 1990).
4.2.1. Cells producing TNF
Macrophages are the major source of TNF and these cells can be
stimulated substantially with LPS to increase secretion. TNF is produced by all
types of macrophages thus far tested, including macrophages of pulmonary,
hepatic, peritoneal, and bone marrow origin (Beutler and Cerami, 1988a).
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Cell maturation, as well as differentiation along mononuclear phagocytic
line, is essential for TNF biosynthesis. Martinet et al (1988) found that
LPS-activated alveolar macrophages expressed TNF transcripts, synthesized and
released TNF whereas resting alveolar macrophages did not. Activated alveolar
macrophages released several-fold more TNF than did autologous blood monocytes.
Becker et al (1989) and Rich et al (1989) also demonstrated that maturation of
mononuclear phagocytes in vitro enhanced their ability to produce TNF. They
found that TNF production by LPS-stimulated alveolar macrophages peaked at
approximately 8 h and ended after 24 h.
Kriegler et al (1988) found that activated monocytes synthesize a novel,
rapidly inducible cell surface cytotoxic integral transmembrane form of TNF.
TNF is also produced by lymphocytes (Cuturi et al, 1987; Bendtzen, 1988)
and endothelial cells (Dinarello, 1989). As reported by Beutler and Cerami
(1988a), T-lymphocytes produce abundant quantities of TNF mRNA and protein
when induced with the calcium ionophore A23187 in conjunction with phorbol
myristate acetate (PMA). Steffen et al (1989) showed the presence of TNF
mRNA in the cytoplasm and TNF protein in the granules of individual human
basophil/mast cells. Young et al (1987) have also demonstrated the presence of
TNF responsible for natural cytotoxicity in murine mast cells.
4.2.2. Control of TNF biosynthesis
Controlled modulation of cell-derived protein mediators, such as TNF, is
essential since these molecules not only orchestrate the inflammatory response, but
also are crucial to normal cellular growth and differentiation (Kunkel et al, 1989).
Endotoxin enhances TNF mRNA transcription and induces TNF mRNA
translation (Becker et al, 1989) as well as TNF secretion compared to monocytes
without LPS stimulation (Nissen-Meyer et al, 1988). Collart et al (1986) reported
that interferon (IFN) y, by itself, is apparently not capable of stimulating release
of macrophage-derived TNF, but it potently augments LPS-induced TNF release.
Priming the monocytes with rIFN—y before LPS exposure resulted in an increase
in TNF production (Nissen-Meyer et al, 1988). The molecular mechanism of this
enhancement occurs at both the transcriptional and post-transcriptional levels.
Besides endotoxin and IFN-7, other compounds have been shown to be
capable of inducing TNF production in monocytes/ macrophages, e.g., protein
kinase C-activating agents, immune complexes and the complement protein Csa
(Schollmeier, 1990).
Dexamethasone and other glucocorticoids can markedly suppress the
production of TNF by LPS-treated macrophages when given a pre-treatment or
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added along with the challenge (Beutler et al, 1986). The work of Kunkel et al
(1988) indicated that prostaglandin E2 (PGE2) regulated macrophage-derived TNF
gene expression and resulted in reduction of genomic transcripts for TNF.
Kunkel et al (1989) suggested that PGE2 acts as an endogenous autocoid with
regulatory activity for TNF production. This regulation appears to be mediated via
the intracellular accumulation of cAMP.
4.2.3. TNF production in pathological situations
Borm et al (1988) have investigated the release of TNF from blood
monocytes in a group of coal miners and non-dust-exposed individuals. They
found that monocytes from dust-exposed individuals revealed higher TNF release
as compared to normal controls.
A rat study showed that after given by intratracheal instillation, silica
caused increased release of TNF by alveolar macrophage than titanium dioxide did
(Driscoll et al, 1990,). Piguet et al (1990a) showed that TNF plays an important
part in silica-induced pulmonary fibrosis in mice since a single instillation of
silica leads to a marked increase in the level of lung TNF mRNA and
silica-induced collagen deposition is almost completely prevented by anti-TNF
antibody, but is significantly increased by continuous infusion of mouse rTNF.
4.2.4. Inhibition of TNF
As it seems likely that TNF mediates several in vivo activities that can
profoundly effect the well-being of an individual, it is clear that TNF activities
must be diligently regulated. As with almost any soluble factor, TNF activities
could be controlled at any of the several steps from gene transcription to the
final step in the response of a target to TNF binding (Kunkel et al, 1989).
Evidence was presented by Lin et al (1988) that spleen cells from normal,
untreated mice produce a factor that inhibits TNF cytolytic activity. Seckinger et
al (1989) reported that urine of some febrile patients contains a TNFa inhibitory
activity. Characterization indicated an apparent molecular mass of 33,000 Dalton.
TNFa inhibitor blocks the different biologic activities induced by TNFa by
interfering with the interaction of the ligand and its receptor (Lin et al, 1988;
Seckinger et al, 1989). The further study of Seckinger et al (1990a) indicated that
the TNFa inhibiting activity originally described might be a soluble form of the
TNF receptor itself. They purified the inhibitor and found that it forms a stable
complex with TNFa and regulates TNFa bioactivity at the protein level (Seckinger
et al, 1990b).
4.2.5. The biological effect of TNF
Evidence that TNF plays a beneficial role by mediating resistance to a
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wide range of organisms in a variety of infectious disorders is growing (Beutler
and Cerami, 1988a). However, inflammation also carries risks of its own. It is not
difficult to understand that excessive production and release of TNF may rapidly
lead to pathological changes (Beutler and Cerami, 19885).
Endothelium is an important target for TNF. Brett et al (1988) and
Goldblum et al (1989) reported that TNF increases the permeability of endothelial
cell monolayers to macromolecules and lower molecular weight solutes by a
mechanism involving a pertusis toxin-sensitive regulatory G protein. However, the
work of Gaskill (1988), using a rat model, suggested that TNF does not affect
the permeability of the endothelial plasma membrane. Varani et al (1988) showed
that pre-treatment of rat pulmonary artery endothelial cells with TNF increased
their sensitivity to killing by PMN stimulated with PMA or Csa in a time- and
dose- dependent manner.
TNF was shown to modulate distinct PMN functions. Kapp et al (1989)
demonstrated that TNF was a potent activator of the oxidative metabolism of
human PMN. Ozaki et al (1988) found that TNF was a weak direct activator of
oxygen radical production by PMN. However, pretreatment of PMN with TNF
markedly potentiated oxygen radical production induced by opsonized zymosan.
They suggested that the products of the lipoxygenase pathway play an important
role in mediating the effects of TNF on PMN. Richter et al (1989) described that
TNF could activate single adherent human PMN by causing the secretion of
lactoferrin from secondary granules and myeloperoxidase from primary granules.
Regulatory G- protein and local changes in the concentration of cytoplasmic Ca2+
were instrumental in this TNF-induced PMN degranulation.
Ozaki et al (1988) confirmed that TNF possessed chemotactic activity for
PMN. Mason and Epps (1989) described, by using a mouse subcutaneous sponge
implantation model, that injection of both TNF and Csa stimulated an influx of
PMN. In the study of Ming et al (1987) human rTNF was found to be
chemotactic for both monocytes and PMN.
Palombella et al (1987) showed that TNF can increase the number of
epidermal growth factor (EGF) receptors on human FS-4 fibroblasts. In another
study, they reported that simultaneous addition of TNF and EGF to FS-4
fibroblasts grown in serum-free medium resulted in a synergistic stimulation of
DNA synthesis and cell growth (Palombella et al, 1988).
Elias et al (1988a) demonstrated in their study that TNF is important
stimulator of fibroblast glycosaminoglycan biosynthesis. In another study, Elias
(19885) showed that TNF could interact with IL-1 or IFN to inhibit the
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proliferation of normal diploid fibroblasts via prostaglandin-dependent mechanisms
since this inhibition was reversed when fibroblast prostaglandin production was
blocked (Elias et al, 1988a). Mauviel et al (1988) reported that TNF caused
inhibition of collagen production by human dermal fibroblasts in a dose-dependent
manner and the effect of TNF is exerted before the processing steps of
procollagens.
Larrick et al (1987) demonstrated that rTNF caused activation of human
granulocytes since granulocytes incubated with rTNF showed a dose-related
increase in nitroblue tetrazolium dye reduction, in granulocyte polarization, in
superoxide anion release, and in visually apparent aggregation. Pichyangkul et al
(1988) found that after treatment with TNFa, the expression of surface adhesive
proteins was increased on human granulocytes.
4.3. Comparison of IL-1 and TNF and synergism between them
4.3.1. Comparison of IL-1 and TNF
TNF and IL-1 are two distinct groups of proteins. Although direct
comparison of the linear amino acid of TNF and IL-1 reveals no homology and
there is also no overlap in receptor binding between the members of each group,
these cytokines have many related and overlapping biological functions (Larrick
and Kunkel, 1988; Dinarello, 1988).
The effects of IL-1 or TNF on a variety of cells in vitro, as well as
systemic effects in vivo, are often biologically indistinguishable. Both IL-1 and
TNF stimulate prostaglandin E2 and platelet-activating factor production by
cultured endothelium (Dinarello, 1989). Both of them stimulate procoagulant
activity, leukocyte adherence, fibroblast proliferation and synthesis of plasminogen
activator inhibitor (Dinarello et al, 1986). Both TNF and IL-1 induce the release
of collagenase and arachidonate metabolites by cultured synovial cells and
fibroblasts (Larrick and Kunkel, 1988). Both rIL-1 and rTNF induced
dose-dependent PMN migration into rat peritoneal cavities (Faccioli et al, 1990)
and release of a factor by macrophages into the supernatant in vitro which
induced PMN migration. Both IL-1 and TNF induce IL-2- receptors, IL-6, colony
stimulating factors and acute phase proteins (Oppenheim et al, 1989).
The most likely explanation of these related functions is that TNF and
IL-1 stimulate similar intracellular messages and alter cellular metabolism in a
similar way (Dinarello, 1988). Oppenheim et al (1989) believed that the
overlapping effects of IL-1 and TNF are in part due to the induction of the
same spectrum of cytokines and their receptors. IL-1 and TNF are also
frequently released together by cells (Oppenheim et al, 1989).
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The activity of TNF differs dramatically from that of IL-1 in that IL-1 is
not toxic to a variety of tumor targets for which TNF is a potent cytotoxin
(Dinarello, 1989). Rampart et al (1989) reported that IL-1 and TNF exert their
pro-inflammatory effects in vivo via different mechanisms since, in an in vivo
model of inflammation, IL-1-induced PMN leukocyte accumulation was slower in
onset and was inhibitable by actinomycin D and cycloheximide. In contrast,
TNF-induced PMN leukocyte accumulation was rapid in onset and very short of
duration. Sayers et al (1988) reported that about 100 times more TNF than IL-1
protein was required to produce a comparable PMN infiltration in the peritoneal
cavity.
4.3.2. Synergism between II—1 and TNF.
When IL-1 and TNF are used together in experimental studies, the net
effect often exceeds the additive effect of each cytokine (Dinarello, 1989).
IL-1 and TNF, when injected intradermally together, act synergistically in
inducing PMN infiltration (Movat et al, 1987). Wankowicz et al (1988) and Sayers
et al (1988) also found that there was synergy between TNFa and IL-1 in the
induction of PMN migration during inflammation.
It was shown that rIL-1 and TNF act synergistically in the production of
fibroblast prostaglandin (Elias et al, 1987). They demonstrated (Elias et al, 1988c)
that both IL-1 and TNF alone has a mild stimulatory effect on fibroblast
proliferation. In contrast, a dose-dependent inhibition of fibroblast proliferation
was noted when fibroblasts were simultaneously exposed to rIL-1 and TNF and
this inhibition appeared to result from IL-1 and TNF synergistically stimulating
fibroblast prostaglandin production. Furthermore, Elias et al (1990) described that
combining rIL-1 and rTNF resulted in a synergistic increase in expression of IL-
la activity by fibroblasts.
Dinarello (1989) suggested that the synergism between the two cytokines
was due to second messenger molecules rather than up-regulation of cell
receptors.
4.4. Plasminogen activator and plasminogen activator inhibitor
4.4.1. Plasminogen activator
Plasminogen is the inactive precursor of plasmin, the central enzyme
responsible for fibrinolysis. Plasminogen activators (PA) are a group of specific
neutral, serine proteases that proteolytically convert plasminogen to plasmin
(Goldfarb, 1983). Plasmin, directly or indirectly, can promote degradation of all
components of the extracellular matrix (Blasi et al, 1987).
PAs are serine proteases which fall into two immunologically and
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biochemically distinct types: tissue-type (t-PA) and the urokinase-type (u-PA).
T-PA appears to be the primary mediator of vascular fibrinolysis; it is synthesized
and secreted by endothelial cells as well as tumor cells (Hart and Rehemtulla,
1988). Binding to fibrin is necessary for effective activation of plasminogen by
t-PA. U-PA is synthesized and secreted by many cell types at different stages in
their life cycle, such as macrophages (Chapman et al, 1984), epithelial cells
(Gross et al, 1990) and endothelial cells (Levin and Loskutoff, 1982). U-PA
plays a central role in regulating extracellular proteolysis in a variety of normal
and pathological processes involving cellular functions, tissue destruction and cell
migration (Blasi et al, 1987; Hart and Rehemtulla, 1988).
4.4.1.1. Production of PA and its regulation
Unkeless et al (1974) showed that cultured thioglycollate- stimulated
peritoneal macrophages synthesize and continuously release high levels of PAs
whereas unstimulated macrophages do not. However, Drapier et al (1979) found
that thioglycollate- elicited mouse peritoneal macrophages secrete PA into the
extracellular medium during in vitro cultivation only after contact with serum.
Chapman et al (1984) found that normal alveolar macrophages synthesize
and express a membrane bound urokinase-type PA. Robinson (1988) reported that
normal human alveolar macrophages produced PA in a time- and plasminogen
concentration- related manner.
Levin et al (1982) reported that cultured bovine endothelial cells produced
both urokinase and tissue-type PAs. Gross et al (1990) described large quantities
of u-PA activity both in conditioned media and cell lysates from epithelial
monolayers in culture. Stimulation of alveolar epithelial cell monolayers with LPS
or TNF increased the levels of secreted PA.
Colony-stimulating factor was shown to enhance the production of PA by
J774 cells, a mouse monocyte-like macrophage precursor cell line (Chen and Lin,
1984). Sitrin et al (1987) described that the acute lung injury induced in rabbit
by an intravenous injection of PMA was characterized by extensive intra-alveolar
fibrin formation and the substantial increase of the level of PA activity in
bronchoalveolar lavage was found to contribute to the extent of fibrin deposition.
Chapman et al 1986 reported that human alveolar fluid from normal
controls contained PA. In contrast, alveolar fluid from patients with sarcoidosis or
idiopathic pulmonary fibrosis had low or absent PA activity. However, total
cell-associated PA was not substantially different between patients and normal
subjects.
Whitaker et al (1982c) showed that pleural mesothelial cells have potent
fibrinolytic activity. Donaldson et al (1988c) confirmed that mesothelial cells have
considerable PA activity in vitro. This activity is depressed by damage to
mesothelial cells, such as insult caused by mineral dusts (Donaldson et al, 1988a).
4.4.1.2. Biological effects of PA
PAs play a general role in cellular migration, tissue remodelling and
invasive processes of tumour cells (Goldfarb, 1983).
Liotta et al (1981) demonstrated that glycoprotein and collagenous
components of basement membrane were poor substrates for PA and plasmin
alone was not sufficient to completely degrade the whole basement membrane.
Therefore, plasmin, generated through the action of PA, was considered to play a
role only in the degradation of noncollagenous components of basement
membrane.
Chapman et al (1984) have examined the role of macrophage- derived PA
in the degradation of both insoluble fibrin and elastin matrices. The results
indicated that cells degraded an insoluble fibrin matrix in the presence of
plasminogen whether or not the macrophages contacted the fibrin. Live
macrophages also degraded insoluble elastin only when in contact with the elastin.
In another study (Chapman et al, 1988), they observed that human alveolar
macrophages can degrade glycoprotein and elastin elements of extracellular
matrices by an enzymatic process and plasminogen has critical importance in this
process. Bignon et al (1985) suggested that plasmin, derived from plasminogen
activator, may affect the proteoglycan "coat" around the more fibrous matrix
collagens and elastin.
4.4.2. Plasminogen activator inhibitor
PA is regulated by several mechanisms such as specific interaction with
fibrin, the abundant plasmin inhibitor c^- antiplasmin as well as PA inhibitors
(PAI) (Sprengers and Kluft, 1987). However, PAIs play an important role in fine
regulation of location and extent of plasminogen activation.
Two distinct protease inhibitors specific for PAs have been identified: PAI
type-1 (PAI-1), is the major PAI in plasma and is derived primarily from
endothelial cells, platelets and some neoplastic cell lines. This inhibitor is involved
in the regulation of plasma t-PA activity (Blasi et al, 1987; Sprengers et al,
1987) The other, PAI type-2 (PAI-2), first purified from placenta extracts, is
released by cultured monocytes-macrophages of different origin, U937 cells and
PMN (Blasi et al, 1987). It plays a role in the regulation of extracellular PA
activity involved in tissue remodelling (Hart and Rehemtulla, 1988). These two
inhibitors are proteins of MW about 50,000, they differ in immunological reactivity
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and in some physiological characteristics (Blasi el al, 1987). Protease nexin-1 is
the third immunologically different PA inhibitor group. It is synthesized by a
number of anchorage-dependent cells including fibroblasts and kidney epithelial
cells. It limits activation of secreted u-PA (Sprengers and Kluft, 1987).
4.4.2.1. Production and regulation of PAI
Evidence was provided that cultured endothelial cells produced a rapid
inhibitor of u-PA and t-PA (Philips et al, 1984). A further study by Levin
(1986) showed that human endothelial cells release two forms of a PAI: an active
form that readily binds to, and inhibits, PAs and an latent form that has no
anti-activator activity but which can be activated by denaturation.
Mouse peritoneal macrophages release a fibrinolytic inhibitor after
stimulation by endotoxin in vitro (Chapman and Stone, 1985a). The inhibitor
blocked urokinase directly and was very similar to placental PAI. In another
report, Chapman and his colleague (1985^) demonstrated that human alveolar
macrophages released an endotoxin-inducible urokinase inhibitor. Wohlwend et al
(1987) reported that human monocyte/ macrophages produce PA specific inhibitors
that form covalent complexes with u-PA.
Klimetzek and Sorg (1979) described that peritoneal washout macrophages
and casein or proteose peptone-elicited macrophages released fibrinolysis inhibitors.
Macrophages in serum-free cultures continued to release inhibitors for at least 48
h. Dong et al (1988) demonstrated in an experimental pancreatic ascites tumour
that inside the tumour cell, PA is the predominant activity, but in the
extracellular fluid, the opposite is the case.
Sitrin et al (1986) demonstrated that the least dense rabbit alveolar
macrophages released 6 times greater procoagulant activity than the activity
displayed by denser cells. Markus et al (1980) showed that PA was significant
elevated in lung tumors compared to normal lung and that u-PA was the
predominant PA in lung tumors.
Zeheb et al (1987) reported that incubation of rat hepatoma cells with the
synthetic glucocorticoid dexamethasone rapidly inhibits t-PA activity by inducing a
specific PAI-1. Kruithof et al (1986) described a PAI from the histiocytic
lymphoma cell line U-937 which is immunologically related to a PA-inhibitor
from human placenta and the primary role of the PAI is to regulate the activity
of u-PA. Idell et al (1988) reported that in oleic acid- induced lung injury, the
procoagulant activity of bronchoalveolar lavage fluids of sheep was markedly
increased, whereas fibrinolytic activity was either depressed or undetectable.
Kopitar (1981) reported the presence of a urokinase inhibitor in peripheral
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pig leukocyte cytoplasm. In another study, Kopitar et al (1985) showed that a PAI
which inhibits primarily u-PA was isolated from the cytosol of human peripheral
leukocytes.
4.4.2.2. Modulation of PAI activity by cytokines
Cytokines, such as IL-1 and TNF, have been confirmed to play important
roles in modulation of PAI production and its activity.
Medina et al (1989) confirmed that treatment of bovine aortic endothelial
cells with either IL-1 or human rTNF dramatically increased the level of PAI
mRNA. Schleef et al (1988) also found that both rIL-l(3 and rTNFa decreased
human umbilical vein endothelial cells t-PA and increased PAI-1 in a dose- and
time-dependent manner. Nachman et al (1986) showed the induction of PAI
synthesis by IL-1 in human cultured endothelial cells.
Michel et al (1989) demonstrated that rIL-1 (3 induced a rapid and
significant accumulation of both t-PA and u-PA mRNA and type 1 and 2 PAI
mRNA in fetal lung fibroblasts. Rogister et al (1990) reported that cultured rat
astroglial cells treated with IL-1 released enhanced PAI. In contrast, Campbell et
al (1991) showed that human rIL-1 inhibits PAI-1 production by human articular
cartilage and chondrocytes.
Scarpati and Sadler (1989) found that in endothelial cells treated with
TNF, PAI-2 was induced in part by inhibiting mRNA degradation. However,
PAI-1 was not affected by TNF. Georg et al (1989) described that TNFa induced
PAI-1 antigen in the human fibrosarcoma cell line HT-1080, and PAI-1 and
u-PA antigens in the human carcinoma cell line T -CAR1, t-PA antigen was not
affected or slightly decreased.
Medcalf et al (1988) showed that Human rTNF stimulates gene
transcription of PAI-1 and PAI-2, and simultaneously suppresses constitutive gene
expression of t-PA in human fibrosarcoma cells. They proposed that a
TNF-mediated anti-fibrinolytic state may cooperate with the induction of
procoagulant activity to stabilize the fibrin deposits commonly found in inflamed
tissue.
4.5. Growth factors
Besides controls intrinsic to the cell, cellular replication is modulated by
exogenous growth factors, a class of molecules that instructs cells to synthesize
DNA and divide (Bitterman et al, 1982). In addition, polypeptide growth factors
also play roles in differentiation, development, chemotaxis and activation of
inflammatory cells, tissue repair, and disease (Deuel, 1987).
Growth factors are synthesized and secreted by both normal and
transformed cells. Abnormal secretion of growth factors probably results in diseases
characterized by a proliferative cellular response or by fibrosis (Deuel, 1987).
There are many classes of growth factor (Kelley, 1990), but only two
growth factors, i.e., epidermal and fibroblast growth factors are discussed here. As
suggested by Gospodarowicz (1985), the tissue range sensitivity of fibroblast growth
factor complements and sometimes overlaps with that of epidermal growth factor.
4.5.1. Epidermal growth factor
Epidermal growth factor (EGF) is mitogenic for a variety of mesenchymal
cells and epithelial cells in culture. EGF markedly stimulates proliferation of those
cells and leads to enhanced keratinization and squame production (Gospodarowicz,
1985). It also delays the ultimate senescence of the cells, thereby increasing their
culture lifetime (Rheinwald and Green, 1977).
Sundell and colleagues (1980) demonstrated that infusion of murine EGF
intravenously in fetal lambs caused epithelial hyperplasia of the conducting airways,
resulting in morphologically more mature-appearing lungs than found in twin
control animals. Gross et al (1986) showed that EGF enhances the rate of
surfactant production in fetal rat lung slices and subsequently augments cellular
proliferation.
Connell and Rheinwald (1983) reported that human mesothelial cells grew
rapidly in culture when provided with EGF. They adopted a fibroblastic shape,
forming parallel, multilayered arrays at saturation density and reducing synthesis
and content of their four major keratins.
Fotev et al (1987) showed that wound exudates stimulated DNA synthesis
in normal quiescent mesothelial cells with macrophages as the principal
components of the exudate responsible for the activity. Cultured
macrophage-conditioned media also induced an increase in mesothelial replication.
Their further study (Fotev et al, 1987) confirmed the presence of a mesothelial
mitogenic factor in the supernatant of wound exudates and macrophage cell
cultures.
EGF binds to a specific cell surface receptor (Kelley, 1990). The EGF
receptor is internalized when activated by EGF and is subsequently degraded.
Recycling of the EGF receptor is insignificant, thus the interaction of EGF with
its receptor provides a negative feedback loop that "down-regulates" the potential
for additional signaling by EGF (Deuel, 1987).
4.5.2. Fibroblast growth factor
The biological effects of fibroblast growth factor (FGF) in vitro can be seen
with respect to cell transformation, migration, proliferation, differentiation, and
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senescence. It also stabilizes cell phenotypic expression and extends the culture
life span (Gospodarowicz, 1985).
The effects of FGF include stimulation of cellular transport systems,
polyribosome formation, protein synthesis, ribosomal and tRNA synthesis, and
eventually DNA synthesis followed by cell division (Gospodarowicz, 1985).
Leibovich and Ross (1976) found a macrophage-dependent factor that
stimulates the proliferation of fibroblasts in vitro. Bitterman et al (1982)
demonstrated that human alveolar macrophages stimulated with particulates and
immune complexes may modulate, in part, the replication rate of alveolar
fibroblasts by releasing a growth factor within the alveolar microenvironment. In
another study, Bitterman and colleagues (1983) found that alveolar macrophages
lavaged from the patients with interstitial lung diseases secreted measurable growth
factor activity. Macrophages from patients with sarcoidosis and more intense
inflammation secreted higher levels of fibroblast mitogens. The study of Rom et al
(1988) suggested that the alveolar macrophage-derived FGF is similar to
insulin-like growth factor-1, recognized as a progression factor for fibroblasts.
Phan et al (1987) examined the release of macrophage-derived FGF
activity by murine peritoneal macrophages with regard to its regulation by
arachidonate metabolites, and found that products of cyclooxygenase and
lipoxygenase pathways are potentially important both as exogenous and auto- or
self-regulators of macrophage derived FGF release.
4.5.3. Cytokines as growth factors
IL-1 and TNF are also able to stimulate the growth of fibroblasts and
other cells and may play a role as growth factors.
Dinarello (1984) demonstrated that IL-1 produced by mononuclear cells
stimulates fibroblast proliferation and collagen production. Bronson et al (1987)
showed that the amount of hyaluronate in the medium fraction of normal dermal
fibroblasts was increased dramatically in the presence of IL-1.
However, it is presently unclear whether this represents a true growth
factor function of IL-1 or rather that IL-1 acts to increase the production of
receptors for endogenous growth factors (Dinarello, 1988).
Palombella et al (1987) reported that TNF can increase the number of
EGF receptors on human FS-4 fibroblasts and this increase may be related to the
the mitogenic action of TNF in these cells. They suggested (Palombella et al,
1988) that EGF was responsible for driving the majority of the cell into S phase,
while TNF appeared to make the cells more responsive to the mitogenic action of
EGF.
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However, some studies indicated that the synergy between IL- 1 and TNF
lead to the inhibition of fibroblast proliferation via prostaglandin-dependent
mechanisms (Elias, 1988a).
4.6. Asbestos and monokines
4.6.1. Asbestos and IL-1
Godelaine and Beaufay (1989) showed that the in vitro exposure of mouse
peritoneal macrophages to chrysotile stimulated them to release IL-1. At equal
doses, quartz was a more potent inducer than chrysotile. However, injury caused
by chrysotile or quartz to macrophages did not merely cause a leakage of IL-1
from the cells, since the intracellular levels of the mediator were increased
rather than decreased upon exposure to these particles.
The immunostimulatory effects of respirable mineral dusts on Wistar-rat
alveolar macrophages and T-lymphocytes were studied in vitro (Oghiso and Kubota,
1987). Silica and crocidolite, but not titanium-dioxide, were found to significantly
stimulate production of IL-1 by the macrophages.
Kagan et al (1985a) showed that inhalation of either crocidolite or
chrysotile asbestos in the rat is associated with augmented release of
immunostimulatory substances having both IL- 1 and IL-2 functional activities.
Kagan et al (1989) found that these asbestos-related effects were most pronounced
in the higher density-defined (younger) macrophage fractions. The effects of
crocidolite exposure tend to be more prominent and to persist for a longer period
after the cessation of asbestos inhalation exposure than chrysotile. Since IL-1
activity is controlled by the I-region of the major histocompatibility complex, the
effect of asbestos inhalation on alveolar macrophage la antigen expression was
also investigated (Kagan et al, 1985a). Asbestos inhalation is associated with
enhanced la antigen expression on alveolar macrophages, an effect which is more
pronounced after crocidolite than after chrysotile exposure.
Rosenthal et al (1989) showed that there was no IL-1 production by
alveolar macrophages in vitro in the absence of LPS stimulation in control or
fibre exposed cultures. However, after addition of suboptimal concentrations of
LPS, chrysotile and crocidolite asbestos markedly stimulated IL-1 production.
In the study by Hartmann et al (1984), rats were exposed, by intermittent
inhalation, to crocidolite, chrysotile asbestos or clean air and then were immunized
with fetal calf serum antigens. Macrophage-lymphocyte co-culture supernatants,
when obtained from immunized, asbestos exposed rats, contained greater IL-1 and
IL-2 activity than identical supernatants from immunized, sham exposed animals.
These differences between group were not, however, observed in supernatants
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from unimmunized rats, or when supernatants were generated in the absence of
immune lymphocytes. These observations suggest that asbestos exposure is
associated with enhancement of immune responses.
4.6.2. Asbestos and TNF
Dubois et al (1989) demonstrated that chrysotile asbestos and silica
augmented TNF production by alveolar macrophages in a concentration-dependent
manner in culture. Moreover, the use of the TNFa-specific antisera indicated that
TNF represents most of fibroblast growth activity generated by mineral dust-
stimulated alveolar macrophages. They also found that endogenous leukotrienes,
such as leukotriene B4, produced by alveolar macrophages play a role in the
cellular events which lead to enhanced TNF activity in response to asbestos and
silica particles.
Rosenthal et al (1989) reported that in the absence of LPS stimulation,
TNF production by alveolar macrophages was minimal in control or fibre exposed
cultures. When incubated with suboptimal concentrations of LPS, alveolar
macrophages exposed to chrysotile and crocidolite asbestos secreted high TNF
activity.
4.6.3. Asbestos and PA and PAI
Hamilton et al (1976) described that intraperitoneal injection of asbestos
into mice induces the formation of exudates containing macrophages that produce
PA. In vitro, the addition of asbestos to macrophage cultures also stimulated PA
secretion. The in vitro treatment of mouse peritoneal macrophages by asbestos
stimulated the expression of plasma membrane bound PA activity (Lison et al,
1989).
Cantin et al (1989) described that macrophage and BAL fluid PA activity
was significantly increased in asbestos exposed sheep with abnormal X-rays,
whereas no such change was seen in exposed sheep with normal X-rays. Workers
with no signs of asbestosis had normal BAL fluid PA activity whereas PA activity
was sharply increased in those with early signs of asbestosis. However, PA
activity in workers with confirmed asbestosis was within the normal range.
Godelaine et al (1989) found that both normal and LPS- activated mouse
peritoneal macrophages induced increasing fibrinolysis after exposure to UICC
chrysotile asbestos, but there was a longer lag period for normal macrophages.
Strong stimulation of PA release by chrysotile or crocidolite-treated macrophages
was observed compared to slight stimulation by rockwool and glass fibres.
Donaldson et al (1988c) showed that PA activity of rat mesothelial cells was
inhibited after treatment with non-toxic doses of crocidolite asbestos.
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4.6.4. Asbestos and growth factor
Lemaire et al (1985c) demonstrated that supernatants from bronchoalveolar
lavage cells of asbestos intratracheally exposed rats stimulated tritiated thymidine
incorporation by lung fibroblasts to a greater extent than supernatants from
control rats. In another study, Lemaire et al (1986a) reported that alveolar
macrophages from asbestos intratracheally exposed rats showed a significantly
increased production of FGF and the increase persisted up to 6 months.
Concanavalin-A stimulated blood mononuclear leukocytes from asbestos-treated rats
showed reduced fibroblast growth inhibitory activity. Lemaire et al (1986a)
suggested that local production of FGF may be a contributing factor in the
development of asbestos-induced pulmonary fibrosis, whereas systemic suppression
of fibroblast growth inhibitory activity may represent a consequence or an
amplifying factor of the fibrotic process.
Lemaire et al (19865) also evaluated the effects of supernatants of BAL
cells on lung fibroblast proliferation and found that supernatants of BAL cells
from rats which had received intratracheal instillation of chrysotile asbestos had
significantly higher FGF activity than control levels.
Adamson and Bowden (1990) demonstrated that BAL macrophages from
rats intratracheally exposed to short fibre asbestos secreted factors that enhanced
both proliferation and secretion of collagen by fibroblasts in culture, but there was
no evidence of a fibrotic response in these animals. Conversely, exposure to long
fibre crocidolite caused no increase in the secretion of FGFs by BAL
macrophages, but did induce pulmonary fibrosis. The authors contended that FGF
release by interstitial macrophages might be far more important in inducing
pulmonary fibrosis than the release of growth factor by BAL macrophages. The
ability of fibres to cross the epithelium may thus be an important descriptor of
their pathogenicity.
Wiedemann et al (1985) showed that amosite asbestos fibres enhanced the
production of a mesothelial cell-derived soluble factor with molecular weight
greater than 12,000 daltons which stimulates fibroblast DNA synthesis. Renier et al
(1990) reported that rat pleural mesothelial cells treated with chrysotile or
crocidolite showed a significant dose-dependent increase in [^HjdThd incorporation
compared to untreated cells and further study indicated that asbestos produces
unscheduled DNA synthesis.
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PURPOSE AND SCOPE OF THE STUDY
The foregoing literature review has shown that, despite a substantial body
of research into the role of leukocytes in fibre-related lung disease, the pleura
has attracted limited attention. A number of studies, with emphasis on pleural
pathological change resulting from asbestos inhalation or pleural inoculation,
however, have been done. Few publication have focused on the characterization of
the pleural leukocytes.
In the present study, intratracheal asbestos instillation in PVG and HAN
rat models were used throughout. The aims of the study were:
(1). to determine whether or not intratracheal injected-asbestos could reach the
pleural cavity.
(2). to investigate the changes in pleural leukocyte populations and in their
cytokine-producing abilities as well as fibrinolytic activity induced by intratracheal
asbestos.
(3). to compare activation of pleural leukocytes from intratracheal
C .parvum-exposed rat lung with those from asbestos- exposed lung.
(4). to compare the functions of alveolar leukocytes and pleural leukocytes after
intratracheal instillation of asbestos.
(5). to investigate the interaction of pleural leukocytes and pleural mesothelial
cells and influence of asbestos on the interaction.
(6). to assay the effects of asbestos in culture on alveolar macrophages cytokine
production.
It was hoped that the study would yield information of general relevance




Syngenetic, PVG rats from the Institute of Occupational Medicine's Animal
Unit were used throughout. Male or female rats, 12 weeks of age or greater at
the commencement of experiments were used. WISTAR-derived rats of the HAN
strain, purchased from the Western General Hospital Animal Centre, Edinburgh,
both male and female and 12 weeks of age or more, were also used where
indicated.
2. Asbestos and other mineral dusts
The Union Internationale Contre Le Cancer (UICC) standard asbestos
samples of crocidolite, amosite and chrysotile (A) were used in the study.
Specially prepared long and short amosite fibres were also used (Donaldson et al,
1989a). The long fibre amosite was generated as a cloud in an exposure chamber
and the airborne fibres were found to have a size distribution substantially longer
than that of the standard UICC amosite. The long fibre sample used in the study
was collected from the chamber air on to filters. Preparation of the short fibre
amosite samples was as follows: a quantity of the bulk long fibre sample
described above was ground in a ceramic ball mill and sedimented in water,
comprehensive analysis of the final sample showed no loss of crystallinity and an
elemental composition close to the parent long amosite sample (Donaldson et al,
1989a). Fibre length and diameter distributions of the long and short fibre amosite
dust clouds were described earlier by Davis et al (1986a) in which fibres > 0.4
/xm in length and with an aspect ratio > 3:1 were sized by scanning electron
microscopy at a magnification of x 10,000. Almost all fibres were less than 5 /xm
in length for short fibre amosite and long fibres were prepared from raw
amosite that contained a high proportion of long fibres greater than 20 /xm.
The titanium dioxide (Ti02) was the rutile form supplied by Tioxide
Limited (Stockton-on-Tees). The quartz used was the DQ, 2 standard sample
(Messrs, Dorentruper Sand-und Thonwerke GmbH of Dorentrup, Westphalia)
(Robock, 1973).
3. Use of C.parvum to study the result of inflammation in the alveolar and
pleural spaces
Heat-killed Corynebacterium parvum was obtained from Wellcome
Reagents, Beckenham. When required for intratracheal instillation, a volume of 0.2
ml, containing 1.4 mg of C.parvum, was injected via the trachea into the lungs.
4. Exposure of animals and cells to asbestos fibres and other dusts
4.1. Intratracheal instillation of dusts
Rats were anesthetized with ether, the trachea exposed and a small
incision was made and a blunt-ended needle introduced. A volume of 0.5 ml of
Dulbecco's phosphate-buffered saline (PBS), containing required doses of asbestos,
dusts or 0.2 ml of C.parvum suspension, was then injected, and the skin closed
with metal clips. Control rats were uninjected or injected with PBS alone. It was
found that there was no difference between these two controls in our studies. The
injected rats were killed at intervals up to one month and lavages were then
carried out.
4.2. Dust exposure in vitro
Bronchoalveolar lavage leukocytes were suspended in F10 medium (Gibco,
Paisley) containing 2% bovine serum albumin (BSA) (Sigma, Poole) at a
concentration of 1 x 106/ml. A suspension of the test dust in PBS was added
into the culture at the desired concentration and then cultured for 24 hours.
4.3. Long term inhalation of asbestos and/or quartz for the transmission
electron microscope study
Dust clouds were generated in 1 m3 exposure chambers. The asbestos dust
clouds were produced using a modified Timbrell generator. The quartz dust cloud
was generated using a turntable generator to obtain better control at the low dose
levels required. The planned exposure levels were 10 mg/m3 of respirable
asbestos and 2 mg/m3 of quartz. Since in the laboratory, routine monitoring of
dust clouds is by mass, using an MRE sampler, asbestos or particulate dust was
generated separately for part of each day at a concentration calculated to produce
the required mean over the whole seven hour exposure period. The asbestos
clouds were generated for five hours each day, while the particulate dusts were
generated for two hours each day (Davis et al, 1986a).
Rats of the HAN strain were treated by combined exposure to asbestos
and particulate dusts for one year. Most of the animals were allowed to live out
their full life span except that some rats were killed at the end of the dusting
period and six months or even shorter time period later. Bronchoalveolar and
pleural lavage to obtain leukocytes were carried out.
5. Lavage techniques
5.1. Bronchoalveolar lavage
Watford) and the trachea cannulated with a blunt, 18- gauge needle secured with
nylon thread. The lungs were removed from the thorax and bronchoalveolar
lavage was performed by injecting 8 ml of PBS at 37 °C into the lungs via the
cannula. PBS was then withdrawn after massage and the entire procedure was
repeated 4 times.
Rats were killed by intraperitoneal injection of Nembutal (Ceva Ltd,
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5.2. Pleural lavage
To obtain pleural leukocytes, pleural lavage was carried out by inserting a
round-ended 8-gauge cannula through the parietal pleura between the lower two
ribs and injecting 5 ml PBS at 37 °C into the pleural space monitored via the
opened peritoneal cavity. The PBS was then withdrawn after massaging the rib
cage and this procedure was carried out 4 times.
Pleural lavage fluid was obtained by injecting 2 ml F10 medium plus 2%
BSA into the pleural cavity, then withdrawing after massaging prior to pleural
lavage. The fluid was spun at 1,000 rpm for 10 min, the cells discarded, and the
fluid retained.
6. Preparation of cell supernatants
Cell suspensions were spun at 1,000 rpm for 5 min and resuspended in
F10 medium with 2% BSA to obtain a concentration of 1 x 106/ml and incubated
at 37°C, 5% CO2 for 24 hrs. For leukocyte stimulation, lipopolysaccharide (LPS,
Sigma Poole) was added into the culture at 100 ng/ml. The supernatants were
collected and centrifuged at 3,000 rpm for 10 min to remove cell debris, then
stored at -70®C prior to assay.
7. Separation of pleural leukocytes
Pleural leukocyte suspension at 6 x 106/ml in F10 medium + 2% BSA
were thoroughly mixed with Sepracell (Sepracell-MN, Sepratech Corporation,
Oklahoma) at a ratio of 1:3. The mixture was then spun at 3,000 rpm for 15
min. The fraction at the top of Sepracell was macrophage enriched and the
fraction on the bottom was the mast cell-enriched population. The fractions were
transferred into universals and washed 3 times with F10 medium, and resuspended
in F10 medium plus 2% BSA.
8. Preparation of Cell lysate
Whole or separated pleural leukocyte populations, at 1 x 106/ml, were
frozen in liquid nitrogen and thawed in 37 °C water bath immediately. This
procedure was repeated three times and the suspensions were then spun at 3,000
rpm for 10 min to get rid of cell debris. This soluble fraction from the lysed
cells will be henceforth referred to as the lysate.
9. Primary culture of rat mesothelial cells
Mesothelial cells which were isolated from scrapes of the peritoneal cavity
and frozen down at early passage (Donaldson et al, 1988a) were recovered from
liquid nitrogen. The cells were then cultured in F12 medium (Flow Laboratories,
Rickmansworth) containing 10% fetal calf serum (FCS, Gibco, Paisley) until




10.1. Measurement of plasminogen activator (PA) activity
The plasminogen-dependent and -independent fibrinolytic activity of
bronchoalveolar leukocytes and mesothelial cells were measured using iodinated
fibrinogen according to the modified chloramine T method of Unkeless et al
(1974). A pH 7.5, 0.25 M buffer was prepared as follows: 2.5 g NaH^PO^H^
(May & Baker Ltd, Dagenham) was dissolved in 400 ml distilled water and 14.25
g Na2HPC>4 (anhydrous, May & Baker Ltd, Dagenham) in 50 ml distilled water
using heat to aid solution; these were then mixed and made up to 500 ml with
distilled water. For the labelling of fibrinogen with Na^^-Iodine (Na1Z5I), 10 fil
of a 1 mg/ml solution of fibrinogen (Sigma, Poole) was made up in the buffer
solution, which had been filtered through a 0.2 /im membrane (FlowPore D, Flow
laboratories, Sartorius, West Germany) was placed in the bottom of a conical tube
and then 5 /d of Na125I (containing 500 /xCi) (Amersham International,
Amersham) was added. Then, 50 mg chloramine T (Sigma, Poole) was dissolved
in 20 ml of 0.25 M buffer and 10 /d of the solution was added to the tube and
mixed gently for 15 sees. L-cysteine hydrachloride (Sigma, Poole) 10 mg was then
dissolved in 10 ml of 1:5 diluted buffer and 100 /d of this solution was added to
the tube and mixed. Finally, 50 mg KI (Sigma, Poole) was dissolved in 10 ml
buffer and 1 ml of this solution was added to the tube, then mixed gently. Free
1 2 5I was removed from the above mixture by chromatography on a Sephadex
G25 column (PD-10 column, Pharmacia, Milton Keynes) equilibrated with PBS
containing 0.01% fibrinogen. The 1 2 5I-fibrinogen was eluted with 0.01%
fibrinogen solution and up to 0.5ml x 25 fractions were collected.
The efficiency of iodination was examined by trichloroacetic acid (TCA,
BDH Chemical Ltd, Poole) precipitation. Five /d aliquot of each fraction plus 50
/.d of FCS were mixed with 2 ml of 20% TCA and the radioactivity was counted.
The sample was then spun at 2,500 rpm for 10 min, the supernatant poured off
and the TCA precipitated counts were measured. The bound [1 2 5I]~ fibrinogen
normally accounted for more than 95% of the total counts in the labelled
fractions (Fig. M.l). The fractions containing the radiolabeled fibrinogen (first
peak) were combined and stored in refrigerator prior to use.
1 2 5I—labeled fibrinogen was diluted in PBS with 1 mg/ml unlabelled
fibrinogen so that an 80 fil aliquot contained 1 x 105 cpm. Aliquots of 80 /d of
this solution were add to wells of Falcon microtiter plates (Linbro, Flow
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Figure. M.l Effect of TCA precipitation on the radioactivity (cpm) of
[1 2 5I]-fibrinogen
Each point represents the mean of 2 separate experiments performed in
triplicate. SD, which were not presented for clarity, varied from 5-75% of means.
The first peak is fibrinogen-bound 1 2 5I and the second peak is free 1 2 5I.
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Figure M.2 Effect of concentration of urokinase on Fibrinolysis
Results are presented as mean and SD of one experiment in triplicate.
The concentration of PLG was 1 jtg/ml.
53 A
wells were then incubated at 37 °C for 4 hr with 100 fd F10 medium containing
2.5% freshly thawed FCS to convert fibrinogen to fibrin. The plates were washed
twice with 200 /xl PBS prior to use.
The cells were incubated either with or without 1.2 ^tg/well plasminogen
(PLG, Kabi, Stockholm and a gift from Dr. I.McGregor, Blood Transfusion
Centre, Edinburgh) in 200 fil F10 plus 2% BSA for bronchoalveolar cells and in
200 fi\ F12 plus 2% BSA for mesothelial cells, to measure PA activity. The plates
were incubated at 37 °C in a 5% CO 2/95% air mixture for 24 hr and 150 /il of
aliquot was sampled from each well to assess the solubilized [1 2 5I]fibrin. The
assay was carried out in triplicate.
10.2. Measurement of plasminogen activator inhibitor (PAI)
To determine whether pleural leukocytes secrete PA inhibitor, pleural
leukocytes or their supernatant were added to cultures of bronchoalveolar
leukocytes and mesothelial cells (both at 0.25 x 106/ml) with or without PLG for
24 hr, to assess their effects on fibrinolysis. The dose-responses of pleural
leukocytes and their supernatants were determined. The background counts were
normally about 400 cpm both with and without PLG in the assay.
10.3. Characterization of PAI in pleural leukocyte supernatant
The fibrinolysis assay was used for simultaneously measuring both PA and
PAI activities in cell supernatants or lysates. This was achieved by adding
urokinase and PLG to [1 2 5I]fibrin plates to a concentration that causes a
moderate degree of fibrinolysis and then observing if the addition of supernatant
or lysate enhanced or decreased fibrinolysis.
The concentration of urokinase (kindly provided by Dr. I.McGregor, Blood
Transfusion Centre, Edinburgh), plasmin (Sigma, Poole) and streptokinase (Sigma,
Poole) were used at a concentration causing 50% of total f1 2 5I]fibrinolysis. The
activity of PAI in the pleural leukocyte cells and supernatants was determined by
titration against urokinase and PLG. In our assay, the concentrations of PLG and
urokinase were chosen at 1 /ig/ml (excessive dose) and 0.05 U/ml, respectively
(Fig. M.2). Solubilized [125I]fibrin was assessed as described above. For typical
urokinase and PLG-mediated fibrinolysis, the counts of spontaneous release were
about 4,000 cpm. The counts of trypsin- treated wells gave approximately 25,000
cpm.
The PAI activity was expressed as percent inhibition of PLG- dependent
fibrinolysis caused by urokinase in the presence of diluted supernatants, compared
with the fibrinolysis in the absence of supernatants. PAI activity was determined
according to the following equation:
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Percent (Fib.without Sup.-blank)-(Fib.with Sup.-blank) x 100
inhibition=—
(Fib.without Sup.-blank)
where units of fibrinolysis = cpm, Fib.= fibrinolysis, Sup. = supernatant.
To partially characterize the PAI, the activity of the inhibitor in the
pleural leukocyte supernatant after incubation at 50^C or 70®C for 1 hr was
compared with that of an untreated supernatant. To assess the molecular weight
of the inhibitor, the supernatant was centrifuged using a centricon-10
microconcentrator (Amicon Division, W.R.Grace & Co., Danvers), with a 10,000
D cut off.
For further characterisation of PAI in pleural leukocyte supernatant, the
acid-resistance of PAI in pleural leukocyte supernatant was determined. The
supernatant was first treated with 2N HC1 at PH 3.5 for 2 hrs and then adjusted
to PH 7.4 with 2M NaOH. The supernatants were sterilised by filtering through
0.2 /xm membrane. The supernatants before or after acid- treatment were measured
for PAI activity in the above assay.
11. C3H mouse thymocyte proliferation assay for detecting IL-1 activity
IL-1 activity in supernatants was quantified using the C3H mouse
thymocyte assay (Mizel, 1981). Mice, age at 2-4 week, were killed by ether
overdose (May & Baker Ltd, Dagenham, England). Thymus glands were removed
and single cell suspensions of thymocytes were prepared by disaggregation. The
cells were washed and suspended at 6 x 106/ml in RPMI-1640 medium (Gibco,
Paisley) with 10% FCS, 20 /xM 2-mecaptoethanol (Sigma, Poole) and 25 mM
hepes buffer (BDH Chemical Ltd, Poole), PH 7.1-7.4 adjusted with 1M NaOH.
One hundred /d of the cell suspension were added to each well, together with 50
/d of RPMI medium containing 20 /xg/ml of phytohemagglutinin (PHA, Sigma,
Poole) and 50 /d of dilutions of control RPMI medium or test pleural leukocyte
supernatants. The plates were then incubated at 37 °C in 5% CO 2 for 48 hr. The
cultures were pulsed with 0.25 /xCi 3H-methyl- thymidine per well (Amersham
International, Amersham). After one more day of culture, the cells were harvested
onto glass filters, and 3H incorporation was quantitated by scintillation
spectrophotometry. The activity of test samples was calculated by comparing with
the standard curve (Fig. M.3) of a series of dilutions of IL-1 (3 standard (A gift
from Dr. D.Burnett, Lung Immunobiochemical Research Laboratory, General
Hospital, Birminham).
12. L929 cell-lytic assay for measuring TNF activity
Murine L929 cells (from Dr.Julian Symonds, Department of Rheumatology,
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Figure M.3 IL-1/3 standard curve
Standard curve was produced by plotting concentration of IL- 1/3 standard
against thymocyte proliferation as measured by [ 3H] thymidine uptake. Each point
represents the mean and SD of 12 separate experiments in triplicate. The
equation of standard curve was Y = 2086 + 374 lnX, Y: cpm; X: IL-1/3 activity,
U/ml; r=0.92.
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Figure M.4 TNFa standard curve
Standard curve was obtained by plotting TNF concentration against activity
in L929 survival as measured by O.D. Each point stands for the mean and SD of
8 separate experiments in triplicate. The equation of the curve was Y = 65.68 -
14.14 lnX, Y: percentage of sample O.D. to control O.D., X: TNFa activity,
U/ml; r=0.93.
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Northern General Hospital, Edinburgh) were grown in minimal essential medium
t\
(MEM medium, Gibco, Paisley) containing 5% FCS. For use in the TNF assay
(modified according to Warner et al, 1989), confluent, monolayers were trypsinized
and suspended in assay medium (MEM + 5% FCS, no antibiotics) at a
concentration 0.3 x 106/ml. One hundred pi aliquots of cell suspension were
added to each well of a 96-well microtiter plate and the plates incubated at
37 °C, 5% C02 for 24 hr. The supernatant was then aspirated and discarded.
One hundred /d of assay medium containing 1 pg/ml actinomycin D (Sigma,
Poole) were added to all wells. Fifty pi of pleural leukocyte supernatants and 50
pi of assay medium with 2 pg/ml of actinomycin D were added to experimental
wells in triplicate; these were then double- diluted using a multichannel pipette.
Following 18-20 hr incubation, the plates were emptied by inversion then stained
with 100 pi/well of crystal violet methanol solution. The plates were washed with
water and allowed to dry. Optical density at 540 nm was determined with a
MR650 plate reader (Dynatech Laboratories Inc, USA). TNF activity in the
supernatant was determined by comparison with a TNFa standard (a gift kindly
supplied by Dr.Julian Symonds, Department of Rheumatology, Northern General
Hospital, Edinburgh) dilution curve (Fig. M.4).
For confirming the TNF activity in alveolar and pleural leukocyte
supernatants, a rabbit anti-TNF serum (kindly supplied by Dr. Josepn Fantone
and Dr. Steven Kunkel, Ann Arbor, Michigan, USA) was used in our assay.
Pre-bleed rabbit serum was used as a control. Fifty pi of suitable concentration
of pleural leukocyte supernatant or TNF standard with 2 pg actinomycin D and
50 pi of serial dilutions of rabbit TNF anti serum or control serum were added
into microtiter plate with L929 cells, then incubated and stained as above.
13. Use of CTLL-2 cell proliferation assay to measure IL-2 activity in
supernatants of pleural leukocytes
The IL-2 dependent cell line CTLL-2 cells were cultured in RPMI
medium with 10% FCS supplemented with 5% IL-2 enriched rat splenocyte
supernatant in the absence of hepes. When required, the cells were washed twice
with fresh medium and resuspended in the medium at concentration of 1 x
105/ml. Fifty pi of cell suspension were dispensed into each well of microtiter
plates, followed by the addition of 50 pi of test supernatants. Plates were
incubated for 24 hours at 37 °C in a 5% CO
2 and 95% air atmosphere. Each
well was labelled with 10 pi of 3H-thymidine (0.25 pCi) and then incubated for
one further day. 3H-thymidine uptake by CTLL-2 cell was measured to determine
IL-2 activity in supernatant.
14. Endotoxin measurement and removal
Contaminating levels of endotoxin in the media used in the studies were
determined by using a kit (COATEST, KABI Diagnostica, KabiVitram Ltd,
Uxbridge, Middx).
Polymyxin column (Detoxi-Gel affinitypak columns, Pierce Chemical
Company. Illinois, USA) were used to remove endotoxin from medium. An
endotoxin depleting efficiency of 99% with these columns was found.
15. Macrophage and PMN chemotaxis assay
The chemotactic activity of pleural leukocyte supernatants was measured
using Blindwell chambers (Donaldson et al, 1990). The target cells, macrophages
were obtained by bronchoalveolar lavage of control rats (>95% pure) and PMN
were obtained from rats one day after intratracheal instillation of 1.4 mg
C.parvum (80% neutrophils). In the chemotaxis assay, two controls were used:
the positive control was zymosan- (Sigma, Poole) activated rat serum, ie. rat
serum which was incubated with 1 mg/ml of zymosan at 37 °C for 1 hr and then
centrifuged at 3,000 rpm to remove the zymosan; the negative control was F10
medium plus 2% BSA alone. Two hundred /d of controls or test supernatants
were placed in the lower compartment of the Blindwell chamber. To detect the
chemotactic activity of supernatants for macrophages, a 5-/mi nucleopore filter
(Pleasanton, California) was placed on top. The top part of the chamber was
screwed down and 400 /d of F10 medium + 2% BSA containing 6 x 10 s
macrophages were placed in the upper compartment. The chamber was then
incubated for three and half hours at 37 °C in a moist 5% CO 2 atmosphere. The
cell suspension in the top compartment was then pipetted gently up and down
and decanted. The top compartment of the chamber was unscrewed and the filter
carefully removed from the chamber, washed twice in PBS and stained with Diff
Quick (Merz-Dade, Dudingen, Switzerland). The filters were allowed to dry before
mounting in DPX plastic mountant under a cover slip. The macrophages which
had migrated through the filter were counted at xl 000 magnification by light
microscopy. To measure the neutrophil chemotactic activity of pleural leukocyte
supernatants, 3-/im in pore diameter filter (Pleasanton, California) was used and
the incubation time was 45 min. Other procedures were the same as those for
measurement of macrophage chemotactic activity.
16. Mesothelial cell lysis and detachment assay for determining mesothelial cell
damage
Mesothelial cells were grown and serially passaged in F12 medium with
10% FCS until required. In the lysis and detachment assay (Donaldson et al,
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1988^), the mesothelial cells were plated into 96-well microtiter plate at 5 x 104
cells per well in 100 p\ F12 medium plus 10% FCS. The cells were labelled
overnight with 51Chromium (51Cr, Amersham International, Amersham) at 74
KBq per well in 100 /d F12 medium + 10% FCS. In preliminary experiments, it
was found that after 24 hr incubation, the spontaneous release of 51Cr by
mesothelial cells during 8 hr after incubation was less than 25% of total 5 7Cr
uptake as determined by lysis with 1% Triton-X-100 (Sigma, Poole) (Tab. M.l).
After incubation, supernatants were removed and the monolayers were washed 2
times with 200 /d of PBS. The lavaged pleural leukocytes were resuspended with
F12 medium containing 2% BSA at different concentrations and 200 p\ of cell
suspension were pipetted onto mesothelial cell monolayers to achieve final ratios
between pleural leukocytes (effectors) and mesothelial cell (targets) of 0:1. 0.1:1,
1:1, 10:1 and 20:1. After co- culture of targets and effectors for 4 hr at 37°C,
the microtiter plates were centrifuged for 5 min at 1,000 rpm. Release of soluble
51Cr, a measure of cell lysis, was determined by aspirating 50 /d of supernatant
from each well, then transferring to tubes and counting in a 7 counter. Cell lysis
was expressed as cpm after being multiplied by four.
Table M.l MESOTHELIAL CELL 51-CHROMIUM UPTAKE AND SPONTANEOUS
RELEASE
Total Uptake Time course of spontaneous release (hours)
0 2 4 6 8
14906(8372)a 1613(519) 1862(519) 2739(1056) 3169(1259) 3292(975)
(10.8%) (12.5%) (18.4%) (21.3%) (22.1%)
an=2 separate experiments in triplicate, results are presented as
mean (SD) cpm.
The detachment of mesothelial cells was measured by aspirating the
remainder of the supernatant of mesothelial cells, the monolayers of the cells
were then washed with 200 /d of PBS. This was repeated twice and combined
washes were counted for 51Cr activity of detached and loosely adherent cells.
Final detached 51Cr activity was determined by following equation: Y - (X x
3)*.
*
Y: 51Cr activity in remaining supernatants of mesothelial cells and two
washes, X: 51Cr activity in 50 p\ supernatant of mesothelial cells for measuring
cell lysis.
58
17. Attempts to detect mesothelial cell growth factor in pleural lavage fluid
Mesothelial cells growing in flasks were trypsinized, washed and
resuspended in F12 medium + 2% FCS at a concentration 0.25 x 10G/ml; 200 pi
of the cell suspension was then transferred into microtiter plate and incubated at
37 °C, 5% CO 2 overnight. The medium was replaced by 50 pi of F10 medium +
2% BSA and 50 /d of diluted test supernatants or pleural lavage fluid. F10 + 2%
BSA alone was used as the negative control. Meanwhile, each well was labelled
with 0.5 pCi [ 3H]-methyl-thymidine and further overnight incubation was carried
out. The culture supernatants were then poured off and 200 pi of trypsin (Sigma,
Poole) was added into wells. The cells were harvested on glass fibre filters after
10 min incubation at room temperature. The filters were dried and the cellular
[3H] thymidine incorporation was measured by liquid scintillometry in a (3
counter.
18. Observation of latex microspheres and C.parvum organisms in both
bronchoalveolar and pleural lavage leukocytes
To study the possible transfer of particles from the alveolar to the pleural
space, animals were intratracheally instilled with 0.4 ml of PBS containing a 1:20
dilution of monodispersed fluorescent carboxylated microspheres which have a
geometric diameter of 0.770 pm (beads, Polysciences Inc., Warrington). The beads
were injected together with C.parvum as required.
Cytospin preparation of bronchoalveolar and pleural leukocytes were
observed by epi-fluorescent light microscopy to detect the beads. The macrophages
and neutrophils from both populations were divided into two groups: -with or
without beads. In the group with beads, the cells were further divided into 3
subgroups: -cells containing less than 5 beads, cells containing 6-10 beads and
cells containing more than 10 beads; a differential count was also carried out.
In addition, following C.parvum exposure alone, the lavaged leukocytes
were examined for intracellular organisms. Both macrophages and neutrophils were
divided into two groups:-with or without intracellular C.parvum organisms.
19. Transmission electron microscope study of pleural structure and pleural
leukocytes after instillation of asbestos
Fresh pleural lavage leukocytes were spun down and then suspended in
2.5% glutaraldehyde (BDH Ltd, Essex) in 0.1M sodium cacodylate (Fisons
Scientific Apparatus, Loughborough, Leics) solution. The cell suspension was kept
on ice for 2 hr and then washed three times with 0.1 M sodium cacodylate
solution. The leukocytes were resuspended in 2% osmium tetroxide (Os04, BDH
Ltd, Essex) in 0.1M sodium cacodylate solution for 2 hr and washed 3 times with
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0.1M sodium cacodylate solution again. After the third wash, the supernatant was
replaced by 1 ml 2% warmed liquid agar and spun at 1,000 rpm for 5 min.
Following setting of the agar the solid pellet was removed from the tube and cut
into 1 mm size cubes which were then stored in 0.1M sodium cacodylate
solution prior to further processing (modified according to Robinson, 1977).
The sodium cacodylate solution was removed and 10% acetone (May &
Baker Ltd, Dagenham) in distilled water was added and rotated on Rotary Mixer
for 15 min, then decanted. This was replaced with 25%, 50% and 70% acetone
solution sequentially. A 90% acetone solution was then added and rotated for 15
min, this was repeated twice followed by 3 changes of absolute acetone. Equal
parts of absolute acetone solution and 100% epoxy resin (Araldite CY 212, Agar
Scientific Ltd, Stansted, Essex) was substituted in and rotated for 3 hr. Finally,
cell cubes were removed into 100% Araldite and rotated overnight. The cell cubes
were then embedded into moulds filled with araldite, one cube to each mould,
and polymerised at 60®C for 48 hr (Robinson, 1977).
For pleural structure studies, tissues at 1 mm3 size were cut from the
visceral and parietal pleura of rats killed by intraperitoneal Nembutal injection.
Fixation was the same as above except for the agar treatment stage.
The cell or tissue araldite blocks were squared off and then trimmed to
form a "pyramid". When necessary, 1 fim resin sections were cut to examine and
enable areas of interest in the block face to be pinpointed for subsequent
ultramicrotomy. Sections were stained by covering them with a few drops of 1%
methylene blue (BDH Ltd, Essex) and then heating the slide on a hotplace at
60®C - 70®C for a few minutes. Excess stain was washed off in running hot
water and the slides were air-dried and examined under light microscope
(Robinson, 1977).
Ultrathin sections were cut using glass knives made by a knifemaker
(Ultracut; LKB Instrument Ltd, South Croydon, Surrey). Sections were collected
on cupper grids (Agar Aids, Stansted, Essex) which were then held on grid sticks
(TAAB Laboratories Equipment Ltd, Reading). Sections were stained in a saturated
solution of uranyl acetate (BDH Ltd, Essex) in 70% alcohol for 20 min and
washed 3 times with 70% alcohol, then dried. They were then stained in lead
citrate (BDH Ltd, Essex) solution (0.2% in 0.1M NaOH) for 5 min prior to
rinsing in 0.1M NaOH solution. Finally, the sections were washed three times
with distilled water and dried (Robinson, 1977).
The sections were examined using a CORA electron microscopy (CORA
electron microscopy Ltd, Manchester) and Hitachi H-7000 electron microscope
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(Hitachi Ltd, Japan).
20. Opsonization of amosite asbestos and mineral dusts
Rat whole blood was prepared and left at 37 °C for 1 hr to allow clotting,
then spun at 3,000 for 15 min. The serum was heated at 56Qc, 1 hr for
complement inactivation or non-treated. One mg/ml of dusts (long, short fibre
amosite, DQ12 or TiO 2) were incubated in PBS, heat-inactivated or
non-inactivated serum, 50 /<g/ml rat IgG (Sigma, Poole) or human fibronectin
(Sigma, Poole) solution at 37 °C for 30 min on an rotater. After incubation, the
dust particles were washed twice with PBS and spun at 3,000 rpm, 10 min. After
that, dust PBS-suspension was added to culture of control alveolar macrophages (1
x 106/ml) at a concentration of 50 ^g/ml and incubated overnight and TNF
activity in the cell supernatants was determined.
For observing the effect of different doses of IgG on ability of dusts to
stimulate TNF production by alveolar macrophages, 10, 100 to 1000 /tg/ml of IgG
were used to opsonize dusts. Further investigation was carried out to determine
the possible enhanced effect of complement activation in opsonization with IgG.
After opsonization with IgG the fibre were treated with heat-inactivated or
non-heat-inactivated rat serum at 37 °C for 30 min, then washed with PBS and
resuspended in PBS.
21. Presentation of results and statistical analysis
Results were expressed as the mean ± standard deviation (SD) or mean ±
standard error of mean (SEM) (when indicated in results) as an index of
variation. Results were subjected to analysis of variance. When there was a
significant F value for the effect of treatment, individual means were compared
for significance using t test (Ryan et al, 1985). Significant difference of different
groups was also analysed using Student's t test (Bailey, 1959).
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RESULTS
1. Components of lavage leukocytes of normal rats
1.1. Normal PVG rat bronchoalveolar and pleural leukocyte populations
Table 1.1 shows the populations of the different leukocyte types present in
lavages of the bronchoalveolar and pleural spaces. The alveolar leukocytes were
mostly macrophages, whereas the pleural leukocytes contained substantial
proportions of mast cells and eosinophils.
Table 1.1 DIFFERENT CELL TYPES PRESENT IN NORMAL PVG RAT
BRONCHOALVEOLAR AND PLEURAL LEUKOCYTE POPULATIONS
Total number Differential percentage
(xlO6) Macrophages Lymphocytes Mastcells Eosinophils
Bronchoalveolar
leukocytes 4.8(1.5)a 97(3.2) 3(3.2) 0 0
Pleural
leukocytes 4.5(1.0)b 82(5.6) 1(1.2) 11(5.4) 6(2.8)
an=3 rats, bn = 14 rats. Each result is presented as mean(SD). No
neutrophils were seen in either normal cell populations.
Figures 1.1 to 1.6 show light microscope and transmission electron
microscope pictures of components of pleural leukocytes.
1.2. Normal HAN rat bronchoalveolar and pleural leukocyte populations
The bronchoalveolar leukocyte populations of HAN rats were very similar
to those of PVG rats (Table 1.2). The total number and components of pleural
leukocytes of HAN rats, however, were slightly different to those of PVG rats.
There were more lavagable pleural leukocytes from HAN rat pleural space than in
PVG rat pleural space. Macrophages in the HAN rats accounted for a lesser
percentage in whole pleural population whereas mast cells and eosinophils were
proportionally greater compared with PVG rats.
Only when indicated, the results were obtained from experiments using
HAN rats. Otherwise, the results were derived from PVG rats.
2. Pleural leukocyte responses to intratracheal instillation of crocidolite asbestos
2.1. The effect of intratracheal instillation of crocidolite asbestos on the pleural
leukocyte populations
Figure 2.1 shows the differential pleural leukocyte count from rats at
different times following intratracheal instillation (I/T) of 5 mg crocidolite asbestos.
One day after I/T asbestos, the pleural leukocyte population was unaffected,
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Figure 1.1 Components of normal pleural leukocytes (x200)
Figure 1.2
(x5,000)
Transmission electron micrograph of normal pleural macrophage
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Figure 1.3 Transmission electron micrograph of normal pleural mast cell
(x5,000)
Figure 1.4 Transmission electron micrograph of normal pleural eosinophil
(x5,000)
6 2 B
Figure 1.5 Transmission electron micrograph of pleural polymorphonuclear
leukocyte after inhalation exposure to amosite and quartz (x5,000)
Polymorphonuclear leukocytes (PMN) were not normal resident in the
pleural space. They appeared only during the pleural inflammation induced by
intratracheal instillation of C.parvum or dusts, including asbestos, into the
airspaces or inhalation of asbestos.
Figure 1.6 Transmission electron micrograph of pleural mesothelial cell (x5,000)
Pleural mesothelial cells were not normal components of the free cells in
pleural space. However, following intratracheal instillation of asbestos or long term
inhalation of asbestos, these cells were found occasionally in the pleural leukocyte
population. fi 9 C
Control 1 3 14 30
Time post instillation (day)
Figure 2.1 Differential numbers of pleural leukocytes from rats at various times
after I/T 5 mg crocidolite asbestos
For clarity the standard error of means (SEM), which was less than 15%
of the mean, is not presented in the figure. Each point represents mean of 5-13
separate experiments. Asterisk denotes a significant difference from control:
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Control 1 5
Dose of crocidolite asbestos (mg)
10
Figure 2.2 Differential numbers of pleural leukocytes from rats one day after
I/T various doses of crocidolite asbestos
SEM, which was less then 15% of the mean, is not presented in the
figure for clarity. Each point represents the mean of 5-13 separate experiments.
Asterisk denotes a significant difference from control: *=P<0.05.
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Table 1.2 DIFFERENT CELL TYPES PRESENT IN NORMAL HAN RAT
BRONCHOALVEOLAR AND PLEURAL LEUKOCYTE POPULATIONS
Total number Differential percentage
(xlO6) Macrophages Lymphocytes Mastcells Eosinophils
Bronchoalveolar
leukocytes 5.0(2.7)a 99(0.7) 1(0.8) 0 0
Pleural
leukocytes 8.7(3.0)b 71(2.6) 2(1.6) 15(2.4) 12(4.6)
an=7 rats, = 4 rats. Each result is presented as mean(SD). No
neutrophils were seen in either normal cell populations.
From 3 days up to one month after 5 mg asbestos instillation, the total
numbers of macrophages increased significantly compared with control pleural
leukocytes. Meanwhile, eosinophils increased markedly, although other pleural
leukocytes remained at the same level.
Figure 2.2 illustrates the populations of pleural leukocytes one day after
instillation of various doses of crocidolite asbestos up to 10 mg. The higher doses
of crocidolite caused a slight recruitment of neutrophils. However, other types of
cells remained the same as controls.
2.2. Increased production of plasminogen activator inhibitor by pleural leukocytes
after rats were instilled intratracheally with crocidolite asbestos
2.2.1. The production of plasminogen activator (PA) by normal alveolar
macrophages and pleural mesothelial cells
Figure 2.3 shows that normal alveolar leukocytes induced plasminogen
(PLG)-dependent fibrinolysis which had a dose- response to the concentration of
alveolar leukocytes, there was no PLG-independent fibrinolysis. However, pleural
leukocytes caused neither PLG-dependent nor PLG-independent fibrinolysis. The
results indicated that alveolar leukocytes produced a plasminogen activator in
culture. Figure 2.4 demonstrates that mesothelial cells induced PLG-dependent
fibrinolysis, but not PLG-independent fibrinolysis.
2.2.2. The production of plasminogen activator inhibitor (PAI) by normal pleural
leukocytes
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Figure 2.3 PLG-dependent and -independent fibrinolysis caused by alveolar and
pleural leukocytes
Each bar represents the mean and SEM of triplicate wells in 3 separate














0:1 1.25:1 2.5:1 5:1 10:1
Pleural leukocytes : mesothelial cells
Figure 2.4 Effect of increasing concentrations of pleural leukocytes on
mesothelial cell-induced fibrinolysis
Each point represents mean (SEM) of triplicate wells in two separate
experiments.
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alveolar leukocyte and mesothelial cell fibrinolysis were tested after the addition of
pleural leukocytes or their supernatants. The fibrinolytic activity of both cells was
inhibited by pleural leukocytes (Figs. 2.4, 2.5) and that of alveolar leukocytes was
inhibited by pleural leukocyte supernatants (Fig.2.6). This reduction in fibrinolytic
activity was dose-dependent with both pleural leukocyte number and supernatant
dilution. In contrast, PLG-independent fibrinolysis by both populations remained at
a very low level that was near the background and this was not inhibited by
pleural leukocytes or their supernatants.
For characterization of the specific point of action of the fibrinolysis
inhibitor, i.e., activity on plasmin or plasminogen activator, three different
fibrinolytic systems were used: urokinase plus PLG, streptokinase plus plasminogen,
and plasmin alone. The concentrations of urokinase, plasmin, and streptokinase
were chosen to degrade about 50% of the [l^IJfibrin. Figure 2.7 illustrates the
effect of pleural leukocytes and their supernatants on fibrinolysis induced by
urokinase plus PLG. The fibrinolytic activity of urokinase was dramatically
inhibited by either pleural leukocytes or their supernatants. The fibrinolytic activity
of plasmin was less inhibitable than that of urokinase, with less than 40% of total
fibrinolysis being blocked (Fig. 2.8). No inhibition of fibrinolysis induced by
streptokinase plus PLG was seen after the addition of pleural leukocyte
supernatants for up to 24 hr (Table 2.1).
Table 2.1 EFFECT OF PLEURAL LEUKOCYTE SUPERNATANT ON FIBRINOLYSIS
INDUCED BY STREPTOKINASE PLUS PLG
Streptokinase (U/ml) 1 10 100
Dilution of supernatant
1:8 42886(3111) 41071(5494) 33347(5563)
1:4 38949(3750) 35596(1074) 32505(3321)
1:2 36885(2222) 35122(1808) 35654(2734)
Results are presented as the mean(SD) cpm of 2 separate experiments
in triplicate. No stat ist ically significant difference was found
between different concentrations of pleural leukocyte supernatants.
From these preliminary results, we believed that there existed a PA
inhibitor(s) in the supernatant of pleural leukocytes. Because of the ability of the
inhibitor to act mainly on urokinase plus PLG, it was presumed that the pleural







0:1 0.625:1 1.25:1 2.5:1 5:1
Pleural leukocytes : alveolar leukocytes
Figure 2.5 Effect of increasing concentrations of pleural leukocytes on alveolar
leukocyte-induced fibrinolysis
























Figure 2.6 Effect of increasing concentrations of pleural leukocyte supernatant
on alveolar leukocyte-induced fibrinolysis




















Concentration (x10*/ml) or dilution
2.5/
Figure 2.7 Effect of increasing concentrations of pleural leukocytes, or their
supernatants, on fibrinolysis induced by urokinase plus plasminogen (PLG)
















Concentration (x10*/ml) or dilution
2.5/
Figure 2.8 Effect of increasing concentrations of pleural leukocytes, or their
supernatants, on plasmin-induced fibrinolysis
Each point is mean (SEM) of triplicate wells in four separate experiments.
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some work to identify the cell source of PAI and to characterize the inhibitor was
carried out using the urokinase plus PLG fibrinolysis system.
By using separation techniques, two subpopulations of pleural leukocytes
were obtained: a macrophage-enriched population (93% macrophages) and a mast
cell-enriched population (76% mast cells and 20% macrophages) (Table 2.2 and
Figs 2.9, 2.10). The inhibition of fibrinolysis caused by supernatants from these
subpopulations indicated that macrophages are by far the major source of PAI
release in culture (Fig. 2.11). There was no significant difference between
inhibition caused by whole pleural leukocytes and inhibition caused by the
macrophage-enriched population. The fact that there was no increase in PAI
activity corresponding to the increased proportion of macrophages in the
macrophage-enriched subpopulation (from 82% to 93%) may be explained by
slight damage caused to macrophages during the separation process.
Table 2.2 DIFFERENT CELL TYPES PRESENT IN RAT PLEURAL LEUKOCYTE
SUBPOPULATIONS AFTER SEPARATION
Differential percentage







rats, ^n=4 rats. Each result is shown as mean(SD).
In these experiments, a certain level of fibrinolysis was obtained with
urokinase plus PLG such that PA could be detected by enhanced fibrinolysis and
PAI could also be detected as reduced fibrinolysis. Studies with lysates indicated
that pleural leukocytes contain high PA activity intracellularly (Fig. 2.12). This
activity seems to be contained mainly inside mast cells, with very limited
intracellular PA activity in macrophages.
The inhibitory activity of supernatants from pleural leukocytes remained
constant after incubation at 56®C for 1 hr but was virtually abolished after
incubation at 70®C for 1 hr (Fig. 2.13). The supernatant of pleural leukocytes
was also assayed for fibrinolytic activity after being fractionated into 2 parts:
molecular greater and less than 10,000 daltons. The fibrinolytic activity of
urokinase plus PLG was inhibited by the high-molecular weight (MW) fraction,
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Figure 2.9 Light micrograph of macrophage-enriched pleural leukocytes (x200)
Figure 2.10 Light micrograph of mast cell-enriched pleural leukocytes (x200)
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Dilution of supernatant
Figure 2.11 Inhibition of urokinase plus PLG—induced fibrinolysis by supernatants
of separated subpopulations of pleural leukocytes
Each point represents mean (SEM) of triplicate wells in two separate
experiments.
Dilution of lysate or fluid
Figure 2.12 Effects of lysates of separated subpopulations of pleural leukocytes,
or pleural lavage fluid, on fibrinolysis induced by urokinase plus PLG




Figure 2.13 Inhibitory effects of heat-treated pleural leukocyte supernatants on
fibrinolysis induced by urokinase plus PLG
Each point represents mean (SEM) of triplicate wells in three separate
experiments.
Dilution of supernatant
Figure 2.14 Inhibitory effects of different fractions of pleural leukocyte
supernatant on fibrinolysis induced by urokinase plus PLG
Each point represents mean (SEM) of triplicate wells in two separate
experiments.
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while no inhibitory effect could be observed in the low-MW fraction (Fig. 2.14).
Acid treatment of the inhibitor revealed that the inhibitor was acid labile (Fig.
2.15). These results provided evidence that the inhibitor of urokinase in
supernatants of pleural leukocytes is a high-MW, heat and acid labile substance,
probably a protein. Moreover, it was found that stimulated with LPS, pleural
leukocytes did not produce increased PAI activity in culture than non-stimulated
pleural leukocytes (Table 2.3)
Table 2.3 THE EFFECT OF LPS STIMULATION ON PAI PRODUCTION
BY PLEURAL LEUKOCYTES
Dilution of supernatant % inhibition of fibrinolysis
With LPS Without LPS
1 :32 30.62 (8.16) 28.13 (11.14)
1:16 50.23 (13.95) 48.35 (12.83)
1:8 72.38 (14.2) 76.70 (7.80)
1:4 90.66 (5.08) 97 .12 (3.02)
Results are presented as the mean(SD) of percent inhibition of
urokinase-induced fibrinolysis from 3 separate experiments in triplicate.
2.2.3. Increased production of PAI by pleural leukocytes from rats intratracheally
instilled with crocidolite asbestos
As reported above, normal pleural leukocytes do not express any PA
activity in culture but, intracellularly, pleural leukocytes, mainly mast cells, contain
large quantities of PA activity. After intratracheal instillation of crocidolite
asbestos, there was no PA activity detectable in asbestos-exposed pleural leukocyte
supernatants. There was also no significant difference in PA activity in cell lysates
of control pleural leukocytes and leukocytes one day after 10 mg crocidolite I/T
(Table 2.4).
Two controls, 0.5 ml PBS I/T and complete normal controls, were
compared and the PAI secretion by the leukocytes from these two control rats



















Figure 2.15 Effect of acid-treatment on the activity of PAI in pleural leukocyte
supernatant
Results are presented as mean and SEM of 5-7 experiments in triplicate.
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Table 2.4 PA ACTIVITY IN THE LYSATES OF PLEURAL LEUKOCYTES
FROM CONTROL AND ASBESTOS INSTILLED RATS







Results are presented as the mean(SD) cpm of 2 separate experiments in
triplicate. No statistical significant difference was found between the two
treatment groups. Crocidolite I/T: 1 day after 10 mg crocidolite given by
intratracheal instillation.
Table 2.5 PLASMINOGEN ACTIVATOR INHIBITOR SECRETION BY
PLEURAL LEUKOCYTES FROM UNTREATED AND PBS-TREATED RATS
Di lution PBS i/T Normal
1:32 59.81 (19.58) 62.94 (6.22)
1:16 73.15 (15.39) 79.32 (2.81)
1:8 78.99 (14.18) 83.79 (5.00)
1:4 94.41 (4.00) 96.92 (2.14)
Results are presented as mean(SD) of percent inhibition of urokinase-induced
fibrinolysis by pleural leukocyte supernatants, n=6 rats for both groups. There
was no significant difference between two groups.
However, as shown in Fig. 2.16, the percent inhibition of urokinase
activity caused by pleural leukocytes from asbestos- exposed rats was significantly
greater than controls. At almost all of the time points following exposure to
asbestos, supernatants exhibited markedly increased PAI activity. Nevertheless,
there was no significant difference in the production of inhibitor between different
time points following asbestos instillation. The apparent difference in Fig. 2.16
was masked by the variation between experiments.
Figure 2.17 shows the inhibition of urokinase-induced fibrinolysis caused by
67
Time after asbestos instillation (day)
Figure 2.16 Inhibition of urokinase plus PLG-induced fibrinolysis caused by
supernatants of pleural leukocytes from rats at various times after I/T 5 mg
crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 3-14
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
Dose of crocidolite asbestos (mg)
Figure 2.17 Inhibition of urokinase plus PLG-induced fibrinolysis by supernatants
of pleural leukocytes from rats one day after I/T different doses of crocidolite
asbestos
Each point stands for the mean and SEM of triplicate wells in 5-14
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: **=P<0.01 and ***=P<0.001.
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supernatants of pleural leukocytes from rats one day after various doses of
asbestos I/T. It was very clear that asbestos stimulated secretion of PAI by pleural
leukocytes in a dose-related manner, although the cells recovered from rats dosed
with 1 mg asbestos did not express significantly higher PAI activity in culture than
controls.
2.3. Interleukin-1 (IL-1) production by rat pleural leukocytes in culture after I/T
crocidolite asbestos
Normal pleural leukocytes produced IL-1 in culture, even in the absence
of endotoxin stimulation (Fig. 2.18). The activity of IL-1 in supernatants of
normal leukocytes without stimulation was about 167 U/ml compared to IL-1/3
standard. After 100 ng/ml of LPS stimulation, the activity of IL-1 by pleural
leukocytes reached approximately double the normal levels, to about 268 U/ml.
At the highest concentration of LPS-stimulated supernatant (1:4), the abnormal
reduction of IL-1 activity might be due to too high concentration in IL-1 in
supernatant which inhibits the mitogenesis of C3H mouse thymocytes.
Five mg crocidolite asbestos I/T resulted in a decrease in the IL-1 activity
of pleural leukocyte supernatants as demonstrated by Fig. 2.19. One day after '5
mg crocidolite, the IL-1 activity decreased most significantly. With increasing
time after instillation, the IL-1 activity recovered towards normal levels. Moreover,
IL-1 production was increased over control levels by 30 days after I/T asbestos.
Figure 2.20 illustrates the dose-related effect of crocidolite I/T on IL-1
elaboration by pleural leukocytes in culture. For all asbestos-treated leukocyte
supernatants, IL-1 activity decreased and this decrease was correlated with the
increase of the dose of instilled asbestos.
2.4. Crocidolite asbestos I/T depresses the high secretion of tumor necrosis factor
(TNF) by pleural leukocytes in culture
As shown in Figure 2.21, normal pleural leukocytes secreted a high level
of TNF in culture in the absence of LPS. The concentration of TNF in
supernatants of normal leukocytes was about 648 U/ml using recombinant TNFa as
a standard. There was no significant difference between two different controls,
i.e., completely normal rats and saline I/T rats. The presence of 100 ng/ml of
LPS enhanced the TNF production by several times (about 1760 U/ml) compared
to the constitutive release.
Up to 30 days after 5 mg crocidolite asbestos I/T, the capacity of pleural
leukocytes to secrete TNF in culture was reduced significantly compared to
controls. There was, however, no detectable time-related effect in this reduction












Without LPS With LPS
Figure 2.18 IL-1 production by normal pleural leukocytes with or without
simulation with LPS
Results are presented as mean and SEM of 10-14 separate experiments
performed in triplicate. The concentration of LPS used in the study was 100
ng/ml. Asterisk denotes a significant difference from corresponding dilution of
control: **=P<0.01 and ***=P<0.001.
Control 1 3 14 30
Time after asbestos instillation (day)
Figure 2.19 IL-1 release by pleural leukocytes from rats at various times after
I/T 5 mg crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 9-15
separate experiments. Asterisk denotes a significant difference from corresponding




Control 1 5 10
Dose of crocidolite asbestos (mg)
Figure 2.20 IL-1 release by pleural leukocytes from rats one day after I/T
various doses of crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 9-16
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
50 r
Control Control+LPS Saline
Figure 2.21 TNF production by normal pleural leukocytes with or without
stimulation with LPS and by pleural leukocytes from I/T saline control
Each point represents the mean and SEM of triplicate wells in 9-22
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: ***=P<0.001.
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month (Fig. 2.22).
Fig. 2.23 illustrates that one day after intratracheal instillation, increasing
doses of crocidolite in the lung caused a gradual decrease in the ability of the
pleural leukocytes to release TNF in vitro-, this was particularly notable for 10 mg
crocidolite group, where TNF secretion was inhibited almost completely.
2.5. Effects of anti-TNF serum on TNF activity in pleural leukocyte supernatants
Anti-TNF serum was found to inhibit the activity of the TNFa standard.
Figure 2.24 shows a clear inhibitory effect of rabbit anti-TNF serum on TNFa
standard in a concentration- related manner.
Anti-TNF serum also had an inhibitory effect on TNF activity in pleural
leukocyte supernatants. In contrast, control serum had no such inhibitory effect
(Fig. 2.25).
2.6. Determination of contaminating endotoxin level in the media used in the
studies
To ascertain the relationship between contaminating endotoxin in the media
and spontaneous release of cytokines in the present studies, endotoxin levels were
determinej. The activity, in pg/ml of media were as following:- distilled water 0,
saline 0, PBS 16, MEM + 5% FCS 29, F10 + 2% BSA 106, RPMI + 10% FCS
0, F12 + 10% FCS 46, the levels in the prepared supernatants were 98-112.
TNF activities in pleural leukocytes supernatants which were prepared in medium
before or after endotoxin removal by polymyxin columns showed no significant
difference: TNF activities (mean(SD)n, U/ml calculated from a dilution
of 1:16):- normal medium 1086(172)12; endotoxin-depleted medium 1063(81)12.
3. Alveolar leukocyte responses to intratracheal instillation of crocidolite asbestos
In this section, all experiments were carried out using HAN rats due to
the shortage of supply of PVG rats.
3.1. The effect of crocidolite asbestos I/T on the bronchoalveolar leukocyte
populations
Table 3.1 shows the distribution of different components in alveolar
leukocyte population various times following 5 mg crocidolite asbestos I/T. It was
difficult to perform bronchoalveolar lavage sometimes due presumably to the
blockage of airways by instilled fibres, so that the total cell numbers in the
lavage were not accurate. The results were therefore presented as percentages of
cells rather than total numbers.
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Time after asbestos instillation (day)
Figure 2.22 TNF production by pleural leukocytes from rats at various times
after I/T 5 mg crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 10-22
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
Dose of crocidolite asbestos (mg)
Figure 2.23 TNF production by pleural leukocytes from rats one day after I/T
various doses of crocidolite asbestos
Each point represents the mean and SEM of triplicate wells of 9-22
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
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Dilution of TNF anti-serum
Figure 2.24 Percent inhibition on the activity of TNFa standard caused by
anti-TNF serum




Figure 2.25 Effect of control and anti-TNF sera on TNF activity in
supernatants of normal pleural and bronchoalveolar leukocytes
Each bar represents the mean of 3-6 separate experiments in triplicate.
The dilution of supernatants was 1:16. SEM, varies from 12 to 86% of mean,
was not shown on the graph. P.L.pleural leukocyte supernatant; A.L.alveolar
leukocyte supernatant; C.S.:- control serum and A.S:- anti-TNF serum.
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Table 3.1 BRONCHOALVEOLAR LEUKOCYTE COMPONENTS VARIOUS
TIMES AFTER 5 mg CROCIDOLITE ASBESTOS I/T
Time Total number Differential percent age
(Day) (xlO6) Macrophages PMN Lymphocytes Eosinophils
Cont ro1 5.0(2.7) 99(0.7) 0 1(0.8) 0
1 2.7(2.5) 64(35.5) 26(39.9) 1(0.7) 9(8.9)
3 1.8(1.2) 70(12.4) 14(8.4) 1(0.7) 15(8.3)
14 2.4(1.9) 95(1 .3) 3(1.4) 1(0.6) 1(0.8)
30 3.1(2.0) 95(6.4) 4(5.5) 1(0.8) 0
n-7-12 rats. Results are presented as mean(SD).
It was clear that the percentage of macrophages decreased dramatically 1
day after asbestos instillation due to the marked increase of PMN in the alveolar
space at the same time. Meanwhile, the percentage of eosinophils increased
although this cell component was hardly seen in normal bronchoalveolar leukocyte
populations. From three days after asbestos I/T, the percentage of macrophages
went up slightly and was restored almost completely 2 weeks after instillation.
This corresponded to the rapid decrease of the percentage of PMN in the alveolar
spaces from 3 days after asbestos I/T. Similar to the pattern with PMN, the
percentages of eosinophils remained at higher levels during the first three days
after instillation and then waned.
The changes of cell components of bronchoalveolar leukocytes one month
after various doses of crocidolite asbestos I/T are shown in Table 3.2. In
comparison to control, most cell components remained almost at the same level
except for a moderate increase in the percentage of PMN in the asbestos-
exposed group. The total cell numbers increased markedly compared to control,
although the 5 mg group had less numbers which may result from lavage
difficulty.
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Table 3.2 BRONCHOALVEOLAR LEUKOCYTE COMPONENTS ONE MONTH
AFTER I/T VARIOUS DOSES OF CROCIDOLITE ASBESTOS
dose Total number Differential percentage
(mg) (xlO6) Macrophages PMN Lymphocytes Eosinophils
Cont ro1 5.0(2.7) 99(0.7) 0 1(0.8) 0
0.5 8.8(3.6) 94(6.9) 5(6.7) 1(0.4) 0
1 10.6(5.5) 97(1.9) 2(1.5) 1(0.5) 0
5 3.1(2.0) 95(6.4) 4(5.5) 1(0.8) 0
n=6-12 rats. Results are presented as mean(SD). Compared to control, total cell
numbers of 0.5 and 1 mg groups were significant different (P<0.05).
3.2. IL-1 production by bronchoalveolar leukocytes from rats various times after
I/T 5 mg crocidolite asbestos
Figure 3.1 shows that normal alveolar leukocytes produced IL-1 at about
36 U/ml in culture without added stimulation compared to IL-1/3 standard, which
was much less than IL-1 activity produced by normal pleural leukocytes
(Fig.2.18). Intratracheal instillation of crocidolite asbestos caused decrease of IL-1
elaboration by bronchoalveolar leukocytes in culture. From 1 day to 14 days after
instillation, the IL-1 activity in the leukocyte supernatants decreased dramatically
compared to control supernatants. However, when it was one month after asbestos
instillation, IL-1 production by alveolar leukocytes increased considerably and was
beyond the level of control leukocytes.
The effect of various doses of crocidolite I/T on IL-1 production by
alveolar leukocytes was presented in Fig. 3.2. A dose-related effect of instilled
asbestos on alveolar leukocytes was seen in IL-1 production.
3.3. Increased production of TNF by bronchoalveolar leukocytes after rats were
intratracheally instilled with crocidolite asbestos
Figure 3.3 shows that normal alveolar leukocytes released TNF
spontaneously at the level of 561 U/ml which was slightly lower than that released
by normal pleural leukocytes. Crocidolite asbestos I/T caused bronchoalveolar
leukocytes to produce more TNF in culture than control at various times except
one day post instillation. However, there was no significant effect of time.
As shown in Fig. 3.4, although 0.5 mg asbestos I/T seemed not to be
able to stimulate alveolar leukocytes, 1 or 5 mg asbestos caused increased
production of TNF by alveolar leukocytes with a dose-response pattern.
Time after asbestos instillation (day)
Figure 3.1 IL-1 production by alveolar leukocytes from rats at various time
after I/T 5 mg crocidolite asbestos
Each bar represents the mean and SEM of triplicate wells in 4-11
separate experiments. Asterisk denotes a significant difference from control:
*=P<0.05, **=P<0.01 and ***=P<0.001. The dilution of supernatant was 1:4.
Dose of crocidolite asbestos (mg)
Figure 3.2 IL-1 production by alveolar leukocytes from rats one month after
I/T various doses of crocidolite asbestos
Each bar represents the mean and SEM of triplicate wells in 6-11
separate experiments. Asterisk denotes a significant difference from control:
***=P<0.001. The dilution of supernatant was 1:4.
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Time after asbestos instillation (day)
Figure 3.3 TNF production by alveolar leukocytes from rats at various times
after I/T 5 mg crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 5-15
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: **=P<0.01 and ***=P <0.001.
Dose of crocidolite asbestos (mg)
Figure 3.4 TNF production by alveolar leukocytes from rats one month after
I/T different doses of crocidolite asbestos
Each point represents the mean and SEM of triplicate wells in 5-15
separate experiments. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05 and ***=P<0.001.
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The specificity of TNF activity in alveolar leukocyte supernatants was also
tested using rabbit anti-TNF serum and control serum. Results indicated that TNF
activity in the supernatants was inhibitable by anti-TNF serum and not by control
serum (Figs. 2.25).
4. Studies on combined effects of crocidolite and other dusts on pleural and
bronchoalveolar leukocytes
In this section, all of experiments were carried out using HAN rats.
4.1. In in vivo studies on combined effects of crocidolite and other dusts I/T on
bronchoalveolar and pleural leukocytes
4.1.1. Cellular changes in the bronchoalveolar and pleural spaces after crocidolite
and/or other dusts I/T
Table 4.1 shows the components of bronchoalveolar leukocytes one month
after 2.5 mg dusts I/T individually or in combination. When dusts were instilled
individually, TiO 2 and crocidolite did not cause important changes in alveolar
leukocyte components, whereas quartz (DQ1 2) resulted in massive recruitment of
leukocytes with a high percentage of PMN. A synergistic effect on total number
of leukocytes was observed with crocidolite plus DQ 1 2. The slight decrease in
total number in the asbestos-treated groups was considered to be due to lavage
difficulties caused by airway blockage by asbestos fibres.
BRONCHOALVEOLAR LEUKOCYTE COMPONENTS ONE MONTH AFTER
I/T INDIVIDUALLY OR IN COMBINATION
Dust Total No. Differential Percentage
(xlO6) Macrophage PMN Lymphocyte
Control 4.98(2.67) 98.86(0.69) 0.14(0.38) 1.00(0.82)
TiO
2 3.82(0.55) 98.33(1.15) 0.67(1.15) 1.00(0)
DQw 26.27(3.38) 57.33(18.50) 42.00(18.52) 0.67(0.58)
Cro 2.43(0.62) 97.67(1.53) 1.33(1.53) 1.00(0)
Cro+Ti02 3.57(0.53) 96.67(1.15) 3.33(1.15) 0(0)
Cro+DQ,2 43.27(11.15) 72.00(5.29) 27.00(5.29) 1(0)
n-9 rats for controls and 3 rats for all other treatment. Results are presented
as mean(SD). Cro.—crocidolite asbestos. There is a statistically significant
difference between control v DQj2 (P<0.001), control v cro+DQj2 (P<0.001)
and DQj2 v cro+DQj2 (P<0.05).
The components of the pleural leukocytes after I/T asbestos and/or other
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dusts are presented in Table 4.2. Instillation of dusts caused an increase in total
numbers. In the crocidolite plus DQ1 2 group, the total number increased most
dramatically. The percentages of macrophages decreased with combinations of
crocidolite plus Ti02 or DQ12, whilst that of eosinophils increased.
Table 4.2 PLEURAL LEUKOCYTE COMPONENTS ONE MONTH AFTER
DUSTS IIT INDIVIDUALLY OR IN COMBINATION
Dust Total number Differential percentage
(xlO6) Macrophages Lymphocytes Mast-cells Eosinophils
Cont ro1 4.5(1.0) 82(5.6) 1(1.2) 11(5.4) 1(0.8)
Ti02 10.8(2.3) 84(2.3) 1(1.0) 8(1.2) 7(3.0)
DQ12 9.6(1.7) 89(0.7) 0 5(1.4) 6(0.7)
Cro 11.6(2.5) 82(1.2) 1(1.0) 10(1.2) 7(2.1)
Cro+Ti02 12.5(2.3) 77(7.2) 1(0.6) 10(6.2) 12(5.2)
Cro+DQ,2 19.6(2.3) 79(2.1) 2(1.5) 6(2.0) 13(2.7)
n-4 rats for control and 3 rats for all other treatment groups. No PMN was
seen in all of groups. Results are presented as mean (SD). All dusts groups are
significantly higher than control groups (P<0.001). Cro v cro+DQ j2 Is also
significantly different (P<0.01).
4.1.2. TNF and IL-1 production by bronchoalveolar and pleural leukocytes one
month after 2.5 mg dusts I/T individually or in combination
Figure 4.1 shows that in comparison to TNF level produced by control
alveolar leukocytes, TiO 2 stimulated alveolar leukocytes produced considerably
increased TNF activity, whereas DQ 1 2 I/T lead to decreased TNF production by
the cells. Crocidolite asbestos did not affect the production. No notable interaction
on TNF production resulted from the combination of crocidolite asbestos and
other dusts.
In the pleural space, there was a totally different picture. Fig. 4.2
illustrates that individually all of the dusts caused a significant reduction of TNF
production by pleural leukocytes. The combination of crocidolite asbestos with
other dusts, however, stimulated a dramatic increase of TNF release by the cells
with a considerable synergetic effect. When crocidolite was instilled together with
DQ12, their stimulating effect increased nearly 5-fold compared to control. Even
when crocidolite was combined with TiO 2 which is considered an inert dust, they
stimulated pleural leukocytes to produce 2-fold more TNF in culture than control.
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Figure 4.1 TNF production by alveolar leukocytes from rats one month after
I/T 2.5 mg dusts
Each bar stands for the mean and SEM of 3 separate experiments
performed in triplicate. The dilution of supernatant was 1:64. Asterisk denotes a
significant difference from control: **=P<0.01. Cro:-crocidolite asbestos,
C+T:-crocidolite plus TiOz, C+Q:-crocidolite plus quartz.
Figure 4.2 TNF production by pleural leukocytes from rats one month after I/T
2.5 mg dusts
Each bar stands for the mean and SEM of 3 separate experiments
performed in triplicate wells. The dilution of supernatant was 1:64. Asterisk
denotes a significant difference from control: **=P<0.01 and ***=P <0.001.
Abbreviations as for Figure 4.1.
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Figure 4.3 shows that after all of dusts I/T individually or in combination,
bronchoalveolar leukocytes elaborated significantly increased IL-1 activity in culture
compared to control. However, no important interaction between those dusts
could be observed. Among those dusts, Ti02 had the greatest stimulating effect,
whereas DQ, 2 had the least.
IL-1 production by pleural leukocytes one month after 2.5 mg dusts given
by intratracheal instillation is shown on Fig. 4.4. Compared to control, excluding
DQ, 2 I/T which stimulated pleural leukocytes to elaborate significantly increased
IL-1 activity in vitro, other dusts alone or in combination did not significantly
alter elaboration of IL-1 by pleural leukocytes.
4.2. In vitro studies on the effect of dusts on TNF and IL-1 elaboration by
bronchoalveolar macrophages
Normal bronchoalveolar leukocytes, mostly macrophages (>98%), were
treated with 50 /tg/ml of crocidolite, TiO 2 and DQ, 3 individually or in
combination in culture. Figure 4.5 shows that there were very similar patterns of
TNF and IL-1 production by alveolar macrophages in culture treated with
different dusts. Compared to control, all of dusts except TiO 2 stimulated
macrophages to produce more TNF or IL-1 in culture. Individually, both the
highest levels of TNF and IL-1 were found in the culture of alveolar
macrophages treated with DQ, 2. The combination of crocidolite and TiO 2
appeared to stimulate the macrophages to produce both TNF and IL-1 additively.
However, the combination of crocidolite and DQ 1 2 had no stimulating effect over
and above their effect individually.
5. Studies on separate fractions of normal pleural leukocytes
As mentioned in Section 2, by using separation techniques, two
subpopulations were obtained: a macrophage-enriched population (93%
macrophages) and a mast cell-enriched population (76% mast cells and 20%
macrophages) (Table 2.1).
5.1. Fibrinolytic activities in separate fractions
The present studies revealed that macrophages are the major source of
PAI release in culture (Fig. 2.11). However, pleural leukocytes contain high PA
activity intracellularly (Fig. 2.12) and the activity located mainly inside mast cells.
5.2. IL-1 activity in supernatants of separate pleural leukocytes
Figure 5.1 shows that compared to unseparated pleural leukocytes, both
macrophage- and mast cell-enriched pleural leukocyte subpopulations produced less
IL-1 activity in culture. Moreover, IL-1 activity in supernatant of the mast
cell-enriched population was markedly higher than in supernatant of macrophage
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Figure 4.3 IL-1 release by alveolar leukocytes from rats one month after I/T 2.5
mg dusts
Each bar stands for the mean and SEM of 3 separate experiments
performed in triplicate wells. The dilution of supernatants was 1:8. Asterisk
denotes a significant difference from control: ***=P<0.001. Abbreviations as for
Figure 4.1.
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Control Ti02 Quartz Cro C+T C+Q
Figure 4.4 IL-1 elaboration by pleural leukocytes from rats one month after
I/T 2.5 mg dusts
Each bar stands for the mean and SEM of 3 separate experiments
performed in triplicate wells. The dilution of supernatant was 1:8. Asterisk denotes





























Control Ti02 Quartz Cro C+T C+Q
Figure 4.5 TNF and IL-1 production by alveolar macrophages treated with 50
/xg/ml dusts in vitro
Each bar stands for the mean and SEM of 2-4 separate experiments
performed in triplicate wells. The dilution of supernatant was 1:64 for TNF, and
1:16 for IL-1. Asterisk denotes a significant difference from control: *=P<0.05,




Figure 5.1 IL-1 production by different fractions of normal pleural leukocytes
Each bar represents the mean and SEM of 4-8 separate experiments in
triplicate wells.
50 r
1:256 1:128 1:64 1:32 1:16
Dilution of supernatant
Figure 5.2 TNF production by different fractions of normal pleural leukocytes




5.3. TNF production by separate pleural leukocytes in culture
A similar pattern to IL-1 was found in TNF production by unseparate and
separated pleural leukocytes, i.e., unseparated pleural leukocytes produced more
TNF than both separated subpopulation. Between the two separated subpopulations,
the mast cell-enriched population produced considerably more TNF in culture
than the macrophage-enriched population (Fig. 5.2).
6. Effect of dusts on pleural leukocytes in vitro and chemotactic activity in
pleural leukocyte supernatant
6.1. TNF and IL-1 elaboration by normal pleural leukocytes treated with 50 /rg/ml
dusts in vitro
Although we found no evidence to show that pleural leukocytes in situ
could make contact with intratracheally instilled or inhaled dusts, studies were
undertaken to find out the effect of dusts on cytokine production by pleural
leukocytes in culture. The results confirmed that there was no significant
difference in TNF and IL-1 (Fig. 6.1) production by pleural leukocytes treated
with Ti02, DQ12 or crocidolite asbestos in vitro, although dust stimulated
increased production of cytokines by the leukocytes compared to control. Quartz
did not, however, significantly stimulates TNF secretion although it was increased
compared to control.
6.2. Macrophage and PMN chemotaxis caused by pleural leukocyte supernatants
Figure 6.2 shows that there was no chemoattractant for macrophages in
control supernatant or in supernatant of pleural leukocytes one day after 5 mg
crocidolite I/T, compared to negative control. Although some variation was seen,
PMN chemotaxsis induced by negative control or by pleural leukocyte
supernatants were not significantly different.
7. Mesothelial cell lysis and detachment caused by pleural leukocytes after
asbestos I/T
7.1. Pleural leukocyte components after crocidolite asbestos I/T
HAN rats were used in most studies on mesothelial cell injury except the
experiments indicated using PVG rats. Fig. 7.1 shows pleural leukocyte
components after asbestos I/T. Macrophage numbers increased 14 days after 5 mg
crocidolite I/T and reached the highest level at day 30 after instillation.
Eosinophil numbers increased from 3 days to 14 days after instillation and then
recovered by day 30. The numbers of mast cells increased significantly by day 14
and quickly recovered to normal levels. No PMN could be observed in the pleural
leukocytes during the whole experimental period.
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Figure 6.1 TNF and IL-1 production by normal pleural leukocytes treated with
50 fig/ml dusts in vitro
Each bar stands for the mean and SEM of 2 separate experiments in
triplicate wells. The dilution of supernatant was 1:64 for TNF and 1:16 for IL-1.



























Negative Positive Normal Cro5mg1D
Figure 6.2 Macrophage and neutrophil chemotaxis caused by pleural leukocyte
supernatants

















Control 1 3 14 3 0
Time after asbestos instillation (day)
Figure 7.1 HAN rat pleural leukocyte components at various times after I/T 5
mg crocidolite asbestos
Each point represents the mean and SEM of 7-12 separate experiments.














Dose of crocidolite asbestos (mg)
Figure 7.2 HAN rat pleural leukocyte components one month after I/T different
doses of crocidolite
Each point represents the mean and SEM of 6-12 separate experiments.
Asterisk denotes a significant difference from control: *=P<0.05, **=P<0.01.
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Figure 7.2 illustrates that one month after various doses of crocidolite
asbestos I/T, there was an increase of macrophages in the pleural leukocyte
population. However, it seemed that lower doses of asbestos caused more
recruitment of macrophages. Other cell components of pleural leukocyte had no
marked changes though the instilled doses of asbestos increased from 0.5 mg to 5
mg.
7.2. Mesothelial cell lysis and detachment caused by pleural leukocytes after
crocidolite asbestos I/T
Figure 7.3 shows that there was no effects on mesothelial cell lysis and
detachment caused by increasing numbers of normal pleural leukocytes co-cultured
with the mesothelial cells.
However, one day after 5 mg crocidolite I/T, the pleural leukocytes caused
remarkable mesothelial cell detachment which increased in response to
augmentation of the numbers of pleural leukocytes (Fig. 7.4-1), lysis of
mesothelial cells was not influenced.
By three days after 5 mg crocidolite asbestos I/T, although pleural
leukocytes still caused slight detachment of mesothelial cells in culture at higher
ratios of pleural leukocytes to mesothelial cells, this was much less than that
resulted from pleural leukocytes at one day (Fig.7.4-2). There was no detectable
mesothelial cell lysis.
From 14 days to 30 days after asbestos I/T, pleural leukocytes did not
cause any measurable mesothelial cell lysis or detachment (Figs. 7.4-3, 7.4-4).
Nevertheless, one month after intratracheal instillation of asbestos, although
the doses of crocidolite asbestos varied from 0.5, 1 to 5 mg, no mesothelial cell
detachment and lysis could be detected (Table 7.1).
7.3. Mesothelial cell lysis and detachment caused by proteases
To reveal the mechanism of mesothelial cell detachment caused by pleural
leukocytes, the possible role of proteases, i.e., trypsin, elastase and collagenase,
were evaluated. Figure 7.5 shows that elastase and collagesase did not cause
important changes of mesothelial cell lysis over the whole dose range. Trypsin
induced slight increase of mesothelial cell lysis at higher doses. However, trypsin
and elastase in culture resulted in apparent increase of mesothelial cell detachment
with the concentrations being higher than 10 /ig/ml (Fig. 7.5). There was no any
detectable mesothelial cell detachment injury caused by collagenase.
8. The activities of normal pleural lavage fluids
8.1. Fibrinolytic activity of pleural lavage fluid























0:1 0.1:1 1:1 10:1 20:1
Pleural leukocytes : Mesothelial cells
Figure 7.3 Mesothelial cell lysis and detachment injury caused by control pleural
leukocytes























Concentration of protease (ug/ml)
Figure 7.5 Mesothelial cell lysis and detachment caused by proteases
Each bar represents the mean and SEM of 2 separate experiments
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Pleural leukocyte# : Mecothelial cell*
Figure 7.4 (1-4) Mesothelial cell lysis and detachment injury caused by pleural
leukocytes from rats at various times after I/T 5 mg crocidolite
Each point represents mean and SEM of 3-9 separated experiments in
triplicate. Compared to the wells without the addition of pleural leukocytes, *
means P<0.05 and ** P<0.01.
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Table 7.1 CELL LYSIS AND DETACHMENT CAUSED BY PLEURAL
LEUKOCYTES FROM RATS ONE MONTH AFTER VARIOUS DOSES OF
CROCIDOLITE I/T
Dose Ratio of pleural leukocytes : mesothelial cells
(mg) 0:1 0.1:1 1:1 10:1 20:1
0.5 ms
Lys i s 3938(1063)a 3785(701) 3737(722) 3835(890) 3721(918)
Detach 0 0 0 0 0
1 mg
Lys i s 3644(479)b 3674(561) 3733(490) 3857(518) 3887(595)
Detach 0 0 0 0 0
5 mg
Lys i s 6605(1521 )c 5702(1123) 5977(1536) 5951(1310) 5658(1284)
Det ach 1190(2045) 401(1240) 195(1187) 587(1117) 473(1501)
an=6 separate experiments, bn=6 separate experiments and cn=9 separate
experiments in triplicate. Detach:-detachment. Results are presented as mean(SD)
cpm.
8.2. IL-1 and TNF activities in pleural lavage fluid
There was no important IL-1 (Table 8.1) or TNF (Table 8.2) activities in
normal pleural lavage fluid. The detected activity was the reflection of background
of the assays.




Pleural lavage fluid 343 (144)a 255 (92) 377 (212)
Pleural leukocyte 13486 (4161)b 18146 (4573) 19056 (4975)
supernatant
an= 4, bn= separate experiments in triplicate respectively. Results are
presented as mean(SD) cpm.
11




Pleural lavage fluid 0.35(0.49)a 0.25(0.34) 0.23(0.35)
Pleural leukocyte 11.87(6.85)b 22.73(11.1) 39.52(15.16)
supernatant
an= 3, bn=7 separate experiments in triplicate. Results are presented as
mean(SD) U/ml.
8.3. Pleural lavage fluid inhibits IL-1 and TNF activities in pleural leukocyte
supernatants
Normal pleural lavage fluid inhibited both IL-1 activity (Fig. 8.1) and
TNF activity (Fig. 8.2) in normal pleural leukocyte supernatants in a lavage fluid
concentration-related manner.
8.4. Pleural lavage fluid inhibits the activities of the IL-1 and TNF standards
After the addition of pleural lavage fluid to IL-1 /3 standard in the C3H
mouse thymocyte assay, the activity of IL-1 standard in stimulating the thymocyte
growth was inhibited in a lavage fluid concentration-related manner (Fig. 8.3).
Figure 8.4 exhibits the inhibitory effect of pleural lavage fluid on TNFa
standard. There was again, a dose response of pleural lavage fluid with respect to
its inhibitory effect on TNFa.
8.5. Pleural lavage fluid stimulates mesothelial cell proliferation
Figure 8.5 shows that pleural lavage fluid from rats within 14 days after 5
mg crocidolite asbestos I/T had no detectable stimulating effect on mesothelial cell
proliferation compared to control. However, when it was one month after
crocidolite I/T, pleural lavage fluid stimulated the proliferation of mesothelial
cells in culture.
9. The activities of pleural leukocyte lysate, mesothelial cell supernatant and
lysate
9.1. Fibrinolytic activity of pleural leukocyte lysates
Studies with pleural leukocyte lysates illustrated that the pleural leukocyte
lysate contained high plasminogen activator activity (Fig. 2.9).
9.2. TNF and IL-1 activities of pleural leukocyte lysates
Table 9.1 illustrates that there was no detectable TNF activity in pleural
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Dilution of pleural lavage fluid
Figure 8.1 Inhibition of IL-1 activity in pleural leukocyte supernatant by pleural
lavage fluid
Each bar stands for the mean and SEM of 12 separate experiments carried
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Dilution of pleural lavage fluid
Figure 8.2 Inhibition of TNF activity in pleural leukocyte supernatant by pleural
lavage fluid
Each bar stands for the mean and SEM of 4 separate experiments carried




0 1:32 1:16 1:8
Dilution of pleural lavage fluid
Figure 8.3 Normal pleural lavage fluid inhibits the activity of the IL-1/3
standard
Each bar stands for the mean and SEM of 2-9 separate experiments
carried out in triplicate. Asterisk denotes a significant difference from
corresponding IL-1 activity of control: **=P<0.01 and ***=P<0.001.
Dilution of pleural lavage fluid
Figure 8.4 Normal pleural lavage fluid inhibits the activity of the TNFa
standard
Each bar stands for the mean and SEM of 4-8 separate experiments
carried out in triplicate. Asterisk denotes a significant difference from
corresponding TNF activity of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
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Time after asbestos instillation (day)
Figure 8.5 Mesothelial cell proliferation caused by pleural lavage fluid from rats
at various times after I/T 5 mg crocidolite asbestos
Each bar stands for the mean and SEM of 8-17 separate experiments in
triplicate. The dilution of pleural lavage fluid was 1:4. Compared to control, **
means P<0.01.
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leukocyte lysates. In addition, no inhibitory effect of pleural leukocyte lysate on
the TNFa standard (Table 9.2). Table 9.3 shows no IL-1 activity in the pleural
leukocyte lysate.
Table 9.1 TNF ACTIVITY IN THE PLEURAL LEUKOCYTE LYSATES
PLLa(Dilution) 1:64 1:32 1:16 1:8 1:4
TNF(U/ml)b 0.02(0.02) 0.02(0.02) 0.02(0.01) 0.02(0.02) 0.02(0.02)
aPLL: Pleural leukocyte lysate; bTNF activity detected by L929 cell line assay;
results are presented as mean(SD) of 6 separate experiments in triplicate.
Table 9.2 THE EFFECT OF PLEURAL LEUKOCYTE LYSATE ON TNFa
STANDARD
PLLa(Dilution) 0 1:64 1:32 1:16 1:8 1:4
TNF(U/ml)b 2.3(0) 1.9(1.2) 2.3(1.5) 2.1(1.0) 1.9(1.4) 1.7(1.8)
aPLL: Pleural leukocyte lysate; bp/yp activity after the addition of pleural
leukocyte lysate into the culture of TNFa standard; results are presented as
mean(SD) of 3 separate experiments in triplicate.
Table 9.3 IL-1 ACTIVITY IN THE PLEURAL LEUKOCYTE LYSATES
PLLa(Dilution) 1:16 1:8 1:4
IL-1 activity (cpm)b 566 (172) 707 (185) 493 (186)
aPLL: Pleural leukocyte lysate; bjp-j activity detected by C3H mouse thymocyte
proliferation assay; and results are presented as mean(SD) of 4 separate
experiments in triplicate.
9.3. TNF and IL-1 activities of mesothelial cell supernatants
Table 9.4 indicates no detectable TNF activity in the supernatants of rat
mesothelial cells. In addition, no detectable IL-1 activity was present in the
supernatants of rat mesothelial cells (Table 9.5). There was also no important
inhibitory effect of mesothelial cell supernatants on TNFa standard (Table 9.6).
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Table 9.4 TNF ACTIVITY IN MESOTHELIAL CELL SUPERNATANTS
MCSa(Dilution) 1:64 1:32 1:16 1:8 1:4
TNF(U/ml)b 0.30(0.31) 0.17(0.14) 0.15(0.13) 0.20(0.16) 0.13(0.14)
aMCS: Mesothelial cell supernatants; bTNF activity detected by L929 cell line
assay; n=3 separate experiments in triplicate, results are shown as mean(SD).
Table 9.5 IL-1 ACTIVITY IN MESOTHELIAL CELL SUPERNATANTS
MCSa(Dilution) 1:16 1:8 1:4
IL-1 activity (cpm)b 281 (152) 271 (80) 323 (73)
aMCS: Mesothelial cell supernatants; ^IL-1 activity detected by C3H mouse
thymocyte proliferation assay; and results are presented as mean(SD) of 2
separate experiments in triplicate.
Table 9.6 THE EFFECT OF MESOTHELIAL CELL SUPERNATANTS ON
TNFcc STANDARD
MCSa(Dilution) 0 1:64 1:32 1:16 1:8 1:4
TNF (U/ml)b 46.4(6.9) 40.1(2) 41.5(0) 41.5(0) 43.1(2.2) 44.6(0)
aMCS: Mesothelial cell supernatants; &TNF activity after the addition of the
supernatants into the culture of TNFa standard; results are presented as
mean(SD) of 2 separate experiments in triplicate.
9.4. TNF and IL-1 activities of mesothelial cell lysates
Tables 9.7 and 9.8 show that there were no detectable TNF and IL-1
activities in the lysates of rat mesothelial cells.
Table 9.7 TNF ACTIVITY IN MESOTHELIAL CELL LYSATES
MCLa(Dilution) 1:64 1:32 1:16 1:8 1:4
TNF(U/ml)b 0.14(0.19) 0.08(0.07) 0.08(0.06) 0.07(0.06) 0.05(0.05)
aMCL: Mesothelial cell lysates; bTNF activity detected by L929 cell line assay;
and results are presented as mean(SD) of 4 separate experiments in triplicate.
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Table 9.8 IL-1 ACTIVITY IN MESOTHELIAL CELL LYSATES
MCLa(Dilution) 1:16 1:8 1:4
IL-1 activity (cpm)b 395 (194) 307 (52) 493 (669)
aMCL: Mesotkelial cell lysates; bIL-1 activity detected by C3H mouse thymocyte
proliferation assay; and results are presented as mean(SD) of 3 separate
experiments in triplicate.
10. Interleukin-2 (IL-2) activity in pleural leukocyte supernatants
To demonstrate that the observed IL-1 activity was not due to IL-2
released from contaminating lymphocytes (Yamaguchi et al, 1989), the pleural
leukocyte supernatants were tested for IL-2 activity using the CTLL cell line
"l r>
which proliferates specifically ^ to IL-2. Figure 10.1 illustrates that there was no
important IL-2 activity in the supernatants of control pleural leukocytes and
supernatants of the leukocytes at various times (from 1 day to 30 days) after
crocidolite asbestos I/T at various doses (from 5 mg to 10 mg), whilst the positive
control, IL-2 standard, gave a marked response. IL-2 activities were also not
detectable in the supernatant of pleural leukocytes from rats various times after
C.parvum I/T (Fig. 10.1).
11. Validation of assays
11.1. TNF L929 cell line assay
The effect of IL-1 (3 standard on TNF L929 cell line assay was shown in
Table 11.1. It was apparent that up to 12.5 U/ml, IL-1 standard sample had no
effect on L929 cell line assay.
Table 11.1 THE EFFECT OF IL-1/3 STANDARD ON L929 CELL LINE
ASSAY
IL-l/3(U/ml) 0.63 1.56 3.13 6.25 12.5
TNF(U/ml) 0.08(0.03)a 0.06(0.03) 0.06(0.03) 0.04(0.03) 0.04(0.03)
aTNF activity detected by L929 cell line assay, and the results are presented as
mean(SD) of 3 separate experiments in triplicate.
Table 11.2 indicates that F10 medium plus 2% BSA had no effect on
L929 cell line assay.
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Media Contl 5/1 5/3 5/30 10/1 Cp1 D Cp5D Stand
Supernatant
Figure 10.1 IL-2 activity in pleural leukocyte supernatants after I/T crocidolite
asbestos or C.parvum
Each bar represents the mean and SEM of 2-12 separate experiments.
Abbreviations represent: Media:- medium alone control; Contl:- control
supernatant; 5/1:- 1 day after I/T 5mg crocidolite; 5/3:- 3 day after I/T 5mg
crocidolite; 5/30:- 30 days after I/T 5mg crocidolite; 10/1:- lday after I/T 10 mg
crocidolite; CplD:- 1 day after I/T 1.4 mg C.parvum; Cp5D:- 5 days after I/T
1.4 mg C.parvum; Stand:- IL-2 standard. The dilution of all of pleural leukocyte
supernatants was 1:2 and the dose of IL-2 standard was 10 U/ml.
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Table 11.2 THE EFFECT OF F10 MEDIUM PLUS 2% BSA ON L929 CELL
LINE ASSAY
F10+2%BSA (Dilution) 1:32 1:16 1:8 1:4
TNF (U/ml) 0.05(0.06)a 0.03(0.02) 0.02(0.01) 0.02(0.01)
aTNF activity detected by L929 cell line assay and the results are presented as
mean(SD) of 3 separate experiments in triplicate.
11.2. IL-1 C3H mouse thymocyte proliferation assay
The effect of TNFa on C3H mouse thymocyte proliferation assay is shown
in Table 11.3. There was negligible effect of TNFa in the assay.
Table 11.3 THE EFFECT OF TNFa ON C3H MOUSE THYMOCYTE
PROLIFERATION ASSAY
TNFa (U/ml) 25 50 100
IL-1 activity (cpm) 819 (292)a 771 (397) 1003 (664)
aIL-l activity (cpm) detected by C3H mouse thymocyte proliferation assay and
the results are presented as mean(SD) of 3 separate experiments in triplicate.
11.3. Fibrinolysis assay
TNFa up to 1000 U/ml was added into fibrinolysis assay. Results indicated
that TNFa did not interfere with PAI activity in pleural leukocyte supernatants
(Table 11.4).
Table 11.4 EFFECT OF TNFa ON FIBRINOLYSIS INHIBITION CAUSED
BY PLEURAL LEUKOCYTE SUPERNATANT
TNF (U/ml) 0 62.5 125 250 500 1000
% inhibition 48.86 40.97 47.01 42.56 38.48 46.08
(17.14) (7.25) (13.64) (10.13) (5.13) (6.63)
Results are presented as mean(SD) of 6 separate experiments in triplicate.
Fibrinolysis was induced by urokinase and PLG. The dilution of supernatant of
pleural leukocytes was 1:16.
12. Reactive pleural inflammation caused by intratracheal instillation of C.parvum
12.1. Alveolar and pleural leukocyte populations after I/T C.parvum
Normal rat alveolar leukocyte populations contained more than 95%
macrophages with a total cell number of less than 5 x 106. One day after
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intratracheal instillation of C.parvum, large number of PMN were recruited to the
bronchoalveolar space and this increased the total cell number to 27 x 106,
although macrophage number remained at the same levels (Fig 12.1). By 3 days
after instillation, numbers of PMN had decreased dramatically and were minimal
by day 5. However, the numbers of macrophages were markedly increased by day
3 and remained elevated at day 5.
Figure 12.2 shows that six hours after C.parvum I/T, except for some
variation in numbers of mast cells and eosinophils, changes of other cell
components in the pleural space were negligible. However, one day after
instillation there was a slight increase in numbers of macrophages, but a marked
increase in numbers of PMNs in the pleural space. The peak of PMNs at day 1
disappeared quickly and no PMNs were found by day 5. However, numbers of
macrophages increased dramatically from day 3 and remained high at day 5.
When the components of pleural leukocytes were compared with those of alveolar
leukocytes, the patterns of alteration in the macrophage and PMN populations
were very similar.
12.2. Analysis of fluorescent polystyrene microspheres (beads) and C.parvum
organisms in both alveolar and pleural cavity
When beads were intratracheally instilled alone, they induced a moderate
alveolitis, which was characterized by 24% PMNs in the bronchoalveolar lavage
(Table 12.1). However, in the pleural space, little effect was seen.
Table 12.1 ALVEOLAR AND PLEURAL LEUKOCYTE POPULATIONS
AFTER BEADS AND/OR C.PARVUM I/T
Treatment Total No Differential percentage
(xlO6) Macrophages PMN Lymphocytes Mastcells Eosinophils
Alveolar leukocvtes
B alone 7.36(1.26) 75(3.5) 24(2.8) 1(0.7) 0 0
B+Cp(dayl) 58.97(2.95) 16(2.1) 84(2.8) 0 0 0
B+Cp(day5) 13.87(1.76) 81(9.5) 18(9.5) 1(0) 0 0
Pleural leukocvtes
B alone 4.10(0.70) 76(6.4) 0 1(0) 16(3.5) 7(2
B+Cp(dayl) 11.80(3.38) 60(0.7) 29(11) 0 6(5.7) 5(5
B+Cp(day5) 9.47(0.55) 86(0) 3(1.5) 6(1) 4(1.7) 1(0






Time after C.parvum instillation <day)
Figure 12.1 Alveolar leukocyte populations at various times after I/T C.parvum
Each point shows mean and SEM of 3 separate experiments. Asterisk









Control 1/4 1 3 5
Time after C.parvum instillation (day)
Figure 12.2 Pleural leukocyte populations at various times after I/T C.parvum
The points show mean and SEM of 2 to 13 separate experiments. For
clarity SEM, which varies from 8% to 30%, is not presented in the graph.
Asterisk denotes a significant difference from control: *=P<0.05, ***=P<0.001.
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C.parvum.
Counting of beads showed that a high percentage (72%) of alveolar
macrophages engulfed beads and most macrophages (>70%) were found to contain
more than 10 beads (Table 12.2). This suggested that after instillation of beads,
macrophages were very active in removing them from the lung surface. However,
beads were negligible in the pleural leukocytes.
Table 12.2 ANALYSIS OF BEADS IN THE ALVEOLAR AND PLEURAL
LEUKOCYTES FOLLOWING BEADS AND/OR C.PARVUM I/T
Treatment % of cells with Distribution of beads in cells (%)
beads 1-5 5-10 >11
Alveolar macrophages
B alone 72 (7.1) 12 (8.5) 17 (4.2) 71 (12.7)
B+Cp (dayl) 37 (6.4) 57 (7.1) 26 (8.5) 17 (1.4)
B+Cp (day5) 15 (1.5) 52 (8.7) 25 (6.2) 23 (2.6)
Alveolar PMNs
B alone 33 (18.4) 90 (2.8) 9 (1.4) 1 (1.4)
B+Cp (dayl) 4 (0.7) 100 (0) 0 0
B+Cp (day5) 0 (0) 0 0 0
Pleural macrophages
B alone <1 100 0 0
B+Cp (dayl) <1 100 0 0
B+Cp (day5) 0 0 0 0
Pleural PMNs
B alone 0 0 0 0
B+Cp (dayl) <1 100 0 0
B+Cp (day5) 0 0 0 0
Results are presented as mean(SD) of two separate experiments. Abbreviation is
the same as Table 12.1.
One day after C.parvum and beads I/T together, a severe inflammatory
response was observed in the alveolar space with the total number of alveolar
leukocytes being up to 8 fold greater than with bead instillation alone, PMN
accounted for more than 80% of the total alveolar population (Table 12.1). Due
to the massive recruitment of PMN into the alveolar space or a turnover of
macrophages entering and leaving the lung, the percentages of macrophages
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containing beads decreased from 72% to 37% and the distribution of beads in the
macrophages changed with most macrophages (>80%) containing less than 10
beads. The dramatic increase in PMN number in the alveolar space after beads
and C.parvum caused a reduction in the percentage of PMNs with beads from
33% in beads alone group to 4% (Table 12.2). Meanwhile, in the pleural space,
PMNs were recruited in relatively high number (29% of the total population) and
the total cell number increased nearly three-fold compared to beads alone group
(Table 12.1). In spite of such severe pleural inflammation resulting from
C.parvum in the airspace, negligible numbers of beads could be observed in the
pleural leukocytes. It was found that the beads which were seen only very
occasionally in cytospins of pleural lavage leukocytes were extracellular, single
spheres, being very different to the beads within cells in the alveolar leukocyte
cytospins.
The results suggested that there is no direct transfer of compact particles
of around 1 ^m between the alveolar space and the pleural space, even during
acute inflammation. To confirm this hypothesis, we extended our observations to
assess numbers of leukocytes containing C.parvum organisms in both spaces. Table
12.3 shows that one day after C.parvum I/T, numbers of macrophages and PMNs
in the alveolar space which were seen to contain organisms were 26% and 34%
respectively. By day 5, the percentages of macrophages and PMNs containing
organisms dropped to 1 and 0%. Nevertheless, organisms could be found in
neither pleural macrophages nor PMNs at any time. These findings indicated that
compact particles with diameter of 0.77 pm (the diameter of bead studied) are
not likely to be transferred from the alveolar space to the pleural space.
12.3. Secretion of cytokines by pleural leukocytes in vitro after I/T C.parvum
Normal pleural leukocytes spontaneously produced IL-1 and TNF in culture
(Figs 12.3 and 12.4). One day after I/T C.parvum, the pleural leukocytes
produced less IL-1 and TNF in vitro compared to normal leukocytes. Five days
after instillation, this reduction was even more marked.
12.4. PAI production by pleural leukocytes in vitro after I/T C.parvum
Fig 12.5 shows that PAI production by pleural leukocytes one day after
I/T C.parvum increased significantly compared to control. However, five days after
C.parvum I/T, PAJ activity produced by pleural leukocytes had recovered to
normal levels.
12.5. Macrophage and PMN chemotaxis caused by pleural leukocyte supernatant
Supernatants of the pleural leukocytes from rats intratracheally instilled
with C.parvum had slight chemotactic activity for macrophages compared to
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Tim© after C.parvum instillation (day)
Figure 12.3 IL-1 production by pleural leukocytes at various times after I/T
C.parvum
Each point represents mean and SEM of 4-9 experiments in triplicate.
Asterisk denotes a significant difference from the corresponding dilution of control:
***=P<0.001.
Time after C.parvum instillation (day)
Figure 12.4 TNF production by pleural leukocytes at various times after I/T
C.parvum
Each point represents the mean and SEM of 4-7 separate experiments
performed in triplicate. Asterisk denotes a significant difference from corresponding
dilution of control: *=P<0.05, **=P<0.01 and ***=P<0.001.
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Time after C.parvum instillation (day)
Figure 12.5 Fibrinolysis inhibition caused by pleural leukocyte supernatants at
various times after I/T C.parvum
Results are presented as mean and SEM of 3-8 separate experiments
performed in triplicate. Asterisk denotes a significant difference from corresponding
dilution of control: **=P<0.01 and ***=P<0.001.
Negative Positive Day 1 Day 5
Supernatant
Figure 12.6 Macrophage and neutrophil chemotaxis caused by pleural leukocyte
supernatants at various times after I/T C.parvum
Each bar shows mean and SEM of 2 to 6 separate experiments. Asterisk
denotes a significant difference from negative control: *=P<0.05, **=P<0.01.
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negative control (Fig 12.6). This activity increased from day 1 to day 5. There
was no PMN chemoattractive activity in pleural leukocyte supernatants, in
contrast, supernatants from pleural leukocyte 5 days after I/T C.parvum showed
reduced ability to attract PMNs compared to negative control.
Table 12.3 ANALYSIS OF C.PARVUM ORGANISMS IN THE ALVEOLAR
AND PLEURAL LEUKOCYTES AFTER C.PARVUM I/T
Cells Percentage of cells with organisms
Alveolar macrophages
day 1 26 (3.1)
day 5 1 (0.6)
Alveolar PMNs








Results are presented as mean(SD) of 3 to 5 separate experiments.
12.6. Mesothelial cell lysis and detachment caused by alveolar and pleural
leukocytes after I/T C.parvum
Figure 12.7 shows that one day after C.parvum I/T, alveolar leukocytes
caused considerable mesothelial cell detachment in an effector rtarget-related
manner; no important mesothelial cell lysis resulted from by the addition of
alveolar leukocytes.
Normal pleural leukocytes induced neither mesothelial cell lysis nor
detachment (Fig. 7.3). However, one day after C.parvum I/T, pleural leukocytes,
which contained more than 28% of PMN, dramatically induced detachment of
mesothelial cells in culture, but had no influence on mesothelial cell lysis (Fig.
12.8).
Figure 12.9 illustrates that 5 days after C.parvum I/T, pleural leukocytes
had almost no effect in inducing mesothelial cell detachment, but caused
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Alveolar leukocytes : Mesothelial cells
Figure 12.7 Mesothelial cell lysis and detachment injury caused by PVG rat
alveolar leukocytes one day after I/T C.parvum
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Pleural leukocytes : mesothelial cells
Figure 12.8 Mesothelial cell lysis and detachment injury caused by PVG rat
pleural leukocytes one day after I/T C.parvum
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Pleural leukocytes : mesothelial cells
Figure 12.9 Mesothelial cell lysis and detachment injury caused by HAN rat
pleural leukocytes 5 days after I/T C.parvum

























Figure 13.1 TNF and IL-1 production by alveolar macrophages treated with 50
/zg/ml long or short fibre amosite in vitro
Each bar stands for the mean and SD of 2-4 separate experiments in
triplicate. The dilutions of supernatant for IL-1 was 1:16, and for TNF was
1:256. Abbreviation represent: Contl:- control, Short-A:- short fibre amosite,
Long-A:- long fibre amosite. Asterisk denotes a significant difference from
control: *=P<0.05, ***=P<0.001.
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mesothelial cell lysis at higher rates between the leukocytes and mesothelial cells.
Since this experiment was carried out using HAN rats due to shortage of PVG
rats, it is difficult to compare this result with the result of Fig. 12.8.
13. Effect of long and short amosite fibre asbestos on cytokine production
The following experiments were carried out using HAN rats.
13.1. TNF and IL-1 production by alveolar macrophages in vitro treated with 50
Hg/ml short and long fibre amosite asbestos
Normal rat alveolar leukocytes contained more than 95% macrophages
(Table 1.1) and are referred to as alveolar macrophages. Table 13.1 shows that
normal alveolar macrophages produced TNF and IL-1 in culture and the
production was increased significantly when the macrophages were stimulated with
100 ng/ml LPS.
Table 13.1 EFFECT OF LPS STIMULATION ON IL-1 AND TNF
PRODUCTION BY ALVEOLAR MACROPHAGES
Cytokine without LPS with LPS
IL—1 (cpm) 2782 (108)3 3894 (441)3
TNF (U/ml) 7.40 (3.27)4 11.82 (1.61)4
Results are presented as mean(SD)n of the experiments performed in triplicate.
The dilutions of supernatants for IL-1 measurement was 1:16, for TNF
measurement was 1:128. There is statistiacally significant difference between with
and without LPS for IL-1 (P<0.01) and TNF (P<0.05).
Figure 13.1 illustrates evidently that alveolar macrophages stimulated with
50 /rg/ml of long amosite produced more TNF in culture than the cells stimulated
with short amosite. Short amosite-treated cells produced the same levels of TNF
as control macrophages. As demonstrated in Fig. 13.1, long amosite asbestos also
stimulated alveolar macrophages to produce more IL-1 activity in culture than
short amosite did.
We also utilised two frequently used dust controls, TiOz and DO 1 2, in
these experiments. It was found that DQ1 2 stimulated alveolar macrophages in
vitro to produce increased TNF compared to control (Fig. 13.2). However, TiO 2
had no significant stimulating effect on macrophages.
13.2 Studies on the effect of opsonized dusts on TNF production by alveolar
macrophages




Figure 13.2 TNF production by alveolar macrophages treated with 50 /rg/ml of
mineral dusts in vitro
Each bar stands for the mean and SEM of 2-3 separate experiments
performed in triplicate. Asterisk denotes a significant difference from control:
*=P<0.05, **=P<0.01.
Figure 13.3 Effect of dust opsonization on TNF production by alveolar
macrophages in vitro
The concentration of rat IgG and fibronectin were 50 /rg/ml. The dose of
dust added to alveolar macrophage cultures was 50 /rg/ml. Each bar is the mean
and SEM of 3 separate experiments performed in triplicate. Abbreviations
represent: Long:- long fibre amosite, short:- short fibre amosite, HI serum:-
heat-inactivated rat serum.
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supernatants rather than TNF activity in diluted supernatants as shown above.
Figure 13.3 shows the effect of the opsonization of dusts on TNF
production by alveolar macrophages in vitro. Dusts opsonized by PBS (effectively
unopsonized) were treated as controls. For long amosite, after opsonization by F10
medium plus 2% BSA and rat serum, TNF-stimulating activity increased slightly.
However, when opsonized by heat-inactivated rat serum or fibronectin, the
stimulating activity of long amosite was increased moderately. IgG-opsonized long
amosite had by far the greatest effect on TNF production by alveolar
macrophages compared to other treatments, with the TNF activity increasing up to
6 fold compared to PBS control. Short amosite had a much less stimulatory effect
compared to long amosite.
Amongst different opsonins, apparently, IgG treatment caused the biggest
enhancement of the capability of short amosite to stimulate macrophages to
produce TNF in culture whilst fibronectin treatment was also moderately effective.
Comparison between TiO 2 and DQ, 2 indicated that DQ, 2 stimulated more TNF
production by macrophages than TiO 2 did and DQ 1 2 had much bigger response
to the opsonization of IgG than Ti02.
Further investigation was carried out to discover the response of different
dusts to IgG opsonization. Figure 13.4 shows that long amosite had the most
considerable response to IgG opsonization than other dusts and TiO 2 had the least
response. With respect to the concentrations of IgG used for opsonization, it
was clear that, at lowest dose of opsonzing IgG, i.e., 10 /tg/ml, the ability of
long amosite in stimulating TNF production by macrophages had been increased to
its maximal level. However, other dusts needed to be opsonized by up to 100
/xg/ml of IgG to exert their maximal stimulating effect on TNF production. For
TiO 2 an even higher dose of IgG was required.
An effort has been made to identify the possible role of serum in the
opsonization of long amosite by IgG. It was found that there was no significant
difference between opsonization by IgG plus rat serum and by IgG plus
heat-inactivated rat serum, which may exclude the possible interaction between
IgG and some heat-labile substances in serum in the opsonization of dusts, such
as complements (Fig. 13.5). BSA which was chosen as a negative, parallel control
to IgG had no effect in opsonization of the fibre.
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Figure 13.4 Effect of IgG opsonization on the ability of dusts to stimulate TNF
production
The concentration of dusts used in study was 50 /ig/ml. Each bar
represents the mean and SEM of 2 separate experiments in triplicate.
Abbreviations as for Figure 13.3.
20 r
Figure 13.5 TNF production by alveolar macrophages treated with opsonized
long fibre amosite
The dust was used in the experiments at a concentration of 50 /xg/ml. The
concentrations of IgG and BSA in the experiments were 50 ^g/ml. Each bar
represents the mean and SEM of 3 separate experiments performed in triplicate.
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14. Analysis of beads in bronchoalveolar and pleural leukocytes after rats were
intratracheally instilled with the beads and dusts
14.1. Bronchoalveolar and pleural leukocyte components after beads and/or dusts
I/T
Table 14.1 shows that total numbers and differential counts of
bronchoalveolar leukocytes various times after beads I/T alone or with other dusts.
Instillation of bead alone caused moderate acute inflammation in the alveolar
space with PMN being 24% of total cells. However, when beads were instilled
together with 5 mg of DQ, 2, a severe inflammation appeared in the alveolar
space (more than 74% PMN in the population) with the total cell number
increasing 2.5 fold. Five mg of chrysotile together with beads also resulted in
severe inflammation (more than 68% PMN), but the total number was low due to
probably difficulty in lavaging from asbestos fibre-blocked airways.
Table 14.1 BRONCHOALVEOLAR LEUKOCYTE COMPONENTS AT
VARIOUS TIMES AFTER BEADS AND/OR DUSTS I/T
Treatment Total No. Differential percentage
(x 106) Macrophages PMN Lymphocytes
1 day after insti11 ation
Beads alone 7.36(1.26) 75(3.5) 24(2.8) 1(0.7)
Beads+DQ,2 18.58(10.49) 26(12.0) 74(12.0) 0
Beads+Chry 3.41 32 68 0
1 month after instillation
Beads alone 5.37(1.32) 98(0) 1(1.4) 1(1.4)
Beads+Croc 5.75(0.71) 94(1.4) 3(0) 3(1.4)
Beads+Chry 2.55(0.57) 95(0.7) 4(2.1) 1(1.4)
Results are presented as the mean (SD) of 2 separate experiments except for
the group of 1 day beads + chrysotile group which has only 1 experiment due to
a mistake in the instillation procedure. Croc: crocidolite; Chry: chrysotile. The
dose of dusts were 5 mg per rat. Beads were diluted 1:20 with PBS and 0.2 ml
of the solution was injected together with 0.3 ml dust suspension.
At one month post beads and/or dusts I/T, alveolar leukocyte populations
had nearly recovered to normal level except for a low level of PMN (Table
14.1).
Table 14.2 illustrates that beads alone or together with dusts I/T did not
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substantially affect the components of pleural leukocytes, the only exception was a
slight recruitment of PMN one day after beads + DQ1 2.
Table 14.2 PLEURAL LEUKOCYTE COMPONENTS VARIOUS TIMES
AFTER BEADS AND/OR DUSTS I/T
Treatment Total No Differential percentage
(x 106) Macrophages PMN Lymphocytes Mast-cells Eosinophils
1 day after instillation
Beads 4.09(0.70) 76(6.4) 0 1(0) 16(3.5) 7(2.8)
Bead+DQ12 5.02(1.39) 73(8.5) 4(5.0) 1(1.4) 13(2.1) 9(1.8)
Bead+Chry 4.31 79 0 2 11 8
1 month after instillation
Beads 3.45(0.64) 82(4.2) 0 1(0.7) 12(5.7) 5(2.1)
Bead+Croc 5.93(1.10) 76(2.8) 0 2(0) 10(1.4) 12(4.2)
Bead+Chry 7.30(0.42) 78(0.7) 0 2(0.7) 8(0.7) 12(0.7)
See footnote to Table 14.1 for detail.
14.2. Counts of beads in alveolar and pleural phagocytes
Table 14.3 shows that there was a high percentage of macrophages with
beads present in the alveolar space (72%) and most macrophages had more than
10 beads (71%). However, one day after beads plus DQ, 2 or chrysotile asbestos
I/T, the percentage of macrophages containing beads decreased and more than
60% of macrophages contained less than 5 beads. One month after instillation of
beads alone, 53% of macrophages were found to contain beads and the
distribution of beads in the cells shifted towards the 1-5 group. The percentage of
macrophages with beads decreased in both beads plus crocidolite and beads plus
chrysotile groups.
Studies on alveolar PMN showed that 1 day after beads and/or dust I/T,
there was a fairly high percentage of PMN-containing beads (20-33%) and most
of them had less than 5 beads (90-96%) (Table 14.4). When one month had
elapsed after instillation, only a few PMN still existed in the lung and all of them
had less than 5 beads per cell.
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Table 14.3 COUNTS OF BEADS IN ALVEOLAR MACROPHAGES
Distribution of beads in cells OA)
Treatment Cells with beads OA) 1-5/cell 6-10/ce11 >10/ce11
1 day after inst: i1lation
Beads 72 (7.1) 12(8.5) 17(4.■ 2) 71(12.7)
Beads+DQ,2 48 (19.8) 64(22.6) 18(5..7) 18(17.0)
Beads+Chry 28 60 20 20
1 month afte r insti1lation
Beads 53 (15.6) 34(2.8) 25(4..2) 41(7.1)
Beads+Croc 39 (7.8) 35(2.8) 24(5. 0) 41(2.1)
Beads+Chry 24 (7.1) 51(12.7) 16(0.• 7) 33(13.4)
See footnote to Table 14.1 for detail.
Table 14.4 COUNTS OF BEADS IN ALVEOLAR PMN
Treatment Cells with beads(%) Dist ribution of beads in ce11s(%)
1-5/cel1 6-10/ce11 >10/ce11
1 day after insti1lation
Beads 33 (18.38) 90(2.8) 9(1.4) 1(1.4)
Beads+DQ,2 23 (14.9) 95(7.1) 5(7.1) 0
Beads+Chry 20 96 4 0
1 month after instillation
Beads <1 100(0)
Beads+Croc 8 (3.5) 100(0)
Beads+Chry 6 (0) 100(0)
See footnote to Table 14.1 for detail.
Tables 14.5 and 14.6 indicated that there were almost no macrophages or
PMN containing beads in the pleural space. Beads were found only very
occasionally and there were free.
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Table 14.5 COUNTS OF BEADS IN PLEURAL MACROPHAGES
Treatment Cells with beads(°/0 Distribution of beads in cells(%")
1-5/cell 6-10/cel1 >10/cell
1 day after insti1lation
Beads <1 100 0 0
Beads+DQ,2 <1 100 0 0
Beads+Chry 0 0 0 0
1 month after instillation
Beads 0 0 0 0
Beads+Croc 0 0 0 0
Beads+Chry 0 0 0 0
See footnote to Table 14.1 for detail.
Table 14.6 COUNTS OF BEADS IN PLEURAL PMN
Treatment Cells with beads(%■) Distribution of beads in ce11s(%)
1-5/cell 6-10/cel1 >10/ce11
1 day after insti1lation
Beads 0 0 0 0
Beads+DQ,2 <1 100 0 0
Beads+Chry 0 0 0 0
1 month after instillation
Beads 0 0 0 0
Beads+Croc 0 0 0 0
Beads+Chry 0 0 0 0
See footnote to Table 14.1 for detail.
Tables 14.7 and 14.8 shows the results of an experiment done incidentally.
By mistake during the procedure of intratracheal instillation, part of the
suspension of beads and chrysotile asbestos was injected into pleural space. Table
14.7 shows extensive recruitment of pleural leukocytes (32.55 x 10G, six times
more than other treatments) with nearly 70% of cells being PMN. Bead counting
in the pleural leukocytes confirmed mis- introduction of beads into pleural space,
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which gave a totally different picture from the normal intratracheal instillation
studies.
Table 14.7 ALVEOLAR AND PLEURAL LEUKOCYTE COMPONENTS 1
DAY AFTER INTRATRACHEAL AND INTRAPLEURAL INSTILLATION OF
BEADS AND CHRYSOTILE ASBESTOS
Total No Differential percentage
(x 106) Macrophages PMN Lymphocytes Mast-cells EosinophiIs
Alveolar
0.9 89 9 2
Pleural
32.55 30 69 0 1 0
Results of an experiment with mixed intrapleural and intratracheal injection of
5 mg chrysotile and beads.
Table 14.8 COUNTS OF BEADS IN ALVEOLAR AND PLEURAL
MACROPHAGES AND PMN
Cell with beads (%) Distribution of beads in cells (%)
1-5/cell 6-10/ce11 >10/cell
Alveolar macrophages
2 60 22 18
Alveolar PMN
7 84 8 8
Pleural macrophages
8 88 10 2
Pleural PMN
<1 92 4 4
Result of an experiment with mixed intrapleural and intratracheal instillation of
beads and 5 mg of chrysotile.
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15. Transmission electron microscopy study on pleural leukocytes and pleural
structure
15.1. Transmission electron microscopy study on the possibility of transfer of
asbestos fibre from airspace to pleural space
Transmission electron microscope studies had been carried out to determine
whether asbestos fibre in the airspace could reach the pleural space. Pleural
leukocytes were examined carefully for the presence of fibres. Both long or short
term asbestos inhalation and intratracheal instillation studies were carried out.
The inhalation studies included HAN rats exposed to 10 mg/m3 chrysotile asbestos
from 1, 3, 4, 6 months till 1 year, exposed to 10 mg/m3 chrysotile and 2
mg/m3 quartz together, 10 mg/m3 amosite and 2 mg/m3 quartz together or 10
mg/m3 long fibre amosite and 2 mg/m3 quartz for one year.
The results of light microscope studies on pleural leukocyte components
after rats were inhaled different asbestos or with other dusts were shown in Table
15.1. It was clear that different time after 10 mg/m3 chrysotile asbestos
inhalation, no PMN could be found in pleural leukocyte populations. There was
no considerable difference among various time groups. The inhalation of
chrysotile or amosite together with quartz caused slight recruitment of PMN in the
pleural leukocyte populations, especially, in 10 mg/m3 long fibre amosite together
with 2 mg/m3 quartz group in which PMN accounted for 6% of total cell
number. In addition, the combination of chrysotile and quartz, amosite and
quartz or long fibre amosite and quartz in inhalation study resulted in the
increase of pleural leukocyte numbers. However, when chrysotile alone groups
were compared with other treatment groups, it was noted that the percentage of
eosinophils increased remarkably apart from 1 year term inhalation study.
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Table 15.1 PLEURAL LEUKOCYTE COMPONENTS AFTER RATS INHALED
ASBESTOS ALONE OR TOGETHER WITH QUARTZ
Total No. Differential percentage
(x 106) Macrophages PMN Lymphocytes Mast-cells Eosinophils
Cont ro1
9.31(4.91)7 73(5.5)7 0 3(3.1)7 17(3.9)7 7(2.6)7
Chrysotile alone
1 month
7.78(1.46)2 69(4.2)2 0 2(1.4)2 14(3.5)2 15(2.1)2
3 months
10.63(0.18)2 71(9.9)2 0 1(0.7)2 15(7.1)2 13(3.5)2
4 months
11.16(4.61)4 71(4.9)4 0 1(0.5)4 15(3.4)4 13(3.9)4
6 months
9.38(2.34)2 67(4.2) 0 2(0.7)2 19(2.8)2 12(0.7)2
1 year
5.61(1.26)2 72(0)2 0 2(0)2 18(5.7)2 8(5.7)2
Chrysotile or amosite + quartz
Chrysotile + quartz, 1 year
14.69(5.88)6 74(10.1)6 1(2.0)6 8(8.6)6 8(6.1)6 9(7.4)6
Amosite + quartz, 1 year
16.31(16.62)3 83(11.6)3 1(0.6)3 1(1.0)3 8(7.4)3 7(3.5)3
Long fibre amosite + quartz, 1 year
17.55(9.05)5 81(9.7)5 6(11.2)5 5(8.1)5 4(4.4)5 4(2.6)5
Results are presented as mean (SD) n. There is statistically a significant
difference in total cell numbers between control v 10mg/m3 long fibre amosite
and in differential percentage of eosinophils between control v all of chrysotile
alone groups (P<0.05-P<0.01) except for the 1 year group.
Table 15.2 indicates that compared to the pleural leukocytes,
bronchoalveolar leukocyte components showed a dramatic change in response to
asbestos inhalation, characterised by substantial recruitment of PMN.
Pleural leukocytes were studied by transmission electron microscopy in an
attempt to find asbestos fibres in the leukocytes, especially, macrophages. From
each treatment up to five blocks were prepared and, in each block more than
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100 cells were observed. After rat inhalation exposure to asbestos for various
time, pleural macrophages appeared very active (Figs. 15.1 - 15.3) compared to
normal pleural macrophages (Fig. 1.2), but no asbestos fibres could be observed
in pleural leukocytes. In the same animals, asbestos fibres were easily identified in
alveolar macrophages (Figs. 15.4 - 15.7).
Table 15.2 BRONCHOALVEOLAR LEUKOCYTE COMPONENTS VARIOUS




PMN Lymphocytes Mast-cells Eosinophils
Chrysotile 1 mont h
7.13(3.05)2 86(6.4)2 13(6.4)2 1(0)2 0 0
Chrysoti1e 3 months
6.71(3.13)2 56(15.6)2 40(11.3)2 4(4.2)2 0 0
Chrysotile 4 mont hs
7.40(1.72)4 66(9.0)4 33(9.0)4 1(0)4 0 0
Results are presented as mean(SD)n.
15.2. Electron microscope study of rat pleura
Figure 15.8 shows an area of control rat visceral pleura. The visceral
pleural was found to be composed of a mesothelium separated by a continuous,
elastic lamina from the juxtapleural alveoli or terminal bronchiole (Figs. 15.8,
15.9). There were tight junctions in the mesothelium (Fig. 15.10). Bundles of
collagen fibres were observed in submesothelial tissue. Mast cells were found
frequently in these areas (Fig. 15.11).
The parietal pleura was composed of a monolayer of mesothelial cells
separated from the parietal muscular layer by a thick connective tissue layer. The
mesothelial cells were flatter than those of the visceral pleura (Fig. 15.12).
Collagen bundles were seen frequently.
15.3. Observation on the pleural structure after intratracheal instillation of
C.parvum or chrysotile asbestos
Figure 15.13 shows rat visceral pleura one day after intratracheal
instillation of 5 mg chrysotile asbestos. There is a accumulation of PMN in
alveoli, and meanwhile, mesothelial cells became very active with much more
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Figure 15.1 Transmission electron micrograph of a pleural macrophage from a
HAN rat exposed, by inhalation, to chrysotile asbestos and quartz for one year
(x9,000)
Pleural leukocytes were lavaged from a rat one year after cessation of
inhalation exposure to 10 mg/m3 chrysotile asbestos plus 2 mg/m3 quartz for one
vear.
Figure 15.2 Transmission electron micrograph of a pleural macrophage from a
HAN rat inhaling chrysotile asbestos and quartz for one year (x8,000)
Pleural leukocytes were lavaged from a rat one year after cessation of
inhalation exposure to 10 mg/m3 chrysotile asbestos plus 2 mg/m3 quartz for one
vear.
9 6 A
Figure 15.3 Transmission electron micrograph of a pleural macrophage from a
HAN rat which had been inhaling chrysotile asbestos and quartz for one year
(x8,Q0O)
Pleural leukocytes were lavaged from a rat one year after cessation of
inhalation exposure to 10 mg/m3 chrysotile asbestos plus 2 mg/m3 quartz for one
year.
Figure 15.4 Transmission electron micrograph of an alveolar macrophage from a
HAN rat inhaling chrysotile asbestos for one month (x5,000)
Alveolar leukocytes were lavaged from a rat inhaling 10 mg/m3 of
chrysotile for month. Chrysotile fibrils can be identified within the macrophage.
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Figure 15.5 Transmission electron micrograph of an alveolar macrophage from a
HAN rat inhaling chrysotile asbestos for one month (x6,000)
Alveolar leukocytes were lavaged from a rat inhaling 10 mg/m3 of
chrysotile for month. The picture shows chrysotile fibrils in the cytoplasm and
phagosomes of the macrophage.
Figure 15.6 Transmission electron micrograph of an alveolar macrophage from a
HAN rat inhaling chrysotile asbestos for three months (x9,000)
Alveolar leukocytes were lavaged from a rat inhaling 10 mg/m3 chrysotile
for three months. Chrysotile fibrils are visible in phagosomes and cytoplasm of the
macrophage.
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Figure 15.7 High magnification transmission electron micrograph of chrysotile
fibrils within an alveolar macrophages (xl7,000)
The picture shows part of an alveolar macrophage from a rat which had
being inhaling 10 mg/m3 of chrysotile for one month. Chrysotile fibrils are
present in the cytoplasm of the macrophage.
Figure 15.8 Electron micrograph of rat visceral pleura and its subpleural
structures (x4,000)
Mesothelial cells with a few microvilli and alveoli can be observed.
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Figure 15.9 Electron micrograph of rat visceral pleura and subpleural structure
(x6,000)
A relatively thick mesothelium plus a terminal bronchiole can be observed.
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Figure 15.10 Junction between two mesothelial cells of the visceral pleura
(xl5,000)
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Figure 15.11 Transmission electron micrograph of rat visceral pleura and the
subpleural structures (x6,000)
A mast cell is present in the subpleural connective tissue.
Figure 15.12 Transmission electron micrograph of rat parietal pleura (xl2,000)
The mesothelium is flatter than visceral mesothelium and is separated, by
a connective tissue layer, from the parietal muscular layer (bottom left).
96 F
mitochondria in the cytoplasm. It is common that mesothelial cells are capable of
proliferating after being injured. Figure 15.14 shows mesothelial debri which is
presumed to be exfoliated cell from the pleura after the mesothelium was
damaged by the presence of asbestos in alveoli.
Figure 15.15 displays, apparently, the migration of PMN from lung
insterstitium towards pleural space one day after intratracheal instillation of 1.4 mg
C.parvum. This may explain the source of PMN found in pleural space during
C.parvum-induced acute inflammation.
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Figure 15.13 Transmission electron micrograph of rat visceral pleura one day
after I/T 5 mg chrysotile asbestos (x8,000)
A neutrophil is present in the subpleural connective tissue. Mesothelial cells
are rich in mitochondria.
Figure 15.14 Transmission electron micrograph of rat visceral pleura one day
after T/T 5 mg chrysotile asbestos (x. booo j
An exfoliated mesothelial cell is present in the pleural space.
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Figure 15.15 Transmission electron micrograph of rat visceral pleura one day
after I/T C.parvum (x6,000)




This thesis has attempted, using a rat model, to elucidate the mechanisms
underlying the pathological effects arising in the pleura, from the deposition of
asbestos in airspaces. In particular, the effects caused by asbestos deposited in the
airspaces on the activities of pleural leukocytes has been studied. The approaches
which were taken included: 1). the determination of inflammatory mediator
production by pleural leukocytes after intratracheal instillation of asbestos; 2). the
possibility of transfer of asbestos fibres from the airspace to the pleura; 3).
interactions between pleural leukocytes from asbestos-instilled rats and pleural
mesothelial cells in vitro; 4). comparison of bronchoalveolar leukocytes and pleural
leukocytes after intratracheal asbestos; 5). limited studies in pleural leukocytes
from rats which had been inhaling asbestos. The results from this model suggest
that deposition of asbestos in the airspaces has important influences on the pleural
leukocyte population without substantial transfer of fibre to the pleural space.
1. Fibrinolysis in the pleural space and the effect of intratracheally instilled
asbestos
1.1. Normal pleural leukocytes and fibrinolysis
1.1.1. Normal pleural leukocyte population
The present work shows that the numbers of pleural leukocyte are 4.5 x
106 and 8.7 xlO8 in normal rats of the PVG and HAN strains respectively.
These figures are similar to the observation of Oberdoerster et al (1983) that total
cell counts in pleural lavages of rats were from 7 to 13 x 106. In these
populations, macrophages account for the majority, which are more than 80% in
PVG rats and 70% in HAN rats. The normal pleural leukocytes also contained
substantial proportions of mast cells and eosinophils. High numbers of eosinophils
and mast cells were also found by Lehnert et al (1985), Oberdoerster et al,
(1983) and Miller et al (1989) in the pleural lavage of rats.
Polymorphonuclear leukocytes (PMN) were not normal residents of the
pleural space in the present study. In contrast, Oberdoerster et al (1983) found
that PMN comprised 26-45% in control pleural lavages. Miller et al (1989)
described some not easily distinguishable cells, with doughnut shaped nuclei, as
juvenile PMN or immature monocytes (45-60%) in air-exposed rats. No difficulty
was experienced in identifying PMN from other cells in pleural lavages. PMN are
characterized by their multi-lobed nucleus confirmed by light microscopy as well
as electron microscopy observation. We believe that, normally, PMN appear only
during an inflammatory response where they exert important defensive functions.
They would not be anticipated to be present as normal residents of the pleural
space. Zlotnic et al (1982) and Pitt's (1985) work showing none, or less than 1%,
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of PMN in normal mice pleural lavages supports this contention.
Mesothelial cells were virtually absent from our normal rat pleural
leukocyte preparations, confirming Spriggs and Boddington's (1968) observation that
mesothelial cells are not evident in washings from normal serous surfaces.
1.1.2. Normal pleural leukocytes produce plasminogen activator inhibitor (PAI)
in culture
Plasminogen activators can convert plasminogen into its active form,
plasmin which is involved in the breakdown of fibrin an directly or indirectly
promotes degradation of all components of the extracellular matrix (Blasi et al,
1987). The activity of plasminogen activators (PA) are regulated by specific
inhibitors so that the regulation of the production of plasminogen activator
inhibitors (PAI) will be important in matrix metabolism and especially in
fibrinolysis. The serous surfaces, such as the pleura, because of their important
function in allowing tissues to move smoothly over one another, must maintain
efficient fibrinolysis.
It has been shown that bronchoalveolar leukocytes and mesothelial cells
activate plasminogen via synthesis of PAs (Donaldson et al, 1988c; Harold et al,
1988), and this was also confirmed in the present study. However, pleural
leukocytes, cultured in vitro, do not activate plasminogen. In contrast, when
either alveolar leukocytes or mesothelial cells were cultured together with pleural
leukocytes or leukocyte supernatants, their fibrinolytic activity was inhibited. We
hypothesized that the inhibitory activity was caused by a substance (inhibitor)
secreted by pleural leukocytes.
In an attempt to find out the point of action of the inhibitor, which could
operate at the level of the plasminogen activator or plasmin, different model
fibrinolysis systems were used to identify the inhibitory substance secreted by
pleural leukocytes. Although the pleural leukocyte-derived inhibitor inhibited
fibrinolysis by plasmin to a certain degree, this was much less than the inhibitory
activity shown against fibrinolysis mediated by urokinase and plasminogen, which
could be up to 100% of the total. From the data it is concluded that pleural
leukocytes produce a plasminogen activator inhibitor that operates mainly against
urokinase-type PAs but also has some activity against plasmin. The finding that
the inhibitor substantially blocked the proteolytic activity of urokinase was
consistent with other workers' findings: the PAI secreted by human macrophages
(Saksela et al, 1985) and PAI in ascitic fluid in an experimental tumour (Dong et
al, 1988) inhibited urokinase but had no activity on tissue-type PA.
PAI from different cell lines have different heat stabilities. In the case of
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human macrophage-derived PAI, heat- treatment at 56 °C for 30 min abolished its
functional activity against urokinase (Chapman and Stone, 1985^). The rat pleural
leukocyte PAI demonstrated in the present studies was heat stable at 56 °C for 1
hr but was completely inactivated after incubation at 70 °C for 1 hr and so was
similar to that described by Saksela et al (1985). The inhibitor is greater than
10,000 D which is consistent with general finding that PAI have a molecular mass
around 40-50 kD (Sprenger and Kluft, 1987) rising to greater than 100 kD if
complexes with proteases are formed (Hart and Rehemtulla, 1988).
Kopitar (1981) has shown evidence that a urokinase inhibitor isolated from
pig leukocytes is stable in the pH region from 3.0 to 8.0. In another study, they
isolated a human leukocyte urokinase inhibitor (Kopitar et al, 1985) and found
that the inhibitor was stable from pH 7 to 9, but was inactivated by acid pH
and above pH 9. Its activity was progressively lost with decreasing pH. The
present study on acid treatment of the inhibitor indicated that the rat PAI is acid
unstable and loses its activity at pH 4.0.
In keeping with a large body of evidence showning that the production of
PAIs is predominantly by cells of the mononuclear phagocyte lineage (Vassalli and
Dayer, 1984; Chapman and Stone, 1985a; Saksela et al, 1985), especially for
PAI-2, the present study confirmed that the cellular source of the PAI was the
pleural macrophages. By separating the pleural leukocytes into subpopulations
enriched for macrophages or mast cells, PAI was found to be principally a
product of the macrophage population.
1.1.3. Normal pleural leukocytes show plasminogen activator (PA) activity
intracellularly
In contrast to the great production and release of PAI by pleural
leukocytes in culture, a predominant intracellular PA activity was demonstrated.
The activity was mainly located in mast cells with limited activity in macrophages
as confirmed by fibrinolytic activity in cell lysates. Many studies have shown that
cell lines release PA and PAI concomitantly, as confirmed by the study of Dong
et al (1988) that inside tumour cells, PA was the predominant activity that
overshadowed PAI. In the extracellular fluid, however, PA activity was masked by
powerful PAI. After secretion, PA and PAI tend to form complexes (Philips et
al, 1984; Vassalli and Dayer, 1984). Due to the formation of enzyme-inhibitor
complexes, active enzyme would be rapidly inhibited by the co-secreted ligand,
which may explain why neither PA nor PAI activities could be detected in pleural
lavage found in the present study (discussed in Section 1.3).
Without doubt PAs play an important role in fibrinolysis. They degrade
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fibrin and other extracellular matrix components in the presence of plasminogen
and participate in important physiological reactions such as inflammation,
malignant invasion, and metastasis (Kruithot et al, 1986). The present study,
previous work from our laboratory (Donaldson et al, 1988c) and results of other
workers (Todd, 1964), have all indicated that mesothelial cells also synthesize a
PA. In the pleural cavity, the metabolism of extracellular matrix could be critical
in maintaining the normal functions of the pleura, and the balance between PA
derived from mast cells, macrophages as well as mesothelial cells and PAI from
mainly macrophages is likely to play an important role in situ.
1.1.4. Endotoxin and PAI production by normal pleural leukocytes
Many workers have reported the production of PAI by cell lines, but with
a requirement for the presence of stimuli. The macrophages lavaged from normal
human lungs, for example, do not contain PAI and only express and secrete the
inhibitor after stimulation with endotoxin in vitro (Chapman and Stone, 19855);
PAI can also be secreted by casein-elicited macrophages (Saksela et al, 1988).
The media used in present experiments have been tested for endotoxin levels and
results revealed low level contamination of endotoxin in the media up to 106
pg/ml. It is presumed that these low levels of endotoxin may be responsible for
the spontaneous production of PAI by normal pleural leukocytes.
Nevertheless, the present study shows that when 100 ng/ml of LPS was
added into pleural leukocyte culture, there was no considerable enhancement of
PAI production by the cells. This result is not consistent with other workers'
findings which demonstrated that generation of PAI was in response to endotoxin
stimulation (Colucci et al, 1985; Crutchley and Conanon, 1986). This might be
because normal pleural leukocytes have reached their maximal production of PAI
in response to to low contamination of endotoxin in the media, and that higher
exogenous endotoxin causes no further stimulation. No further attempts were made
to discern the role of endotoxin in PAI secretion by pleural leukocytes.
1.2. Fibrinolysis induced by pleural leukocytes from rats intratracheally instilled
with asbestos
Exposure to asbestos is associated with diseases of the lung parenchyma
and airway (Wagner, 1986; Hirsch and Bignon, 1985). Of particular interest to
the present study however, are the pleural pathological responses such as
inflammation, fibrous adhesions, fibrosis and neoplasia (Herbert, 1986). One factor
that could lead to these problems is altered fibrinolytic activity, since disorder of
the fibrinolytic enzyme system could be important in leukocyte activation and
altered metabolism of extracellular matrix in the pleural wall. Moreover, matrix
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abnormalities are likely to be be central to the pathological process. Since the
production of approporiate PA/PAI levels by pleural leukocytes could be an
important factor in maintenance of the normal integrity and architecture of the
pleura.
1.2.1. Pleural leukocyte population after intratracheal instillation (I/T) of
crocidolite asbestos
When crocidolite asbestos was intratracheally instilled into rat lungs and
different post-exposure time points were selected, there were modest changes to
the pleural leukocyte population with significantly increased number of
macrophages and eosinophils. The most notable change was the total cell number
increasing from 4.22 to 6.69 x 106. Additionally, in the acute period after
instillation of asbestos some PMNs appeared in the pleural space.
Miller et al (1989) showed that the number of mature macrophages and
macrophage-like cells increased in pleural space, proportionally, in ceramic
fibre-exposed rats compared to the control. Oberdoerster et al (1983) described,
in a rat intratracheal study, peroxidase-positive macrophages (indicative of newly
arrived macrophages) showed an increase in pleural space after amosite asbestos
exposure and remained high throughout the study. A recruitment of pleural
macrophages after fibre deposition in the lung was found in the present study.
Since macrophage-derived chemotactic factor was found to play an important
role in pulmonary leukocyte recruitment in response to instilled particulates or
asbestos fibres (e.g. Hayes et al, 1990; Adamson and Bowden, 1982), attempts
were made to demonstrate pleural leukocyte-derived chemoattractants for
macrophages or PMNs in the present study but no chemoattractants were detected.
The results suggest that pleural leukocytes are not responsible for the recruitment
of pleural macrophages and PMNs caused by asbestos I/T, although there could be
several reasons for failure to demonstrate chemotaxin. Antony et al (1989)
reported that pleural mesothelial cells stimulated by asbestos in vitro released
chemotactic activity for PMNs. Although no evidence is available in the present
study to show the translocation of asbestos fibre from the airspace to the pleural
space (discussed Section 3), it is still possible that pleural mesothelial cells were
stimulated by asbestos to produce chemoattractants.
In the later stage of asbestos-induced inflammation, the increase in
macrophages may result from division of resident macrophages (Adamson and
Bowden, 1982; Sibille and Reynolds, 1990). A study on individuals exposed to
asbestos showed that an increased number of alveolar macrophages was related to
both monocyte recruitment through lymphocyte-derived chemotactic factor(s) and
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to local proliferation of alveolar macrophages (Spurzem et al, 1987). The finding
of Lemaire (19851,) a'so indicated that macrophage replication may contribute to
the long increase in inflammatory cells in animal treated with long fibre
chrysotile. Intraperitoneal injection of asbestos fibres induced an inflammatory
exudate characterized by increased macrophage numbers (Hamilton et al, 1976)
and in which approximately 70% of the asbestos-induced macrophage incorporate
[3H] thymidine indicating that many of the cells are young cells, having recently
divided locally. No attempt was made to determine whether the increased
leukocyte number found in the present study was due to local macrophage
replication in the pleural space.
With increasing time after crocidolite asbestos deposition, the total numbers
of pleural eosinophils increased significantly. It is not clear what role eosinophils
play in the asbestos- induced events in the pleural space. However, the production
of inflammatory mediators or cytokines (discussed in Section 2) was not related
to changes in this cell population. Seaton et al (1989) suggested that eosinophilic
effusion in the pleura caused by fungal and viral infections result from the release
of eosinophil chemotactic factor from white cells in blood that have escaped into
the pleural cavity. In the present study, recruited PMNs or macrophages in the
pleural space may contribute to the increase in eosinophil numbers but this was
not investigated.
1.2.2. Effect of I/T asbestos on PAI production by pleural leukocytes
Evidence that exposure to asbestos causes abnormalities of the fibrinolytic
system has been presented previously. Cantin et al (1989) found that the early
lower respiratory tract inflammatory response in sheep resulting from chronic
asbestos exposure is associated with a marked increase in PA, both at the
alveolar macrophage surface and in the alveolar extracellular milieu. Other studies
also showed that exposure of mouse peritoneal macrophages to chrysotile for two
hours induced production of PA in macrophages (Lison et al, 1989) and
intraperitoneal injection of asbestos induced PA secretion by the macrophages in
mice (Hamilton et al, 1976). The present finding that pleural leukocytes from rats
exposed to asbestos express increased PAI in culture contrasts with these
observations. In the other studies cited, however, macrophages made direct contact
with the asbestos whereas, in the present study, the asbestos fibres have failed to
transfer from the lung parenchyma to the pleural space in appreciable numbers, if
at all. In the model used in the present study, instillation of asbestos into the
lungs therefore may affect the pleural leukocytes by the transfer of molecular
signals to the pleural cavity from the adjacent parenchyma.
PAI activity in the pleura increased during pathological changes as
demonstrated by Agrenius et al (1989) that 6 hr after quinacrine pleural
instillation for pleurodesis treatment of malignant pleural effusion, the
concentration of PAI-1 increased four fold and that of D-dimer, a product of
lysis of the fibrin in pleural fluid was 5 times higher before treatment. Idell et al
(1989) showed that exudative pleural effusions from patients with congestive heart
failure, loculated pleural effusions, and other conditions, are characterized by
increased procoagulant and decreased fibrinolytic activity. The present study also
suggests that there may be a localised fibrinolytic deficit in the pleura of
asbestos-exposed lung.
Crystal et al (1981) suggested that activated lung inflammatory leukocytes
play a critical role in mediating the pathogenesis of extracellular matrix alterations
and fibrosis in asbestos induced interstitial lung diseases. Spregners and Kluft
(1987) found that newly recruited macrophages are normally more active in
producing inflammatory mediators. As discussed in Section 1.2.1, asbestos I/T
causes either recruitment or local division of pleural macrophages. Those "young"
macrophages are likely to produce PAI actively so causing inhibition of
fibrinolysis although they may also have enhanced connective tissue protease
activity (Brown and Donaldson, 1988).
However, the increased PAI production by pleural leukocytes after
intratracheal asbestos cannot be explained completely by the recruitment of
macrophages since one day after asbestos instillation, the higher dose of asbestos
induced markedly enhanced production of PAI by the leukocytes but no substantial
recruitment of macrophages had yet appeared. This means that, very likely some
inflammatory signal travels from asbestos- exposed parenchyma to the pleural
space. The non-specific airspace irritation alone is not, however, the cause of the
response of the pleural leukocytes since saline-instilled group gave no difference
with controls.
In the present study, pleural leukocytes appear to respond to signals from
lungs inflamed by asbestos deposition. A strong pleural inflammatory reaction
characterized by increased PAI production is then evoked as soon as these
inflammatory signals reach the pleural space and this reaction is related to the
intensity of inflammation and so, very likely, to the strength of the signals.
It is reported that neither fibrin nor fibrinogen are normal constituents of
either the pulmonary interstitium or the alveolar space. However, fibrin deposition
is a prominent component of a number of acute and chronic inflammatory
disorders of the lungs. The sites of early fibrin deposition correlate with the
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location of the subsequent fibrotic process, suggesting that fibrin has importance
for fibroblast attraction, attachment, spread, growth and proliferation (Chapman
and Stone, 1985^; Chapman et al, 1986). Because fibrin resorption is virtually
dependent on synthesis and expression of a classic plasminogen activator of the
urokinase type (Chapman and Stone, 1985^), the increased PAI may lead directly
to increased deposition of fibrin and other extracellular matrix components, such
as fibronectin. These may then form a scaffold for fibroblast adherence and
proliferation to occur.
Hopper et al (1981) have demonstrated the deposition of fibrin on the
surface of peritoneal macrophages in vivo. In another study, based on their
findings, they proposed that the lymphokine-activated macrophages have
thromboplastic properties which would enable local activation of the extrinsic
clotting pathway (Geczy and Hopper, 1981). Because macrophages can produce
fibrin or fibrinogen on their own surface, although there was no severe pleural
inflammation, pleural macrophages could serve as a nidus for pleural fibrosis by
forming the fibrin scaffold around themselves. In the pleural cavity, deposition of
fibrin at the surface of mesothelial cells and fibroblasts could also activate
fibroblast proliferation and facilitate the production of fibrous adhesions between
the two opposite layers of the serosal membrane (Bignon and Gee, 1985). Ferro
et al (1989) reported that macrophages activated by fibrin increase albumin
permeability across pulmonary artery endothelial monolayers, which is mediated
by an oxidant-dependent mechanism. The deposition of fibrin may cause increased
leakage which may result in positive feedback of inflammation.
The relationship between deposition of fibrin and fibrosis in the pleural
cavity is indirectly demonstrated by the fact that intrapleural urokinase inhibited
the development of fibrosis in the rabbit pleural spaces inoculated with high-dose
tetracycline (Good et al, 1979). This implies that enhanced pleural fluid clotting
and inhibition of fibrinolysis is important for inducing pleural fibrosis. The present
observations showing increased PAI production by pleural leukocytes during
asbestos-induced pleural injury, reveals again that asbestos related pleural fibrosis
may be initiated by the inhibition of fibrinolysis.
It has been shown that mesothelial cells have an important role in
fibrinolysis (Porter et al, 1971), and this is supported by the present study.
Whitaker et al (1982a) found that the fibrinolytic activity of mesothelial cells is
depressed by damage to the cells. Donaldson et al (1988c) demonstrated that
crocidolite asbestos inhibited plasminogen dependent fibrinolysis induced by
mesothelial cells. However, in the in vivo situation, mesothelial cell-mediated
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fibrinolysis may be inhibited by PAI released by pleural leukocytes after airspace
asbestos exposure as shown here. Persistent depression of fibrinolysis will,
therefore, be associated with the development of pleural fibrosis (Buckman et al,
1976) through colonisation of fibrin by macrophages and fibroblasts under the
particular conditions pertaining in the pleural space with asbestos exposure
(Donaldson et al, 1988c).
The highest dose of instilled asbestos caused recruitment of PMN, a cell
type not normally present in the pleural leukocyte population. Macrophages may
cause PMN accumulation in the pleural space (Schoenberger et al, 1982).
However, there was no correlation between PMNs and PAI production in this
study. The role that PMNs play in asbestos-induced pleural inflammation remains
unclear. Similarly, the role of eosinophils in the inflammatory events occurring in
the pleural cavity of asbestos- exposed rat is not further elucidated in the present
study. The release of mediators from human mast cells is one of the central
events in inflammatory reactions involving the human lung (Marone, 1985). Mast
cells are also considered to play a role in the development of fibrotic responses
(Miller et al, 1989). However, the present study shows no evidence that mast cells
are involved in PAI production by pleural leukocytes. The functions of the mast
cells in the events leading to asbestos related pleural pathology therefore remains
to be investigated.
1.2.3. Effect of I/T asbestos on pleural leukocyte intracellular PA activity
Cantin et al (1989) have shown evidence that chronic exposure to asbestos
caused a markedly increased PA activity in both alveolar macrophage surface and
alveolar extracellular milieu. The study of Donaldson et al (1987) indicated that
plasminogen-dependent fibrinolysis induced by alveolar macrophages was inhibited
by chrysotile asbestos in vitro. The altered PAI levels in pleural leukocyte
supernatants from rats exposed to asbestos may result from either increased PAI
activity or decreased PA activity. Therefore, intracellular PA activity of pleural
leukocytes has been determined. PA activity in the lysates of control pleural
leukocytes and pleural leukocytes from rats following 10 mg crocidolite asbestos
I/T showed no significant difference. This confirmed apparently that the increased
PAI activity is indeed specifically caused by increased PAI production rather than
decreased PA activity.
1.3. PA and PAI activity of pleural lavage
The study of Chapman and Stone (1985^) indicated that human alveolar
fluid from all normal volunteers contained PA whereas no PAI activity was
observed. In contrast, alveolar fluid from patients with sarcoidosis and idiopathic
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pulmonary fibrosis had low or absent PA activity (Chapman et al, 1986). Idell et
al (1988) found that in control bronchoalveolar lavage (BAL) samples, there was
relatively low levels of procoagulant activity and relatively high levels of
fibrinolytic activity. After induction of lung injury by oleic acid, the procoagulant
activity of BAL was markedly increased whereas fibrinolytic activity was either
depressed or undetectable. However, the work of Sitrin et al (1987) showed that
normal BAL fluid contained high levels of procoagulant activity which did not
vary after the onset of acute lung injury induced in rabbits by an intravenous
injection of phorbol myristate acetate (PMA). There were low levels of PA
activity in normal BAL fluid and the activity increased 9.3-fold over control
values by 12 hr after PMA injection. These studies indicate that, during acute
inflammation or pulmonary diseases, fibrinolytic activity in BAL is altered.
The present study confirmed that there was no detectable fibrinolytic
activity in normal pleural lavage. This could be due to an equal balance between
secretion of PA and PAI by pleural leukocytes with formation of PA and PAI
complex (Dong et al, 1988). An alternative explanation is that there is no active
production of PA or PAI under the unstimulated situation in the pleura.
Fibrinolytic activity in pleural lavage during injury caused by asbestos or other
agents needs further investigation.
1.4. Fibrinolytic activity of pleural leukocytes after I/T C.parvum
1.4.1. Pleural leukocyte components after I/T C.parvum
Instillation of C.parvum induced severe alveolar inflammation, characterized
by recruitment of large numbers of PMN. Although, during acute inflammation,
the total cell number (mostly PMN) was about 6 times higher than normal, the
neutrophil alveolitis lasted only 3 days whilst the macrophage alveolitis was a
relatively long-lived process. The same inflammatory pattern was found in the
pleural space after I/T C.parvum with transient pleural PMN inflammation and
long standing macrophage pleuritis. In our study, the proportions of pleural PMN
increased from 0 to 33% of total leukocytes, then rapidly decreased by day 5,
whereas the macrophage pleuritis persisted. The very similar inflammatory patterns
in both alveolar and pleural spaces indicated that there may be some
communication of inflammatory signals between the two compartments.
C .parvum-elicited bronchoalveolar inflammation has been investigated by
Donaldson et al (1988^) and Brown and Donaldson (1988). As demonstrated by
many workers, macrophage-derived chemoattractants may be responsible for the
alveolitis. Adamson and Bowden (1982) suggested that particulate instillation in the
lung stimulates the generation of a factor(s) chemotactic for PMNs; mononuclear
107
cells are also attracted to the alveoli. Hayes et al (1990) also suggested that
alveolar macrophages may release a PMN chemotactic factor responsible for the
recruitment of PMN into the alveolar space.
The chemotactic activity for PMN and macrophages of pleural leukocyte
supernatants from rats with C.parvum-'mduced inflammation was investigated. The
supernatant of pleural leukocytes from rats 5 days after C.parvum instillation
showed some chemotactic activity for macrophages in vitro, whereas it showed
slight inhibition of PMN chemotaxis. As reported by Donaldson et al (1989b),
C.parvwm-elicited alveolar neutrophil supernatants caused inhibition of chemotaxis
for macrophages. Antony et al (1989) reported that asbestos in vitro stimulated
mesothelial cells to release a chamoattractant for PMN, so it is presumed that
pleural mesothelial cells stimulated by mediators from adjacent C.parvum-induced
inflammatory lung may be responsible for the chemotactic activity for PMN
recruitment to the pleura, this was not, however further investigated in the
present study. The recruitment of PMN ended very rapidly and this may reflect
the defensive functions of the pleura in restricting further inflammation as well as
reflecting the removal of the inflammagen from the lung. The increased
macrophage chemoattractive activity in pleural leukocyte supernatants by day 5
may be responsible for the continuous recruitment of macrophages into the pleural
space after I/T C.parvum.
1.4.2. PAI production by pleural leukocytes during inflammation caused by I/T
C.parvum
The present study found that PAI activity by pleural leukocytes was
significantly increased after I/T C.parvum. However, this returned to normal levels
by day 5. Sibille et al (1990) suggested that there is interaction between alveolar
macrophages and PMN in the lung. Upon stimulation by various stimuli, alveolar
macrophages release chemotactic factors for PMN. This factor will attract PMN
from the capillary lumen to the alveolar space. Once in the alveolar lumen, the
PMN can be activated by various factors, including alveolar macrophage- derived
monokines and release active products, such as oxidants, bioactive lipids and
proteases, which are likely to influence the function of alveolar macrophages and
other fixed lung cells. Presumably, during neutrophil pleuritis, the recruited PMN
may influence pleural macrophage production of PAI. The similarity in the
change in pleural PMN numbers and PAI production during the study period
supports this hypothesis. Since Kopitar et al (1985) have isolated urokinase type
PAI from cytosol of human peripheral PMN, newly recruited PMN may partly
contribute to the increased PAI activity by pleural leukocytes.
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Locally reduced fibrinolysis could promote alveolar fibrin deposition which
may influence tissue repair (Section 1.2.2). In pleural effusion, a strong
inflammatory reaction with a swollen pleural wall and fibrin deposition is
sometimes seen (Widstrom et al, 1982). The rapid return of the PAI levels to
normal in the present study supports the observation that pleural fibrosis rarely
results from acute, resolving pneumonitis.
2. Cytokine production by pleural leukocytes and the effect of intratracheally
instilled asbestos
2.1. Interleukin-1 (IL-1) elaboration by pleural leukocytes
2.1.1. Normal pleural leukocytes produce IL-1 in culture
Although a large body of work has been done to study IL-1 production by
monocyte/macrophage (Martin and Resch, 1988), almost no attention has been
given to pleural leukocytes in this respect. In view of the important role of the
pleura in basic lung functions and the pathology caused in the pleura by fibrous
dusts, the production of IL-1 by pleural leukocytes was determined.
The present study indicated that normal unstimulated pleural leukocytes
secrete significant IL-1 in vitro and this secretion can be enhanced further by
stimulation with 100 ng/ml LPS. By contrast, studies on IL-1 production by
human monocytes reveals no intracellular or extracellular IL-1 production by
unstimulated monocytes (Dinarello, 1984) and most normal cell types and a
number of cell lines produce IL-1 only in response to a variety of stimulants
(Oppenheim et al, 1986). Constitutive production of IL-1 by normal cells can
probably be attributed to a continuing response to prior stimulation in vivo or
alternatively, to the presence of endotoxin contamination of tissue culture media
or plastics. It was shown that culture media, blood separation media, fetal calf
serum, and organic buffer used in culturing IL- 1 producing cells may contain
endotoxin, depending on the source. The "spontaneous" activation of IL-1
secretion by cells may also result from procedures of harvesting, washing, and cell
adherence (Dinarello, 1984). The measurement of endotoxin in media and serum
used in the present study was carried out and low levels of endotoxin
contamination, ranging from 0-108 pg/ml, were found. It is possible therefore that
the spontaneous production of IL-1 by pleural leukocytes in culture is the result
of stimulation of the cells with low levels of endotoxin contamination in the
media. However, as a serosal cell population, similar to pleural mesothelial cells
which are highly susceptible to damage from substances that they do not normally
encounter (Herbert, 1986), it is also possible that pleural leukocytes may be highly
susceptible to alteration in their environments and the effect of this could be
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stimulation of IL-1 production.
Although normal pleural leukocytes produced relatively high IL-1 activity in
culture, these cells were still able to produce significantly more IL-1 activity in
response to 100 ng/ml LPS stimulation. This suggests that, if LPS was responsible
then, it was at sub-optimal levels. The fact that alveolar leukocytes produced
much less IL-1 "spontaneously" than did pleural leukocytes also suggests that
either pleural leukocytes do indeed produce truly spontaneous IL-1 or that
alveolar leukocytes are less sensitive to the low level of endotoxin present in the
media.
2.1.2. Pleural lavage fluid inhibits IL-1 activity in the pleural leukocyte
supernatants
In the present study there was no detectable IL-1 activity in normal pleural
lavage fluid. In fact, pleural lavage fluid exhibited an inhibitory effect on the
activity of both the IL- 1(3 standard and pleural leukocyte IL-1 in a concentration
related manner. This result suggests that there is an IL-1 inhibitor in normal
pleural lavage fluid.
Many studies have demonstrated specific IL-1 inhibitors from different
cellular sources. The work presented by Gosset et al (1988) indicated that
asthmatic alveolar macrophage supernatants contained no detectable IL-1 -like
activity after stimulation by allergen or anti-IgE. In contrast, an IL-1 inhibitory
factor, released by alveolar macrophages, was demonstrated in the supernatants.
An alveolar macrophage-derived IL-1 inhibitor was also confirmed by
Rochemonteix et al (1990). Human monocyte- derived IL-1 inhibitors have also
been demonstrated by Arend et al (1989) and Schur et al (1990). Mechanisms of
action of IL-1 inhibitors has been proposed as: 1) action on IL-1 receptors to
prevent thymocyte proliferation (Schur et al, 1990), 2) action at a post-receptor
stage after the initial activation of the cell by IL-1 (Brown and Rosenstreich,
1987).
IL-1 inhibitor(s) may play an important role in modulating the effects of
IL-1 in the microenvironment. Rochemonteix et al (1990) suggested that the
production of a specific IL-1 inhibitor by alveolar macrophages may be of
importance in protecting the alveolar environment from the deleterious effects of
excessive IL-1 production. In particular, in pleural space, the regulation of IL-1
activity by its inhibitor would be anticipated to have very important role in
maintaining pleural functions.
There could be therefore two possible explanations for the failure to detect
IL-1 activity in pleural lavage fluid, 1) there is a balance between the secretion
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of IL-1 and IL-1 inhibitor, 2) the pleural leukocytes in vivo are much less
stimulated than when they are cultured, because of the culture conditions. There
was no attempt to characterize the IL-1 inhibitor found in the present study as
this was outside the scope of the study but should be an important target for
future studies.
2.1.3. IL-1 production by pleural leukocytes after intratracheal crocidolite
asbestos
In the present study, it is shown that up to 14 days post intratracheal
instillation of 5 mg crocidolite, lavaged pleural leukocytes produced significantly
less IL-1 in culture than control. However, one month after instillation, this
production increased dramatically and was above that of controls. The change of
IL-1 production by pleural leukocytes at various times post asbestos injection
cannot be simply explain by alterations in cell populations. It is presumed
therefore that during asbestos exposure, the capability of pleural leukocytes to
produce IL-1 may be impaired and so that less IL-1 activity can be measured.
However, the change in IL-1 activity shown by pleural leukocytes may be
also influenced by the presence of IL-1 inhibitor. Specific IL-1 inhibitors have
been described by many workers (Arend et al, 1989; Schur et al, 1990; Gosset et
al, 1988). It has been noted that IL-1 inhibitors are concurrently produced by
the cells releasing IL-1 (Tiku et al, 1986^; Larrick, 1989). Since we demonstrated
the activity of IL-1 inhibitor in pleural lavage (Section 2.1.2), presumably, there
may be secretion of IL-1 inhibitor by the cells elaborating IL-1 concurrently or
by other cells in the population so causing decrease of IL-1 activity. Gosset et al
(1988) showed that control alveolar macrophages released IL-1, but that, after
stimulation with IgE, the cells switch to production of an IL-1 inhibitor. Because
the release of IL-1 or its inhibitor appears to be dependent on the state of cell
activation, asbestos deposited in the nearby airspaces could produce a signal that
triggered pleural leukocytes to release IL-1 inhibitor.
It has been reported that normal alveolar macrophages are less sensitive to
LPS than blood monocytes and they release significantly less IL-1 than blood
monocytes (Wewers et al, 1984). In addition, denser alveolar macrophages (less
mature, more monocytic) elaborate more IL-1 than less dense alveolar
macrophages (Haq and Maca, 1986; Fuchs et al, 1988). Since young mononuclear
phagocytes are the prime source of IL-1, IL-1 release in the pleura may be
regulated, at least in part, by factors that control the influx of young monocytes
(Wewers et al, 1984). In the present study, asbestos-recruited leukocytes which are
possibly more monocytic could produce increased IL-1 which could overwhelm the
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inhibitor levels.
Despite the fact that increasing the dose of injected crocidolite resulted in
only minimal changes in pleural cell population, with the appearance of a low
level of PMNs in the pleural cavity, an apparent asbestos dose-dependent decrease
in IL-1 production by the leukocytes was observed at one day post instillation.
Since we have shown there is no substantive translocation of asbestos fibre from
the lung to the pleura in the present model (Section 3), then this is likely to be
the result of an inflammatory signal travelling from the lungs to the pleura. The
response to this signal would be decreased production of IL-1 or increased
production of IL-1 inhibitor.
It has been demonstrated that asbestos exposure lead to increased IL-1
release by alveolar leukocytes: Kagan et al (1985a) showed that inhalation of
either crocidolite or chrysotile asbestos in the rat was associated with augmented
release of IL-1 by alveolar macrophages. In vitro exposure of peritoneal
macrophages to chrysotile also resulted in increased intracellular levels of IL-1 in
those cells (Godelaine and Beaufay, 1989). However, suppression of IL-1 release
was found with pleural leukocytes in the present study after asbestos exposure. It
is possible that the presence of asbestos-induced alveolar inflammation results in a
suppressive pleural response in order to preserve normal lung functions. Since we
found the same result with another cytokine, TNF, and with IL-1 using another
inflammogen, C.parvum (Section 2.1.4), it seems that this short term suppression
may have substantial beneficial value in the pleural space. However, in the longer
term, the IL-1 production was increased. IL-1 may stimulate fibroblasts and
their functions such as collagen synthesis, prostaglandin production and fibroblast
migration (Postlethwaite et al). Thus, the long term increase in IL-1 production
could lead to fibroplasia in the pleura. Increased production of PAI by pleural
leukocytes, which has been demonstrated in the same model, could produce a
fibrous matrix for fibroblast growth and also encourage fibrous tissue growth.
As reported by Pozo et al (1990), LPS-stimulated mouse eosinophils were
able to express IL-1 mRNA in their cytoplasm and produce IL-1 activity; it was
however less than in that of mouse macrophages. Since eosinophils accounted for
a low but significant percentage (6%) of the normal pleural leukocytes, their role
in production of IL-1 by pleural leukocytes should be considered. However, in the
present study, there was no relationship between the number of eosinophils and
IL-1 activity.
2.1.4. IL-1 production by pleural leukocytes is decreased during pleural
inflammation induced by I/T C.parvum
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As a low molecular weight factor which mediates a wide variety of
pro-inflammatory effects, IL-1 has been confirmed to be increased in
inflammation (Lasslle et al, 1990; Fuchs el al, 1988). However, the present study
indicated that during C.parvum- induced pleural inflammation, IL-1 production by
pleural leukocytes was decreased compared to controls and a greater reduction of
IL-1 production was observed at day "" than day ' after C.parvum I/T. It is
possible that the initial reduction in IL-1 activity may be due to the accumulation
of PMN in the pleural space since 1) the percentage of macrophages was
decreased by the presence of neutrophils; 2) IL-1 inhibitor may be constitutively
present in normal neutrophils (Tiku et al, 1986^). During the later stages after
C.parvum instillation, the further reduction in IL-1 production by pleural
leukocytes might result from the additional secretion of IL-1 inhibitor by newly
recruited macrophages (Section 1.4.1). There are reports of IL-1 inhibitors
produced by normal human monocytes (Arend et al, 1989; Schur et al, 1990) as
well as human alveolar macrophages (Gosset et al, 1988) during inflammatory and
immune response. The present findings were consistent with a part of the present
study (Section 1.3) which showed a decreased response in IL-1 production by
pleural leukocytes after deposition of asbestos in airspaces.
2.1.5. The effect of asbestos in combination with other dusts in vivo on IL-1
production by pleural leukocytes
2.1.5.1. Pleural leukocyte components one month after intratracheal instillation
of asbestos in combination with other dusts
The present study showed that the deposition of crocidolite asbestos in
combination with other dusts in the lungs caused considerable recruitment of
pleural leukocytes in which eosinophils increased most significantly. The results
reveal once more that eosinophils may play some role in asbestos-induced pleural
pathology in this model. However, there was no direct relationship between
eosinophils and any inflammatory parameter in present study. Eosinophils are
considered to affect the functions of mast cells, fibroblasts and mesothelial cells
(Venge, 1990; Bignon and Gee, 1985). Eosinophils associated with, or are
predominant in other pleural inflammatory diseases (Bignon and Gee, 1985). In
view of these points, further investigation on the role of eosinophils in pleural
pathological change due to asbestos is necessary.
2.1.5.2. The effect of asbestos in combination with other dusts in vivo on IL-1
production by pleural leukocytes
The present study showed that one month after intratracheal instillation,
only quartz caused significantly increased IL-1 production by pleural leukocytes.
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This may be related to its ability to penetrate to the pleural space (Davis et al,
1991). Crocidolite asbestos did not cause increased IL-1 release. The explanation
of this may be that the dose of asbestos (2.5 mg) used in the study is not high
enough to show stimulatory effect. Nevertheless, there were no important effect in
stimulating IL-1 production caused by dusts in combination.
2.2. Tumour necrosis factor (TNF) production by pleural leukocytes
2.2.1. Production of TNF by normal pleural leukocytes in culture and the effect
of LPS stimulation
Mononuclear phagocytes are a major source of the cytokine, TNF, and
TNF production by the cells can be increased by exposure to LPS in vitro.
Resting alveolar macrophages do not express the TNF mRNA transcripts but,
when activated by LPS, they expressed TNF transcripts, synthesized and released
TNF (Martinet et al, 1988). Rich et al (1989) and Nissen-Meyer et al (1988)
found that the production of TNF by LPS-induced alveolar macrophages and
monocytes was as much as 10 and 100-fold greater than that by non-induced
cells respectively. Adams and Czuprynski (1990) also demonstrated that bovine
monocytes release TNFa in response to stimulation with LPS and this release
peaks at 1-3 hr post LPS treatment, with subsequent decline to background levels
by 18 hr. The present study confirmed that there were very low levels of
endotoxin (0-108 pg/ml) in the media used in the experiments. A contribution of
this low level of endotoxin contamination to the "spontaneous" production of TNF
by pleural leukocytes in culture cannot be ruled out although the depletion of
endotoxin in the media by polymixin B had no influence on spontaneous TNF
release. However, despite this "spontaneous" secretion of TNF, pleural leukocytes
could still be stimulated with 100 ng/ml LPS in culture to release markedly higher
TNF activity.
TNF anti-serum was used in the study and the results confirmed the
specificity of the assay for leukocyte TNF.
2.2.2. Pleural lavage inhibits TNF activity in pleural leukocyte supernatants
In the present study, it was found that there was no detectable TNF
activity in the pleural fluid. In fact, pleural lavage fluid inhibited TNF activity in
both the pleural leukocyte supernatants and the TNFc* standard. The fact that
there was no TNF in pleural lavage but pleural leukocytes released TNF in
supernatants in culture could be due to several factors. The most likely of these
is the presence of functional inhibitor of TNF in the lavage fluids tested. Giovine
et al (1988) demonstrated the co-existence of TNF and its inhibitor in synovial
fluids from rheumatic patients. Lin et al (1988) showed that spleen cells from
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normal, untreated mice produce a factor that inhibits TNF cytolytic activity and
the factor acts on the targets rendering them refractory to TNF binding. Seckinger
et al (1989) have purified an inhibitor of TNFa from urine and characterized its
mechanism of action as the interference of the interaction of the ligand and its
receptor. We suggest that the TNF inhibitor found in pleural lavage may play an
important role in controlling inflammatory reactions in the pleural space which are
mediated by TNF.
2.2.3. The effect of asbestos in the airspaces on TNF production by pleural
leukocytes
Normally, processes of inflammation and response to injury are associated
with augmented release of TNF (Larrick and Kunkel, 1988). Interestingly, our
results demonstrate that deposition of asbestos in the airspace causes pleural
leukocytes to secrete significantly less TNF than control pleural leukocytes. In a
study involving intrapleural injection of crocidolite asbestos (Edwards et al, 1984),
lysosomal enzymes and non-specific esterase were described in mononuclear cells
and giant cells in asbestos-induced granulomas. In the present model, following
I/T asbestos, there is no substantially transfer of asbestos fibres to the pleural
cavity (Section 3) and we therefore suggest that some diffusible mediator(s) may
play a role in spreading inflammation from the airspace, where asbestos deposits,
to the pleural space.
We have demonstrated that pleural lavage fluid contains the TNF inhibitor
activity. In the present study, it was found that pleural mesothelial cells are not
responsible for the TNF inhibitory effect, so it is likely that an inhibitor is
produced by pleural leukocytes which also are the source of TNF. The
asbestos-induced reduction of TNF activity in pleural leukocyte supernatants found
in the present study may be explained by the co-release of TNF inhibitor. The
normal situation is likely to depend on the balance of activities of TNF and its
inhibitor. For normal pleural leukocytes in culture, the production of TNF is
predominant. After asbestos I/T, inflammatory mediators from the lung may
trigger the expression of the TNF inhibitor gene or the release of the inhibitor,
and lead to the decreased TNF activity seen in culture. On the other hand, the
mediators may block the expression of the TNF gene or the release of TNF,
which could also result in a predominance of the TNF inhibitor in the culture.
Rich et al (1989) and Okubo et al (1990) demonstrated that the capability
of alveolar macrophages to produce TNF was significantly greater than that of
blood monocytes. In addition, in vitro maturation of blood monocytes resulted in
an increased production of TNF. The present study demonstrated recruitment of
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pleural macrophages after intratracheal asbestos. These newly recruited
macrophages (monocytes) are therefore likely to produce less TNF and this may
explain the persistent reduction of TNF activity in the longer term after asbestos
exposure.
TNF has been shown to play an important part in silica- induced
pulmonary fibrosis in mice (Piguet et al, 1990a) and possibly to have a role in
coal workers' pneumoconiosis (Borm et al, 1988). In the present study, TNF
production by pleural leukocytes decreased as the result of intratracheal asbestos
and this reduction was related to the dose of asbestos deposited in the airspaces.
Presumably, as an inflammatory mediator, TNF functions beneficially for the body
during inflammation. The suppression of TNF activity described here may prevent
second order responses of the pleura to asbestos deposition in the lung. A
persistent deficit in these TNF-mediated defensive responses, which could include
recruitment of leukocytes and their activation for inflammation and immune
defence, could play a role in subsequent pleural pathology.
Although it was suggested that mast cells may play a role in secretion of
TNF (Beutler and Cerami, 1988a), there was no circumstantial evidence from mast
cell numbers that they were the source of TNF. However, since mast cells have
been suggested to play a role in the response to fibres (Miller et al, 1989), their
functions in the pleural space require further investigation.
2.2.4. Effect of C.parvum-induced pleural inflammation on the TNF activity
produced by pleural leukocytes
At 1 day post I/T C.parvum, it was evident that pleural leukocytes
produced significantly less TNF activity and this reduction was even greater by 5
days. During C.parvum-induced pleuritis, the most marked changes in cell
components were:- (1) considerable increase in PMN numbers on day 1 with
rapid recovery to normal, (2) significant and persistent enhancement of
macrophage numbers.
TNF-specific inhibitors have been confirmed by Giovine et al (1988) and
Seckinger et al (1989). The present study also indicated that there is a TNF
inhibitor in pleural lavage fluid. The decreased TNF activity after I/T C.parvum
may be explained by increased production of TNF inhibitor by pleural leukocytes
(Section 2.2.3) since there is dramatic recruitment of the leukocytes after I/T
C.parvum. However, it seems also possible that decreased TNF activity was caused
by the altered pleural leukocyte components. Studies by Rich et al (1989) and
Okubo et al (1990) revealed that TNF production by alveolar macrophages was
significantly more than that by blood monocytes in response to LPS. In vitro
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maturation of blood monocytes resulted in increased expression of TNF. This
suggests that maturation of mononuclear phagocytes leads to a phenotype capable
of producing higher levels of TNF. Thus, during C.parvwm-induced pleural
inflammation, the huge PMN number means that there are proportionally less
macrophages and also that newly recruited, more monocytic, macrophages would
have less TNF-producing capacity than mature macrophages. The decreased TNF
activity may result from the recruitment of PMNs in first instance, then from
the recruitment of blood monocytes to the pleural space.
2.2.5. Effect of I/T asbestos in combination with other dust on TNF production
by pleural leukocytes
In most studies, animals or cells are exposed to single dust types or
asbestos fibres for ease of interpretation of results. However, many people are
likely to have mixed exposure to different dusts in the workplace. It is important
therefore to know the effect of dust combinations on cell functions. To examine
this, crocidolite asbestos and other particles, individually and in combination, were
instilled and the effect on TNF production by pleural leukocytes was investigated.
One month after intratracheal instillation, asbestos and other dusts alone
caused decreased TNF release by pleural leukocytes. It is difficult to understand
why Ti02, an inert dust, also caused decreased TNF production. However, the
crocidolite-induced reduction of TNF release was consistent with observation in
earlier part of the study that one month after I/T crocidolite, the TNF production
by pleural leukocytes was dramatically decreased (Section 2.2.3). However, any
combination of asbestos with particles caused dramatic increases in TNF
production by pleural leukocytes. The combination of crocidolite and quartz
induced up to 4-fold more TNF activity than the control level. Even the
combination of crocidolite and TiO
2 could stimulate pleural leukocytes to produce
twice the control level of TNF. The results revealed an apparently synergistic
interaction between crocidolite fibre and quartz or TiO 2, in stimulating TNF
production by pleural leukocytes.
In experimental studies in rats on the effects of asbestos coupled with the
inhalation of Ti02 or quartz, Davis et al (1988^; 1991) demonstrated that both
quartz and TiO 2 together with asbestos caused an increase in the numbers of
mesotheliomas compared to asbestos alone. Tumours in animals treated with
asbestos plus quartz also tended to occur earlier than tumours with asbestos alone.
This was supported by the observation of high mesothelioma incidence (10/328) in
pipe makers who had mixed exposure to both crocidolite and "silica" in cement
(Finkelstein, 1983). A significant increase in TNF production by pleural
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leukocytes after 1/T crocidolite plus TiO 2 or crocidolite plus quartz observed in
the present study, indicates that mixed exposure to asbestos and particulate dusts
may lead to transport of asbestos fibres to the pleural space. An increased
transport of particles under such conditions was suggested by Davis et al (1991),
and may have contributed to the dramatically increased response in pleural
leukocyte TNF production. However, the present study failed to demonstrate
translocation from the lung to the pleura when asbestos or quartz was instilled
alone (Section 3).
It was suggested by Davis et al (1988^) that particulate dusts, especially
quartz, have a much greater ability than asbestos fibres to penetrate through the
pleura. In the presence of penetrating particle, it was suggested that fibre
penetration could be made easier since in animals treated with mixtures of
asbestos plus quartz, there was evidence of fibres on the visceral pleural
surface. No experiment has yet been carried out to investigate whether asbestos
reaches the pleural space in increased amount with the type of dust exposure
discussed here. However, in the light of the present findings, that there is a
high TNF production by pleural leukocytes after deposition of asbestos plus other
dusts, it would be very informative to investigate asbestos translocation to the
pleura with such treatments.
2.3. Cytokine production by pleural leukocytes treated with dusts in vitro
Although a variety of studies have demonstrated considerable difference in
cytokine production by alveolar leukocytes in vitro after treatment with different
dusts (Kusaka et al, 1990a; Driscoll et al, 19901), almost no in vitro work has
been carried out on pleural leukocytes. In the present study, the interaction
between dusts and pleural leukocytes was investigated in terms of TNF and IL-1
production. The results indicated that crocidolite, quartz and TiO 2 can stimulate
increased production of TNF or IL-1 by pleural leukocytes in vitro. However,
there was no significant difference between these dusts in ability to cause cytokine
production. This indicates that the effect on pleural leukocyte cytokine secretion,
of intratracheal asbestos is not simply caused by direct interaction between dust
and cells. Some inflammatory signal(s) from adjacent asbestos-inflamed lungs may
also mediate the altered pleural leukocyte response.
2.4. The production of TNF and IL-1 by separated normal pleural leukocytes
To investigate possible cellular source of cytokines released by pleural
leukocytes, two subpopulations of pleural leukocytes were obtained using separation
techniques: a macrophage-enriched population (93% macrophages) and a mast
cell- enriched population (76% mast cells and 20% macrophages). TNF and IL-1
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activities produced by these two subpopulations were tested and results revealed
that both subpopulations secreted less TNF and IL-1 activity in culture than the
unseparated populations. This was likely to be caused by slight cellular injury
during separation procedure. However, the mast cell-enriched population
produced significantly higher activity of both TNF and IL-1 than
macrophage-enriched population.
Mononuclear phagocytes such as peripheral blood monocytes (Elias et al,
1985; Gerrard et al, 1987) and alveolar macrophages (Wewers et al, 1984; Haq
and Maca, 1986) are reported to be the major cell sources of IL-1. Other cells,
however, may also produce IL-1, such as PMN (Canning and Neil, 1989; Tiku et
al, 1986a), epithelial cells (Dinarello, 1984) and eosinophils (Pozo et al, 1990).
However, no report is known to us that demonstrates mast cells as a cell source
of IL-1.
The macrophage (Becker et al, 1989; Martinet et al, 1988) as well as
blood monocytes (Rich et al, 1989; Lonnemann et al, 1989) are also the major
source of TNF production in response to LPS. Several other cell types have also
been reported to produce TNF, including T-lymphocytes and smooth muscle cells
(Beutler, 1988a) as well as mast cells. Steffen et al (1989) showed the presence
of TNF mRNA in the cytoplasm and TNF protein in the granules of individual
human mast cells. Mast cells as a source of TNF was also confirmed by Gordon
and Galli (1990). Young et al (1987) have also demonstrated the presence of TNF
in murine mast cells.
It is difficult to explain our findings of increased TNF and IL-1 by the
mast cell-enriched population compared to the macrophage-enriched population
since intratracheal asbestos- induced changes of TNF and IL-1 activities were not
related to mast cell population in the present study. It is presumed that the
release of mast cell metachromatic granules which contain pharmacologically potent
mediators (Lee et al, 1985) might have an important role in stimulating the
production of TNF and IL-1 by macrophages. Further research is required but
was beyond the scope of the present study.
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3. Transfer of particles into the pleural space
Pathological responses have been found in the pleural cavity of
asbestos-exposed individuals. These include pleural adhesions, diffuse fibrosing
pleuritis and pleural fibrosis as well as mesothelioma (Herbert, 1986; Wagner,
1986). In cytologic studies, it was demonstrated that intrabronchially instilled
amosite asbestos had an effect on lavagable pleural cells (Oberdoerster et al,
1983).
In view of these findings combined with the present investigation showing
functional changes of pleural leukocytes following asbestos deposition in the lung,
it is important to know whether asbestos deposited in the lung reaches the pleural
space.
3.1. Fate of intratracheally instilled beads
3.1.1. Fate of beads instilled along with asbestos fibres
Small (0.77 /un) fluorescent microspheres (beads) were used as markers of
pleural permeability to particles, since they are easily seen when viewed by UV
illumination. Results showed that whenever beads alone, or coupled with quartz or
chrysotile asbestos, were intratracheally instilled, they were not seen in pleural
leukocytes. There were, however, a high percentage of alveolar cells containing
beads. Even one month after I/T beads alone or coupled with other dusts, there
were no detectable beads in pleural macrophages. These findings indicated that, to
all intent and purposes, no beads of this size or shape deposited in the alveolar
space transfer into the pleural space. Neither direct penetration, as confirmed by
the one day study, nor translocation to the pleura via the lymphatic or blood
circulation systems as confirmed by the one month study was evident. In addition,
when more severe inflammation was caused in the alveolar spaces by coupled
injection of beads with quartz or asbestos and by C.parvum, no penetration of
particles to the pleura were observed. This reveals that beads of this size in the
airspace do not reach the pleura and co-instillation of quartz or asbestos does not
assist in this translocation, although Davis et al (1991) suggested that quartz may
help asbestos fibres to penetrate through the pleural barrier.
A accidental experiment may supply some extra information with regard to
fibre transfer. After a rat was intrapleurally injected with beads and chrysotile
asbestos accidentally, the pleural leukocyte pattern became very different to that
of the normal pattern, with dramatically high total leukocyte number and a high
percentage of PMNs. There was also, as would be anticipated, a fairly high
percentage of pleural macrophages and PMNs containing beads. This shows that, if
beads were transferred to the pleural space they would be indeed phagocytosed by
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leukocytes and be detected.
3.1.2. Fate of I/T beads in combination with C.parvum
The present observation showing very similar inflammatory patterns in
alveolar and pleural spaces indicates the existence of some communication of
inflammatory mediators between the two spaces. To test the possibility that
particles might be translocated from the lung to the pleural space during
C.parvum- induced alveolar inflammation, counts of beads within cells in both
spaces was carried out. The results indicated that, following deposition in the
airspace along with C.parvum, although alveolar macrophages and PMNs contain
substantial numbers of beads, almost no macrophages or PMNs were found to
contain beads at the same time in the pleural space.
The present findings failed to demonstrate beads in the pleural space after
intratracheal instillation in various conditions. These results are consistent with the
study of Lehnert et al (1985) which showed that the numbers of particles washed
from the pleural spaces of rats, after their instillation in the lung, were essentially
the same as those harvested from a group of control rats. They concluded that
smooth, spheroidal polystyrene particles with a geometric diameter of = 2 pm do
not pass to the pleural space, even when deposited in the lung in high numbers.
However, contradictory results have been observed as discussed in Section 3.3.
3.2. Fate of C.parvum organisms following intratracheal instillation
During C.pnrva/n-induced alveolar inflammation, many C.parvum organisms
were observed inside alveolar macrophages and PMNs. However, neither pleural
macrophages nor PMNs were found to contain C.parvum organisms. This generally
supports the contention that intratracheally instilled particles do not reach the
pleural space.
3.3. Transmission electron microscope (TEM) evidence of transfer of asbestos
fibres from the airspace to the pleural space
A TEM study was carried out to observe whether any asbestos fibres could
be seen in the pleural macrophages or PMNs after rats were exposed, by long
term inhalation followed by 1 year recovery, by short term inhalation or by
intratracheal instillation, to different asbestos types alone or in combination with
TiO
2 or quartz. The pleural leukocytes were carefully examined by TEM for
internalised asbestos fibres and although large numbers of cells were scanned, no
fibres were ever found in the pleural macrophages or PMNs. Meanwhile, asbestos
was easily discerned in alveolar macrophages.
Experimental findings on the translocation of particles or fibres from the
lung to the pleural space are not all in agreement. Sebastien et al (1979)
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demonstrated asbestos and other fibres at visceral pleural and parietal sites, and in
pleural fluid. Miller et al (1989) found that after inhalation of glass fibres and
ceramic fibres, cells containing partly phagocytosed fibres were present in the
pleural space as early as 3 days post- exposure. The majority of fibres observed in
the pleural lavage supernatants by scanning electron microscope appeared shorter
than 8 /tin. Holt (1983) reported the translocation of inhaled chrysotile to the
pleura by "drift" towards the pleura within macrophages. Pleural migration of
chrysotile fibres after intratracheal injection in rats was also demonstrated by
Viallat et al (1986) and they found that the size and quantity of chrysotile fibres
that reached the pleural cavity of test rats was time-dependent, with two peaks
on day 7, mean number = 0.96 x 105; mean length = 1.3 /mi, and on day 21
with mean number = 1.3 x 10 s and mean diVmefey = 0.3 /im.
However, Oberdoerster et al (1983) could not detect amosite fibres in the
pleura after rats were intratracheally instilled. Light microscope and TEM study
presented by Dodson and Ford (1985) also showed no evidence of amosite fibres
within the pleura or subpleural regions after instillation and macrophages on the
pleural surface were found to contain no fibre.
The present study indicated that beads with a geometric diameter of 0.77
/mi do not reach pleural space at one day or one month after they are deposited
in the lung. This diameter is less than the length of chrysotile fibres observed in
pleural spaces, i.e. up to 1.3 /mi (Viallat et al, 1986). The contention that
particles do not easily transfer is also supported by the C.parvum study. It is
suggested that, in the animal model used in the present study, there is no
detectable translocation of asbestos fibre into the pleural space from the lung after
instillation.
The morphology of the pleura limits the translocation of particles from the
lung to the pleural cavity. The visceral pleura is thick and is composed of five
different layers (Staub et al, 1985). The present TEM study on pleural structures
confirmed these histological patterns. This represents a formidable barrier to
movement of particles from the alveolar to the pleural spaces which particles are
unlikely to breach easily.
However, transportation of particles into the pleura may be facilitated by
specific structures on the pleura, such as milky spots, crevices and pleural stoma
(Kanazawa, 1985). But the present study failed to demonstrate the role of these
structures in transfer of asbestos fibres into the pleura.
Intratracheal instillation and inhalation of asbestos gives very different
pictures (Oberdoerster et al, 1983; Davis et al, 1986^ and the present study) to
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that seen with intrapleural injection of asbestos (Sahn and Antony, 1984; Edwards
et al, 1984; Shore et al, 1983) in terms of pleural cell population changes, as
well as pleural pathological changes. This could be taken as evidence that asbestos
does not enter the pleural space in the case of the first two but that this
response is a reactive one to adjacent inflammation.
Dodson and Ford's findings (1985) on amosite asbestos intratracheal
instillation study indicated that pleural morphological changes following asbestos
exposure included: (1) pleomorphic changes in mesothelial cells ranging from
slightly cuboidal, to protruding "columnar-like" cells, to more bizarre forms; (2)
early proliferation of the mesothelial cells; (3) distortions of the basal lamina.
Limited evidence in the present study also showed the presence of mesothelial cell
injury caused by asbestos exposure.
4. In vitro studies on pleural mesothelial cells
Mesothelial cells are highly susceptible to damage from agents that they do
not normally encounter, including asbestos, silica and foreign protein. All these
cause swelling of the cells, clubbing of microvilli, and separation of the cells from
each other and from the basal lamina, resulting in exfoliation (Herbert, 1986).
We do not believe that there is substantial transfer of fibres sufficient to cause
this type of injury. However, we have reported that inflammatory alveolar
leukocytes can damage epithelial cells in culture (Donaldson et al, 1987^). We
set out to determine whether pleural leukocytes could be activated to cause
damage to mesothelial cells following I/T fibres. Studies were therefore carried out
to investigate the interaction between pleural leukocytes and mesothelial cells.
4.1. Injurious effects on mesothelial cells in vitro caused by pleural leukocytes
from rats exposed to asbestos by intratracheal instillation
In a similar pattern to the earlier part of the present study (Section 1.2.1)
in this sequence of experiments there were increasing numbers of macrophages
and eosinophils in the pleural spaces at different times post crocidolite I/T.
However, differently to the first experiment was the absence of PMN in the
pleural spaces following asbestos I/T.
We have previously used detachment injury of epithelial cells to
demonstrate the potentially injurious properties of inflammatory leukocytes
(Donaldson et al, 1987^). Using the standard assay for measuring cell detachment,
we were able to demonstrate mesothelial cell injury caused by pleural leukocytes
from rats intratracheally exposed to asbestos. The results revealed that
asbestos-derived pleural inflammatory cells caused considerable mesothelial cell
detachment but not lysis injury, an effect we found previously to be
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protease-mediated (Donaldson et al, 19875). The changes of cell components were
not the explanation of the findings since there is no significant difference of
pleural leukocyte components between controls and asbestos I/T animals. Further
studies indicated that mesothelial cells were susceptible to both trypsin and elastase
in terms of detachment injury.
Neutrophil-induced detachment injury of rat pulmonary alveolar epithelial
cells has been reported by Ayars et al (1984) and Simon et al (1986) who
showed that stimulated PMNs produced marked target cell detachment without
lysis. However, PMNs are not involved in mesothelial cell detachment observed in
the present study because there were no PMN in the pleural leukocyte
populations. It must be presumed that pleural macrophages or other cell
components, such as mast cells and eosinophils, may also contain proteases
(Henson et al, 1988) ^able to cause mesothelial cell detachment. These may be
stimulated and released in increased amounts while macrophages or other cells are
triggered by inflammatory messages from adjacent asbestos-exposed parenchyma.
Since this activity of pleural leukocytes declined rapidly, it is probably
overshadowed by newly recruited macrophages or other pleural components which
are less responsive to the alveolar-derived inflammatory signals or are able to
produce more protease inhibitors.
The present study also provided evidence that elastase may play a role in
the mesothelial cell detachment injury caused by inflammatory pleural leukocytes.
This is consistent with other observations: Ayars et al (1984) demonstrated that
elastase and collagenase exert effects on target cell detachment and PMN-
mediated detachment was markedly inhibited by neutral protease inhibitors and
elastase inhibitor. From the effects of active proteases, the mechanisms of
detachment is through the action of granule neutral proteases, rather than toxic
oxygen metabolites, and is probably due to degradation of the extracellular matrix
of the target cells, as suggested by Ayars et al (1984) and Donaldson et al
(1987},). Simon et al (1986) also suggested that damage to pulmonary alveolar
epithelial cells caused by stimulated PMNs was oxygen metabolite-independent.
Brown and Donaldson (1988) found, in an investigation of the role of leukocytes
in connective tissue derangements in the lung, that inflammatory cells which
contained more than 75% of PMNs caused consistently and substantially more
degradation of fibronectin than controls on a per cell basis and serine proteases
are responsible for this matrix degradation.
Detachment could lead to desquamation and exfoliation of mesothelial cells
in vivo and increased permeability of the pleural barrier as well as damage to the
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lubrication function of the mesothelium. As reported, mesothelial cells were not
present in washing from normal pleural spaces (Spriggs and Boddington, 1968),
but may be abundant in many forms of effusion (Herbert, 1986). In our TEM
study, evidence was presented that, during long term inhalation exposure of rats
to asbestos, there was exfoliation of mesothelial cells from their matrix.
Pleural inflammation in humans would be much less intense than the
inflammation produced here experimentally. Thus, the burden of inflammatory
cells may be insufficient for such an extreme detachment response as demonstrated
here in vitro, and the potential to cause injury may also be ameliorated by anti-
protease defence mechanisms in the pleura (Donaldson et al, 1988^). However,
under these conditions low level attack on the mesothelial cells could still lead to
the increased permeability of the mesothelial membrane and accumulation of fluid
with high protein content as described in some inflammatory processes and
tumours of the pleura (Rennard et al, 1985).
4.2. Injurious effects towards mesothelial cells by pleural leukocytes from rats
with C.parvum-'mduced pleural inflammation
Intratracheal instillation of C.parvum resulted in both bronchoalveolar and
pleural inflammation characterized by recruitment of PMNs into those spaces by
day 1 and recruitment of macrophages by day 5. C .parvum-elicited alveolar
leukocytes caused considerable detachment of mesothelial cells, which was
consistent with the findings of Donaldson et al (1988 5) despite the fact that
different target cells were used in the present model. Pleural leukocytes from rats
1 day following C.parvum- exposure which consist of 30% PMN, resulted in
substantial mesothelial cell detachment in a cell concentration-related manner.
However, the leukocytes from rats 5 days after C.parvum I/T which contained
almost no PMN, had no effect in causing detachment injury of mesothelial cells.
However, those cells caused modest target cell lysis.
PMNs exert injurious effects on rat alveolar epithelial cells (Simon et al,
1986; Donaldson et al, 1988^), human A549 pneumocytes (Ayars et al, 1984) and
human endothelial cells (Cronstain et al, 1986). The present study indicated that
pleural PMNs have the potential to cause mesothelial cell detachment since
detachment injury is related to severity of neutrophil pleuritis. However, the
possibility that pleural macrophages or other components may play a role in this
mesothelial cell injury cannot be excluded since there are very different pleuritis
induced by C.parvum and asbestos in terms of cell populations. It would be
anticipated that different mechanisms may lead to these similar phenomenon.
Nevertheless, it is still not clear why pleural leukocytes caused mesothelial cell
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lysis injury by day 5 when newly recruited macrophages accounted for the most
of pleural population.
4.3. Pleural lavage from rats exposed to crocidolite asbestos stimulates
mesothelial cell proliferation in vitro
Various types of inflammatory agent, such as asbestos, microorganisms and
endotoxin have been shown to induce a rapid desquamation of the mesothelium
(Bignon and Gee, 1985). Under certain circumstance, mesothelial cells would
proliferate to repair themselves, leading to hyperplasia (Herbert, 1986). In
addition, pleural leukocyte-derived growth factor could also be important in the
hyperplasia. This may lead to pleural fibrosis and mesothelioma in some cases.
In the present study, pleural lavage fluids were tested for their stimulating
effect on mesothelial cell proliferation. The pleural lavage fluid by day 30 after
instillation stimulated the proliferation of mesothelial cells. The results agree with
the observation of Fotev et al (1987) that peritoneal wound exudates stimulated
DNA synthesis in normal quiescent mesothelial cells.
Inflammatory cells could stimulate a proliferative response in the
mesothelium and lead to the mesothelial hyperplasia described in chronically
irritated pleura (Whitaker el al, 1982^), and also the development of mesothelial
proliferative lesions and mesothelioma in mineral fibre-exposed individuals (Davis
et al, 1986a). This type of response is likely to be mediated by macrophages
since the cells have been shown, extensively, to be able to stimulate growth in a
wide variety of mesenchymal cell types (Martin et al, 1981; Glenn and Ross,
1981). Fotev et al (1987) found that the cells principally responsible for
stimulation of DNA synthesis in mesothelial cells by peritoneal wound exudates
were the macrophages. They confirmed that cultured macrophage-conditioned
media induced an increase in mesothelial replication and postulated that exudate
macrophages secrete mitogenic factor(s). Lemaire et al (1983) reported that
asbestos exposure enhances the release of fibroblast growth factor by sheep
alveolar macrophages. In the present study, the result may imply the release of
mesothelial cell growth factor by pleural macrophages in response to asbestos
exposure. Further work is clearly required to characterise this mediator.
Presumably, if pleural macrophages are present in increased numbers, or in
an activated state, during asbestos-induced injury, then they could release these
factors in sufficient quantities to produce proliferative lesions in the mesothelium.
The present study supports evidence on this point: thirty days following I/T
asbestos, there was substantial recruitment of macrophages into the pleural space.
These may exert mesothelial cell mitogenesis via the production of growth factors.
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This observation may shed light on chronic mesothelial hyperplasia and possibly,
mesothelioma, in mineral fibre exposed individuals.
5. Bronchoalveolar leukocyte response to asbestos
As a major effector system in pulmonary pathobiology, bronchoalveolar
leukocytes have attracted abundant attention as to changes following exposure to
asbestos, eg. plasminogen activator production in asbestosis (Cantin et al, 1989),
IL-1 and TNF production in response to asbestos exposure in vitro (Rosenthal et
al, 1989; Dubois et al, 1989) and in vivo (Bissonnette and Rola-Pleszczynski,
1989; Driscoll et al, 1990,) and so on. The present study was directed mainly at
pleural leukocytes but to compare the responses of pleural leukocytes and
alveolar leukocytes to asbestos exposure, cytokine production by bronchoalveolar
leukocytes following I/T asbestos was assessed.
5.1. Cytokine production by alveolar leukocytes and effect of I/T asbestos
5.1.1. Production of TNF and IL-1 by normal alveolar leukocytes
It has been reported that there was no TNF activity in supernatants of
unstimulated rat alveolar macrophages and that stimulation with LPS was required
to induce production and release of high levels of TNF (Becker et al, 1989;
Adams and Czuprynski, 1990; Martinet et al, 1988). As with TNF, alveolar
macrophages produce IL-1 only in response to a variety of stimulants including
LPS (Oppenheim et al, 1986; Wewers et al, 1984).
Our rat alveolar macrophages produced TNF and IL-1 in vitro without
addition of stimulants. Since a relatively low level contamination of endotoxin (up
to 100 pg/ml) was found in the media used in assays, then these could contribute
to the spontaneous release of both TNF and IL-1 (Dinarello, 1984). This
possibility has been ruled out for observed TNF production since our
endotoxin-depleting study indicated that removal of contaminated endotoxin from
the media does not affect TNF production by pleural leukocytes. Furthermore, we
confirmed that the normal alveolar macrophages were able to produce
significantly enhanced TNF and IL-1 activity in response to 100 ng/ml of LPS.
5.1.2. Alveolar leukocyte population after I/T asbestos
Following intratracheal crocidolite asbestos, there was an acute recruitment
of PMN at 1 day. This is consistent with the work of Donaldson et al (1988^)
revealing that the predominant cell types in lavage fluid were macrophages in
control rats and macrophages plus PMNs in rats exposed to chrysotile. However,
they found that basophils and eosinophils never exceeded \% of the total cells.
This contrasts with the present findings that eosinophils exceeded 15% by day 3.
This may be explained by the different kinds of asbestos or different strains of
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animals. Xaubet et al (1986) and Robinson et al (1986) have described the
increased levels of eosinophils in the bronchoalveolar lavage of asbestos-exposed
individuals. Oberdoerster et al (1983) reported that after amosite I/T, PMNs in
lung lavages of rats increased dramatically by day 1, and decreased from day 3
onwards. Meanwhile, the proportions of macrophages changed in a
complementary way. Similar patterns of variation of PMNs and macrophages were
found in the present study.
One month following I/T asbestos, no important changes in bronchoalveolar
leukocyte populations were observed across asbestos doses except the presence of a
small proportion of PMNs.
5.1.3. Production of TNF by alveolar leukocytes after I/T crocidolite asbestos
Studies on alveolar macrophages exposed to asbestos in vitro indicated that
the addition of 30 /rg/ml crocidolite asbestos to alveolar macrophage pre-incubated
with RPMI and serum resulted in a significant increase in TNF production when
compared to control (Rosenthal et al, 1989). Another in vitro study also showed
that chrysotile asbestos augmented TNF production by alveolar macrophages in a
concentration-dependent fashion (Dubois et al, 1989).
The present study in keeping with these previous findings indicated that
there is an increase in TNF production by alveolar leukocytes. An asbestos-related
dose effect on TNF production by these cells was observed, although lower doses
did not enhance TNF release sufficiently to attain statistical significance. The
absence of an increase on day 1 may be explained by a substantial recruitment of
PMN which may remove TNF via receptor (Shalaby et al, 1987). The increase in
TNF production by the alveolar leukocytes is correlated with the instilled dose of
asbestos. This could be important for fibrosis in the alveolar region of asbestos
exposed individuals since TNF exerts potent growth factor activity for many types
of human fibroblasts (Vilcek et al, 1986) and contributes to fibroblast growth
activity stimulated by other mineral dust as confirmed by Dubois et al (1989).
Palombella et al (1987) have shown that TNF can increase the number of
epidermal growth factor (EGF) receptors on human FS-4 fibroblasts and that this
increase may be related to the mitogenic action of TNF on these cells. In a
further study, Palombella et al (1988) found that there was a synergistic
interaction between TNF and EGF and platelet-derived growth factor in promoting
DNA synthesis and cell division of fibroblasts. In vivo, local release of TNF
causes a focal accumulation of fibroblasts and collagen (Piquet et al, 1990j,). It
is also suggested that TNF can provoke acute pulmonary vascular endothelial
injury through increasing permeability of endothelial cell monolayers (Goldblum et
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al, 1989; Brett et al, 1989) as well as influencing human fibrinolytic system
(Silverman et al, 1990).
As TNF infusion results in alveolar damage, the extensive secretion of
TNF in the lung during exposure to asbestos could be an important step in the
development of fibrosis. Abnormally increased secretion of TNFa by alveolar
macrophages in coal worker's pneumoconiosis has been reported by Lassalle et al
(1990). They concluded that alveolar macrophages are involved in chronic
inflammatory lung reactions to mineral dusts, partly through TNF secretion. Piguet
et al (1990a) confirmed the requirement of TNF for development of silica-induced
pulmonary fibrosis in a mouse model. They showed that a single instillation of
silica lead to a marked increase in the level of lung TNF messenger RNA lasting
for more than 70 days. Silica-induced collagen deposition was almost completely
abolished by anti-TNF antibody, and was significantly increased by continuous
infusion of mouse rTNF.
TNF was also found to be an inducer of the release of IL-1 by
endothelial cells (Nawroth et al, 1986), by mononuclear cells (Dinarello et al,
1986) and by fibroblast (Elias and Reynolds, 1990). IL-1 has synergistic effects
with TNF in many aspects (Wankowicz et al, 1988; Elias and Reynold, 1990)
which would favour inflammation and fibrosis and so its level in the lung with
asbestos deposition is of great potential importance for long-term pathology.
5.1.4. Alteration of IL-1 production by alveolar leukocytes after I/T crocidolite
asbestos
The alveolar leukocyte components changed following asbestos instillation,
the most important change was an increased percentage of PMNs and eosinophils
from day 1 to day 14. Since macrophages are a major source of IL-1 (Ohkawara
et al, 1989; Dinarello, 1984), the decreased IL-1 activity might result from a
decrease in the percentage macrophages or from the production of IL-1 inhibitor
by PMN (Tiku et al, 1986b).
However, the decreased IL-1 activity at day 14 is difficult to explain fully
by the change in cell components since the percentage of macrophages had
recovered to control level. This continuous decrease may be due to injury of
macrophages by asbestos directly or due to the influence of an increased number
of eosinophils.
The considerable enhancement of IL-1 activity released by alveolar
leukocytes one month post instillation could result partly from the recruitment of
macrophages. As revealed by Elias et al (1985), denser alveolar macrophages
which represent less mature cells elaborated more IL-1 than less dense alveolar
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macrophages. Rich et al (1989) and Elias et al (1985) have also shown that
human alveolar macrophages produce less IL-1 in response to LPS than do
monocytes. Kagan et al (1989) demonstrated that significantly greater proportions
of alveolar macrophages were recoverable in the highest density fractions on day
7 and day 17 after crocidolite or chrysotile inhalation exposure, compared to sham
exposure. In the present study, possibly, newly recruited macrophages may
accumulate at sites of asbestos deposition, as supported by the observation of
Warheit et al (1985) that asbestos-generated chemoattractants for alveolar
macrophages were present in the lung lining fluid during inhalation exposure.
Therefore, the IL-1 activity produced by these accumulated cells would be
enhanced.
A large body of literature has accumulated in recent years implicating IL-1
in the pathogenesis of mineral dusts and asbestos-induced lung abnormalities.
Studies indicated an increasing release of IL-1 by alveolar leukocytes in vivo
exposed to particles, such as coal dusts (Kusaka et al, 1990a) and quartz
(Dirscoll et al, 1990,). Lassalle et al (1990) observed higher levels of IL-1
secretion by alveolar macrophages from patients with coal worker's pneumoconiosis
than in those from healthy controls.
As reported by Rosenthal et al (1989), chrysotile and crocidolite asbestos
markedly stimulated IL-1 production by alveolar macrophages with stimulation with
LPS prior to fibre exposure. Enhanced IL-1 activity following asbestos inhalation
in rat was reported by Hartmann et al (1984) and Kagan et al (1985a). The
present study showed that one month after I/T asbestos, IL-1 production increased
dramatically and a dose- related effect of asbestos was observed.
Although PMNs have been found to synthesize and release IL-1 in culture,
this production required stimulation with opsonized zymosan particles (Canning and
Neill, 1989) or PMA (Tiku et al, 1986a). Murine eosinophils are also able to
express IL-1 mRNA when stimulated with LPS (Pozo et al, 1990). However,
alveolar PMN and eosinophils seem not to be responsible for the altered IL-1
activity seen during asbestos exposure.
Human rIL-1 was found to stimulate the synthesis and accumulation of
type I procollagen chains, type I procollagen messenger RNAs and growth of
fibroblasts in vitro (Postlethwaite et al, 1988). Hartmann et al (1984) showed that
asbestos- associated augmented release of IL-1 simulates fibroblast DNA synthesis
and lymphoproliferation. Since IL-1 may modulate the functions of fibroblasts as
well as other inflammatory cells, the persistent augmented release of IL-1 at sites
of inflammation may contribute to fibrogenesis and fibrosis after asbestos
deposition in the lungs.
IL-2 is also able to induce mouse thymocyte proliferation (Kagan et al,
1985a) and sometimes it is co-produced with IL-1 by macrophages (Hartmann et
al, 1984). To exclude the possibility in the present study that IL-1 activity
measured by using mouse thymocyte proliferation assay was caused by the
presence of IL-2, IL-2 activity was measured and none was detected.
5.1.5. Effect of mineral dusts and asbestos in vivo, individually or in
combination, on TNF and IL-1 production by alveolar leukocytes
5.1.5.1. Alveolar leukocyte components after I/T mineral dusts and asbestos
The present study indicated that one month after instillation of compact
mineral dust and asbestos, individually or in combination, the most dramatic
change was a substantial recruitment of alveolar leukocytes. The total number of
the leukocytes was more than six times greater in the quartz treated- group and
ten-fold more in the quartz plus crocidolite group. Another main change induced
by dust instillation was the increased percentage of PMN, being 41% in the
quartz treated group and 27% in quartz plus crocidolite group. The observation
implied that quartz is a very strong stimulant in the lung, which is consistent with
the findings of Donaldson et al (1988c) on inflammatory cell recruitment to
quartz-instilled lung. In another study, Donaldson et al (1990) showed that,
during exposure to airborne quartz, there were substantial increases in alveolar
macrophages and PMNs. Driscoll et al (1990,) also revealed that, 28 days after
intratracheal instillation, dramatic increases in both alveolar macrophages and
PMNs were observed in the quartz group; TiO 2, by contrast, caused only a
moderate increase of both kinds of cells.
It is likely that, within working situations, there is mixed exposure to
asbestos and other mineral dusts. The present study showed that the combination
of quartz and crocidolite in the lungs resulted in dramatically increased cellular
response compared to control and groups receiving single dust. This gives further
support to the findings of Davis et al (1991) that quartz plus asbestos greatly
increased fibrosis and pulmonary tumours above that produced by asbestos alone
during inhalation exposure.
5.1.5.2. Effect of intratracheal mineral dusts and asbestos on TNF and IL-1
production by alveolar leukocytes
One month post mineral dusts and asbestos I/T, individually or in
combination, the most significant increase in TNF production by alveolar
leukocytes was stimulated by Ti02 alone and TiOz plus crocidolite; quartz
decreased TNF production. However, IL-1 production by alveolar leukocytes was
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increased by any dust treatment, individually or in combination, TiO 2 stimulated
the biggest enhancement of IL-1 elaboration, quartz stimulated the least.
The present study indicates that TiO 2-elicited alveolar macrophages
produce much higher TNF and IL-1 activities in culture than quartz or
crocidolite-elicited leukocytes. The results are consistent with the finding of
Kusaka et al (1990a) which indicate that TiOz is capable of stimulating alveolar
macrophage IL-1 production. The increased cytokine production by alveolar
leukocytes after I/T 2.5 mg TiO 2 may represent the effect of the overload of
particulates as Driscoll et al (1990 2) described occurring with 2-10 mg TiO 2 in
200g rats. Crocidolite stimulated IL-1 production by alveolar leukocytes and this
agrees with the study of Hartmann et al (1984) showing crocidolite inhalation is
followed by enhanced IL-1 release by alveolar macrophages. Our finding that
intratracheal quartz resulted in decreased TNF is not consistent with the findings
of Driscoll et al (1990,) but the dose used here (2.5mg) was below effective dose
(lOmg) found in that study. The fact that a mixed population, with up to 40%
PMN, was used in the present study whereas Driscoll et al determined the
response of separated macrophages could also contribute to the different findings.
PMN may not only exert a diluting effect on macrophage number which are the
most potent cell source of both TNF and IL-1 (Driscoll et al, 1990,), but can
also release prostaglandin E2 which has been reported to down-regulate TNF
production (Kunkel et al, 1988). In addition, PMN may also internalize TNF via
their TNF receptors (Shalaby et al, 1987).
Although synergistic effects were observed in the combination of quartz and
crocidolite on cell recruitment, no dramatic changes in cytokine production on a
per cell basis could be detected.
5.1.6. In vitro TNF and IL-1 production by alveolar macrophages in response to
mineral dust and asbestos, individually or in combination
Very similar patterns of TNF and IL-1 production by alveolar macrophages
were found. The co-culture of quartz or crocidolite, but not Ti02, with alveolar
macrophages caused increased release of both IL-1 and TNF. The combination of
crocidolite with Ti02 had an additive effect with respect to cytokine release by
the macrophages, but dual exposure to crocidolite plus quartz had no such
effect. These results were consistent with other workers' observations that quartz
normally acts as a stimulant of TNF and IL-1 production while TiO 2 has limited
or little effect (Driscoll et al, 1990,; Dubois et al, 1989; Kusaka et al, 1990). In
the present study, the combination of quartz and crocidolite lead to reduced
cytokine production by the macrophages compared to quartz alone, possibly as a
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result of a toxic effect.
These results revealed very different response of alveolar macrophages to
mineral dusts and asbestos in vitro and alveolar leukocytes in vivo. Clearly, in
vivo exposure to mineral dusts or asbestos causes a mixed cellular response with
recruitment, activation, turnover, interaction with each other and death, to
varying degree, which cannot be reflected in an in vitro study.
Since alveolar macrophages are capable of releasing cytokines to modulate
the activities of inflammatory and immunocompetent cells, they have the potential
to play a key role in the initiation and perpetuation of inflammatory responses
within the lung. TNF and IL-1 have been documented to have pro- inflammatory
activities (Sections 5.1.3 and 5.1.4). The local release of these cytokines can
influence the initiation and progression of the inflammatory response and favour
the development of pulmonary fibrosis (Piguet et al, 1990a; Borm et al, 1988;
Lassalle et al, 1990).
With regard to the present findings, it is clear that cytokine production by
both alveolar and pleural leukocytes differs in response to instilled mineral dusts
or asbestos. In vivo exposure to crocidolite caused IL-1 production to be
decreased at earlier stages by both alveolar and pleural leukocytes whilst one
month after exposure, the IL-1 release was enhanced. However, the study on
TNF production after exposure to dusts alone or in combination on alveolar and
pleural leukocytes gave a very different pattern: alveolar leukocytes released
increased TNF activity after exposure, whereas pleural leukocytes released
decreased TNF activity compared to control. There was a considerable synergistic
interaction between mineral dusts and asbestos in inducing pleural leukocytes to
release TNF, but there was no such effect in stimulating alveolar leukocytes.
These findings demonstrate that the pleural and alveolar spaces are
different in response to deposition of asbestos or other mineral dusts. The pleural
cavity has a limited opportunity to encounter inhaled or intratracheally instilled
mineral dusts or asbestos fibres (Oberdoerster et al, 1983). This may mean that
pleural leukocytes are affected by dusts or fibres by indirect ways. Alveolar
leukocytes, by contrast, interact with dusts or fibres directly.
In addition, alveolar leukocyte components and pleural leukocyte
components are very different since pleural leukocytes contain many mast cells
and eosinophils which are not resident in the normal alveolar space. From the
point of pathological changes, pleural plaques and mesothelioma are distinct from
alveolar pathological changes resulting from asbestos exposure (Craighead et al,
1982; Wagner, 1986). The present study suggests that there are, in the short
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term, very different inflammatory responses in the two spaces with regard to cell
recruitment and mediator release. This difference in inflammation could be
important in understanding the different pathological responses found in the two
regions.
5.2. TNF and IL-1 production by alveolar macrophages in response to long and
short fibre amosite exposure in vitro
The present study indicates that long fibre amosite stimulated alveolar
macrophages to release substantially increased TNF and IL-1 activity in culture,
whereas short fibre amosite had no significant stimulating effect.
Previous studies have shown differences in the pathogenicity of the long
and short fibre amosite samples (Davis, 1986a) with long amosite being more
active in inducing lung fibrosis, tumours and mesotheliomas than the short
amosite. Donaldson et al (1989a) found that the ability of amosite samples to
cause inflammation, as judged by macrophage and PMN recruitment into the
mouse peritoneal cavity, was ranked in the order: long fibre > UICC sample
(intermediated in fibre size) > short fibre. Adamson and Bowden (1990) reported
that instilled long crocidolite (>2.5 /mi) induced pulmonary fibrosis whereas the
same dose of short fibres did not and suggested that pulmonary fibrosis after long
fibre administration appears unrelated to alveolar macrophage secretion of growth
factor and is probably caused by fibre penetration into the peribronchiolar tissue,
where interstitial macrophage activation may occur. The present study provides
additional evidence for the enhanced pathological activity of long fibre amosite.
The study shows increased cytokine production by alveolar macrophages exposed to
asbestos, which is consistent with other workers' findings (Dubois et al, 1989;
Rosenthal et al, 1989) and reveals that asbestos fibre length appears critical in
this event. These results suggests that the increased pathology caused by long
fibres may be related to the ability of long fibre to cause cytokine secretion.
5.3. The effect of opsonization of dusts on TNF release by alveolar
macrophages
Immunoglobulin G (IgG), as a component of the lung lining fluids, has
been demonstrated to change secretion by alveolar macrophages (Ward et al,
1983; Brieland et al, 1987) and enhance asbestos-stimulated superoxide anion
production by the alveolar macrophages (Scheule and Holian, 1989). In view of
these findings, a study on the effect of opsonized asbestos and other dusts, on
TNF secretion was carried out. The results showed that, compared to the control
("PBS-opsonized" group), the IgG- opsonized group had a substantial greater ability
to stimulate TNF release by alveolar macrophages. Heat-inactivated rat serum
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had a slight enhancing effect on the two most active dusts, long fibre amosite and
quartz. This may reflect the effect of a non- specific protein coating. However,
BSA had no such effect compared to control.
Fibronectin-opsonized long and short fibre amosite had moderate effect in
stimulating TNF release. Amongst the functions of fibronectin are cell-to-cell
attachment, cell adherence to basement membranes and as a matrix for cell
migration and extracellular matrix reorganization (Rossman et al, 1990). Since
leukocytes may process receptors for fibronectin, some stimulation by
fibronectin-coated fibres would be anticipated.
Nevertheless, the most significant effect was caused by IgG opsonization.
IgG opsonization caused all of the dusts, including Ti02, to exert an increased
effect in stimulating TNF production by alveolar macrophages. A further study
using different doses of IgG to opsonize demonstrated that long fibre amosite was
most susceptible to opsonization by IgG while TiO 2 had the least response to
the opsonization.
IgG has been shown to considerably enhance the production of superoxide
anion production by guinea pig alveolar macrophages (Scheule and Holian, 1989)
and reactive oxygen metabolites by human macrophages (Nyberg and Klockars,
1990) in response to chrysotile asbestos. The workers suggested that this is an Fc-
receptor-mediated and relatively specific phenomenon. Pulmonary alveolar
macrophages have been shown to have receptors on their surface for IgG
(Daughaday and Douglas, 1976; Tizard, 1988). Therefore, particles opsonized with
antibody can bind to macrophages and stimulate their metabolism if sufficient Fc
domains interact with Fc receptors to effectively crosslink them (Sibille and
Reynolds, 1990).
An IgG dose-dependent enhancement of TNF production by alveolar
macrophages was observed in the present study. Using pre-incubation and washing,
the increased TNF production in the presence of IgG can be accounted for
entirely by the IgG absorbed onto the asbestos surface. As suggested by Nyberg
and Klockars (1990), immunoglobulins very likely interact with mineral dusts in a
"nonimmunological", antigen-independent way and that the so- formed
dust-immunoglobulin complexes amplifies the production of active metabolites by
the inflammatory cell. However, increased phagocytosis caused by protein-coating
of dusts in this phenomenon may also play part role.
The present study also showed that different dusts have different abilities
to be opsonized with IgG, which indicates that characteristics of the dust surface
are important in the ability to be opsonized by IgG. It is proposed that as more
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toxic and pathogenic dusts, long fibre amosite and quartz have more surface
charge or active areas (Valerio et al, 1987; Wiessner et al, 1990) which causes
them to have a higher affinity for IgG molecules and so bind to.
Since asbestos induces increased expression of macrophage surface IgG-Fc
receptors (Tetley et al, 1976), the dramatic enhancement of long fibre
amosite-induced TNF production by alveolar macrophages observed in the present
study resulted, maybe partly, from increased IgG Fc receptors on the macrophage
surface which would amplify the opsonized effect of IgG.
It is likely that the initial interaction between fibres and cells may be
mediated by relatively nonspecific mechanism since, even unopsonized, long fibres
are more stimulatory to TNF release than short fibres. The enhancement of TNF
production may then result from opsonization of long fibres as a result of
accumulation of IgG during inflammation. This could feed forward leading to
enhancement of inflammatory response. Increased release and accumulation of
other inflammatory mediators could also occur.
Abnormal levels of IgG in lavage of smokers have been documented (Bell
et al, 1981) and this could be important in synergism between asbestos and
smoking in causing lung disease. Patients with asbestosis also have a higher
concentrations of IgG in their lavage than control (Bignon et al, 1978). Begin et
al (1985{j) reported that in asbestos-induced alveolitis, there was an increase of
all classes of immunoglobulin in the bronchoalveolar lavage fluid. The likely
enhancement of inflammation that could result from the IgG-opsonization/ TNF
release cycle could be of great importance for fibre-related lung disease and
requires further investigation.
The complement system is also involved in many inflammatory situation
(Bell et al, 1981; Tetley et al, 1976), and so the possible role of this system in
IgG-opsonized fibre induced TNF release was also examined. The results showed
that fresh rat serum treatment had no effect on IgG-opsonized amosite mediated
enhancement of TNF release by alveolar macrophages. This suggests that IgG
absorbed onto fibres is not sufficient in activating complement presumably because
of failure to undergo the configurational changes in the Fc region that allow Cjq
binding (Roitt et al, 1989).
6. Overview
In the present study, the changes in cytokines and other inflammatory
mediators after exposure to asbestos or other agents were discussed separately.
However, in general, these inflammatory mediators coexist and interact with each
other during inflammation. An attempt to discuss these effects in combination
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will therefore be made.
TNF increases the production of PAI-1 (Laschinger et al, 1990) and
PAI-2 (Scarpati and Sadler, 1989) by endothelial cells. Silverman et al (1990) and
Nieuwenhuizen (1990) demonstrated that the administration of rTNFa in vivo to
cancer patients causes increased tPA activity first, then increased PAI activity by
endothelial cells. Similar results were reported by Medcalf et al (1988) showed
that human rTNF stimulated gene transcription of PAI-1 and -2 and
simultaneously suppressed constitutive gene expression of tPA in a human
fibrosarcoma cell. It was also demonstrated that TNF regulates mRNA for uPA
and PAI-1 in human neoplastic cell lines (Georg et al, 1989).
IL-1 enhances mRNA levels for plasminogen activators, and their
inhibitors, in human fibroblasts (Michel et al, 1989). Nachman et al (1986)
reported the induction of PAI synthesis by IL-1 stimulation of human cultured
endothelial cells. Medina et al (1989) found that IL-1 or TNF enhances the levels
of PAI mRNA in bovine aortic endothelial cells.
TNF and IL-1 have no homology and there is no overlap in their
receptor binding, but their activities show a remarkably high degree of overlap
(Larrick and Kunkel, 1988). Also, IL-la and (3 and TNFo and (3 often are
simultaneously produced in response to the same stimuli (Oppenheim et al, 1989).
In addition, there is interaction between these two cytokines with respect of
induction of synthesis: TNF was found to interact with endothelial cell receptors
to induce release of IL-1 (Nawroth et al, 1986). Le et al (1987) have shown that
TNF can induce the synthesis of both IL-1 a and (3 in human fibroblasts.
Dinarello et al (1986) demonstrated rTNF is an endogenous inducer of IL-1.
Elias and Reynolds (1990) found that individually, rIL-1 and rTNF induced
lung fibroblast expression of IL-1 activity, with rIL-1 being significantly more
potent. Importantly, combining rIL-1 and rTNF synergistically stimulate the
fibroblast IL-1 a production.
In view of the interaction and induction of these inflammatory mediators
and cytokines by each other, it could not be ruled out that alterations in some
mediators during asbestos exposure are modulated as a second order response to
asbestos via other mediators. Nevertheless, in the present study, the fluctuation
in release generally differs between mediators response to asbestos or other
treatment. In addition, some efforts were made to exclude the possibility of cross-
reactivities of inflammatory mediators assays.
7. Conclusion
7.1. The major outcome of the present study
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The present study was undertaken to investigate the effects of asbestos
deposition in the lungs, on pleural leukocytes, and the mechanism of any effects.
Since the rodent is a model used in many laboratories for extrapolation to
humans, the rat model was chosen. As a fast, inexpensive and effective means to
observe the acute effect of asbestos in vivo, intratracheal instillation of asbestos or
other dusts was taken as the major approach in the present study although its
shortcomings are obvious (Driscoll et al, 1990^.
General
Intratracheal instillation (I/T) of asbestos resulted in the activation of
pleural leukocytes characterized by modulation of fibrinolytic status, alteration of
cytokine production and potential to cause injury to mesothelial cell in vivo. All
of these occurred in the apparent absence (or very low level) of transfer of
asbestos into the pleural space.
Specific findings
1. Normal pleural leukocytes secret urokinase-type plasminogen activator
inhibitor (PAI) in vitro while plasminogen activator (PA) activity is observed
intracellularly.
2. Normal pleural leukocytes produce tumour necrosis factor (TNF) and
interleukin-1 (IL-1) in vitro and the production is elevated by LPS stimulation.
3. Asbestos I/T provokes dramatic recruitment of alveolar inflammatory cells,
such as neutrophils and macrophages. In the pleural space, moderate macrophage
recruitment is found after a time-lag.
4. Asbestos I/T causes increased production of pleural leukocyte PAI, measured
in vitro in an asbestos dose- dependent fashion, whereas intracellular PA activity is
not altered.
5. Pleural leukocytes from rat intratracheally exposed to asbestos produce
decreased TNF activity in vitro. However, IL-1 production by pleural leukocytes is
decreased at earlier stages, then increased. There is an asbestos dose- related
decrease in cytokine activity.
6. Intratracheal asbestos along with other mineral dusts considerably increases
TNF release by pleural leukocytes in culture.
7. Pleural leukocytes from rats intratracheally exposed to asbestos cause
mesothelial cell detachment injury in vitro.
8. Normal pleural lavage fluid inhibits TNF and IL-1 activity. Pleural lavage
from rat long term after asbestos I/T stimulates proliferation of mesothelial cells.
9. A number of approaches were employed to try and detect asbestos fibres in
the pleural region after intratracheal instillation. There was no evidence to
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Figure D1 Diagram of the pleural response to intratracheal instillation of asbestos
M:- Macrophages; Ep:- alveolar epithelial cells; F:- fibroblasts; MC:- pleural
mesothelial cells; PF:- pleural fluid; E:- eosinophils and MaC:- mast cells. Solid




translocation of asbestos fibres to the pleural space, even during severe
inflammation both in the lung and the pleura and at long times post instillation.
10. Normal alveolar leukocytes produce TNF and IL-1 activity in vitro and LPS
enhances the production. In contrast to pleural leukocytes, asbestos I/T leads to
increased TNF production. With IL-1 there is first a decrease, then an increase in
IL-1 release by alveolar leukocytes.
11. Long fibre amosite asbestos and quartz exert greater activity in stimulating
alveolar macrophages to release TNF than short fibre amosite and TiO 2,
respectively.
12. Opsonization of asbestos and mineral dusts by immunoglobulin G markedly
increase their activity in stimulating TNF production by alveolar macrophages in
vitro.
13. C.parvum I/T induces inflammation in both bronchoalveolar and pleural
regions characterized by recruitment of neutrophils and macrophages. During the
pleural inflammation, pleural leukocytes release decreased TNF and IL-1 activity, a
transient increase of PAI activity and cause mesothelial cell detachment injury in
vitro.
In Figure D.l an attempt has been made to summarize, in diagrammatical
form, some key results from the present study. Asbestos-stimulated alveolar
macrophages may release diffusible mediator(s) which affect pleura macrophages,
in terms of monokine production. In addition, asbestos fibres might penetrate into
the pleural space and exert effects on pleural macrophages although we saw no
evidence of this. In response to stimulation from the alveolar space, pleural
leukocytes produce increased PAI and IL-1 as found in the present study. This
may result, finally, in deposition of fibrin, as well as proliferation of fibroblasts so
favouring fibrosis. As demonstrated in the present study, following deposition of
asbestos in the airspace, pleural macrophages release decreased TNF. This
phenomenon may result from an alteration in the level of inhibitor(s) in the
pleural fluid. A sustained decrease in TNF levels could increase the possibility of
tumour development. The interaction between different cell components in the
pleural space following intratracheal asbestos are not clear.
7.2. Suggestions for future research
Some suggestions for further work have arisen from the present study with
regard to the role of pleural leukocytes in asbestos-related diseases.
1. As a convenient means, intratracheal instillation is used throughout the study.
However, since this is non- physiological model of exposure, a better reflection of
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the events occurring after asbestos exposure would be gained from inhalation studies
and these should be used to confirm the present observations. In addition, it would
be very interesting to extend the time period to determine whether the pleural
inflammation caused by asbestos in the airspace resolves or decays on cessation of
exposure.
2. In view of present observations, the pleural space is an inhibitory
environment in many respects. Further study would be required to investigate and
characterize the inhibitors present in the pleural space and to examine their
alteration during asbestos exposure in the hope of elucidating asbestos-related
pleural pathological changes.
3. The present findings that there is no translocation of asbestos fibre from the
bronchoalveolar space to the pleural space should be further confirmed. The use of
radiolabelled asbestos fibre would be very useful in this context. In addition, which
messengers play a role in passing the inflammatory signal to the pleural space
needs to be clarified.
4. Although the present studies have shown that inflammatory pleural leukocytes
cause injury to pleural mesothelial cells, the relationship between the leukocytes and
mesothelial cells warrant further research.
5. The cellular basis of the synergism between asbestos and other mineral dusts
in causing pleural injury following deposition in the bronchoalveolar region needs to
be further confirmed and studied.
6. The modulation and interaction among different inflammatory mediators is
not clear at the present. Further work should investigate the relationship between
these mediators in the pleural space.
7. Immunoglobulin G (IgG) has been found to dramatically enhance the
stimulating ability of dust on cytokine production by alveolar macrophages. The
mechanism of such enhancement of dust activity by IgG requires further assessment.
8. In addition to the foregoing it is necessary to examine the full range of the
functions which pleural macrophages, mast cells and eosinophils perform during
asbestos-induced injury to the pleura. Oxidative metabolism, elaboration of other
members of the interleukin family, growth factors, integrins and other key
functional activities, need to be assessed to fully understand the role of the pleural
leukocytes in pleural pathology caused by asbestos and other fibres.
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